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SUMMARY
Although the metabolism o f  vitamin A in diabetes has been investigated by many early 
and recent workers the results are conflicting. Also, it has been observed that zinc 
plays an important role in vitamin A metabolism. This thesis describes a study o f 
vitamin A in two groups o f  diabetic patients with an additional study on experimental 
animals.
Study 1 deals with a case-control study that involve 110 patients with Type 2 diabetes 
mellitus (DM) matched in age and sex with 143 healthy controls. The study is designed 
to evaluate status o f vitamin A and related factors in patients with Type 2 DM.
After correction for the cholesterol and triglyceride levels, concentrations o f  serum 
retinol, a-carotene, a-tocopherol, zinc, copper and cholesterol were similar in diabetic 
patients Type 2 and control subjects. However, the mean serum g-carotene was 
significantly lower in diabetic patients than in control individuals (P <  0.003). When 
compared with controls, patients with Type 2 diabetes mellitus had significantly higher 
concentration o f  serum and urine retinol-binding protein (RBP) (both P < 0.0001). 
Urine concentrations o f zinc and serum concentrations o f  triglycerides were 
significantly higher in patients with Type 2 DM  than those in controls (P < 0.0002, P
< 0.0001, respectively). Urine concentrations o f  creatinine were significantly lower in 
patients with Type 2 DM  than those in controls (P < 0.0001). Furthermore, diabetic 
patients with nephropathy had significantly higher excretion o f RBP and significantly 
lower serum concentrations o f  zinc when compared to other diabetic or to controls. 
There was a significant negative correlation between FBG and g-carotene (r =  -0.18, P
< 0.05) in the total group.
Possible reasons for these differences are discussed. Food frequency consumption and 
24 h dietary recall for diabetic patients and controls were evaluated.
Study 2 deals with 175 diabetic patients with Type 1, Type 2, renal impairment, and 
chronic renal failure(CRF). Non-diabetic patient with CRF were matched in age and 
sex with the diabetic patients with CRF. This study attempts to examine the association 
o f Haemoglobin Aic with vitamin A and related factors and investigate further retinol, 
a-carotene, P-carotene, a-tocopherol and RBP in those patients.
Patients with Type 1 DM had significantly lower plasma concentrations o f  retinol, a -  
tocopherol and RBP when compared with patients with Type 2 DM, diabetic patients 
with renal impairment, diabetic and non-diabetic patients with CRF.
Diabetic patients with CRF or with renal impairment had significantly higher plasma 
concentrations o f retinol and p-carotene when compared to other groups (Type 1 and 
Type 2).
In the third study, the effect o f  supplementation with P-carotene on fasting blood 
glucose (FBG) and lipid levels was studied in streptozotocin-diabetic W istar male rats.. 
The incidence o f diabetes in the late supplemented diabetic group (which had received 
five weeks’ supplementation prior to STZ) was lower (59%, 10 o f 17) than in the early 
supplemented diabetic group (76%, 19 o f  25). However, the difference was not 
statistically significant (p = 0.135). Mean FBG, triglycerides, LDL-C and HDL-C were 
lower in both supplemented diabetic groups than controls. The results suggest that 
supplementation with the anti-oxidant pro-vitamin P-carotene may confer resistance to 
the development o f diabetes, resulting in improvement in both glucose and lipid levels.
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LITERATURE REVIEW
Chapter 1 1
1.1 Introduction
Alterations in vitamin A metabolism have been reported in several diseases; liver and 
intestinal diseases (Smith and Goodman, 1971; Vahlquist et. al., 1978; Janezewska et. 
al., 1991), kidney diseases(Smith and Goodman, 1971; Gerlach and Zile, 1990), 
thyroid malfunction (Smith and Goodman, 1971), protein-energy-malnutrition (Smith 
et. al., 1973a), and anorexia nervosa (Vaisman et. al., 1992).
Several studies evaluating vitamin A status in diabetic patients have provided 
inconsistent results (Murrill et al 1941; Mosenthal and Loughlin, 1944; Ramachandran, 
1973; Wako et al., 1986; Basu et al, 1989; Tuitoek et al., 1996). The occurrence o f 
hypercarotenemia’ has been reported (Ralli et al., 1936). It has been suggested that 
conversion o f  p-carotene to vitamin A is reduced (Ralli et al., 1936; Sobel et al., 1953; 
Tuitoek et al., 1996). Other studies failed to show any hypercarotenemia in diabetes 
mellitus and ruled out any impairment in the absorption or conversion o f  P-carotene to 
retinol in patients with Type 2 DM. (Kimble et al., 1946; Ramachandran, 1973).
M ore recently, an increase in plasma retinyl esters has been reported in Type 2 diabetic 
patients (Wako et al. 1986) and a decrease in serum concentration o f  retinol (Basu et 
al. 1989; Martinoli et al., 1993) and RBP in Type I diabetic patients (Basu et al., 
1989). Other investigators found that retinol concentrations were significantly 
decreased in Type 1 (Krempf et al., 1991) and increased in Type 2 diabetes mellitus as 
compared to control subjects ( Krempf et al., 1991; Havivi et al., 1991; Sasaki et al., 
1995).
Other nutrients may influence plasma vitamin A levels. Several investigators have 
observed that there is an interrelationship between zinc and vitamin A. Zinc and 
vitamin A display many areas o f  interaction. Zinc and vitamin A appear to interact at at 
least two levels; Zinc deficiency may impair synthesis o f retinol-binding protein; thus
* Hypercarotenemia: Total carotene in excess of 270 pg/dl (Mosenthal and Loughlin, 1944) or p- 
carotene in excess of 85 jxg/dl (Kaplan et al, 1987).
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diminishing the transport o f liver vitamin A to nonhepatic sites (Smith et al., 1973b; 
Atukorala et al, 1986). The other physiological site o f zinc- vitamin A interaction is in 
the retina o f the eye where the conversion o f retinol to retinal is mediated by 
metalloenzyme retinol dehydrogenase (Huber and Gershoff., 1975). Moreover, several 
studies have shown normal (Rosner and Gorfiens, 1968; Golik et al., 1993), decreased 
(Kumar and Rao, 1974; Walter et al., 1991) and increased serum zinc levels in diabetes 
mellitus (Mateo et al., 1975; Failla and Kiser., 1981).
Also, interaction between zinc and copper has been documented (Davies, 1980). 
Studies evaluating serum copper concentrations in diabetic patients yielded 
conflicting results (Pidduck et. al., 1970; Failla and Kiser, 1981; Lau and Failla, 1984; 
Raz and Havivi, 1989; Walter et. al., 1991). Several investigators have reported 
increased serum copper concentrations in diabetic patients (Failla and Kiser, 1981; 
Hagglof et al, 1983; Lau and Failla, 1984; Walter et. al., 1991). However, other 
studies found normal serum levels o f copper in diabetic individuals (Pidduck et. al., 
1970). Raz and Havivi (1989) found an increase in serum copper in Type 1 DM  and 
normal in Type 2 DM.
1.2 Vitamin A
Vitamin A is a term used for all compounds other than carotenoids that exhibit the 
biological activity o f  retinol, whereas the word retinoids is used to  describe both the 
natural and the synthetic forms o f retinol, with or without biological activity. Pre­
formed retinol is derived from animal sources; carotenoids are derived from plant 
foods and converted into retinol in the body. Vitamin A is required for a variety o f  
biological processes that include vision, reproduction, maintenance o f epithelial tissues, 
bone development and growth.
Vitamin A applies to retinol, retinaldehyde and retinoic acid which are the basic 
structure for the two natural forms o f vitamin A, retinol (A |)  and 3-dehydroretinol 
(A2 ) [Fig. 1.1]. Vitamin A] occurs as long-chain fatty acid esters in the liver o f 
mammals and salt water fish while the less biologically active form vitamin A2  is found 
in fresh water fish oils.
Chapter 1 3
1.2.1 Historical perspective
In 1913, McCollum and Davis reported that there was a lipid soluble substance 
essential for growth in rats (McCollum and Davis, 1913). They called this substance 
“Fat Soluble A”. Karrer and associates (1931) determined the structure o f retinol 
{Figure 1.2} using a highly purified vitamin A extract that was obtained from shark 
liver oil. Subsequently, Baxter and Robeson were able to obtain crystalline retinol from 
liver oils (Baxter and Robeson, 1940). The first industrial synthesis o f  retinoids was 
obtained in 1947 following Isler and associates’ work on synthetic retinoids (Isler et 
al., 1947). The relationship o f  vitamin A and P-carotene was demonstrated by Von 
Euler and M oore following a series o f  animal experiments (Von Euler et al., 1929; 
Moore, 1930). The structure o f  p-carotene is shown in Figure 1.2. At a much later 
date, Goodman and Olson determined the mechanism o f the conversion o f p-carotene 
to retinaldehyde (Goodman and Olson, 1969).
1.2.2 Nomenclature chemistry and sources
The retinol molecule consists o f  a hydrocarbon chain with a-ionone ring at one end 
and an alcohol group at the other [Fig. 1.2]. The alcohol group can be oxidised in the 
body to an aldehyde, retinal and to retinoic acid.
Retinol is a plain yellow compound insoluble in water but soluble in fat and organic 
solvents, sensitive to light and oxygen. In animal products, such as milk, butter, egg 
yolk, liver, fatty fish, vitamin A exists as long-chain fatty acid esters o f  retinol (retinyl 
esters). Carotenoids present in vegetables and fruits can be converted to  vitamin A in 
the body and therefore described as a provitamin A. It is estimated that 50-60 
carotenoids may have provitamin A activity. Only a few o f these carotenoids occur in 
significant amounts in edible foods (Bauernfeind, 1972). The most predominant form is 
P-carotene. The a-carotenoids and cryptoxanthin have one half the activity o f  P- 
carotene (Underwood, 1984).
Chapter 1
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1.2.3 Functions
Vitamin A is essential for growth, reproduction, vision and the regulation o f 
differentiation and proliferation o f  various cell types. These different functions are 
mediated by different forms o f  the vitamin. In vision, the functional molecule is retinal 
while in reproductive processes, growth and differentiation, the active forms may be 
retinol and retinoic acid respectively.
Vision
Retinal is required as a component o f the visual pigment, rhodopsin, o f the rod cells in 
the retina. When rhodopsin is exposed to  light, it dissociates and forms all-trans-retinal 
and opsin. The all-trans-retinal generated from rhodopsin is converted back to the 11- 
cis-retinal with some loss. Thus, in order to generate rhodopsin for vision, a constant 
supply o f all trans-retinal is required (Wald and Hubbard, 1950). The biosynthesis o f 
1 1 -cis-retinol requires two enzymes; lecithin retinol acyltransferase which is involved in 
esterfication o f all-trans-retinol, and an isomerase-like enzyme which converts all-trans 
retinyl esters into 11-cis-retinol (Canada et al., 1990).
Growth, differentiation and proliferation
It is possible that retinoic acid is required for some biological reactions necessary for 
growth (Futterman, 1962). Zile and De Luca (1968) reported a growth promoting 
effect when retinoic acid was administered to retinol-deficient rats. Rogers (1969) 
examined some biological systems that have been observed to be depressed in vitamin 
A deficiency [sulphate activation, synthesis o f  adrenal steroids and synthesis o f  
ascorbic acid]. His findings suggest that these effects might be due to inanition rather 
than deficiency o f vitamin A. Takahashi examined the effects o f mild vitamin A 
deficiency and ozone (O3 ) exposure on cell proliferation o f epithelial cells in the 
alveolus o f rats. The results indicated the involvement o f vitamin A in the maintenance 
o f  lung epithelial cells (Takahashi, 1993).
Many studies have shown that retinoids play a role in controlling proliferation and 
differentiation. They suppress abnormal cellular differentiation and stimulate cell
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growth when it is normal (Lotan and Nicolson, 1977; Blomhoff et al., 1992; 
W oodward et al., 1996). The appearance o f malignant tumours in animals exposed to 
carcinogens can be delayed or suppressed (Cohen et. al., 1976). The effects o f 
retinoids may be due to the antioxidant activity (Hiramatsu and Packer, 1990).
Reproduction
Retinol, but not retinoic acid is necessary for normal pregnancy. Retinoic acid 
maintained the early but not the later stages o f  pregnancy (Thompson et. al., 1964; 
Wellik and De Luca, 1995). Foetal development is maintained by feeding retinol or P- 
carotene in small amounts, but below a critical level, teratogenic effects occur mostly 
in ocular and urogential tissue (O ’ Toole et al., 1974). It was demonstrated that 
vitamin A transport is high early in pregnancy in the conceptus but declines by 
midgestation, the period just before the rapid differentiation (Takahashi, 1977).
1.2.4 Metabolism
Absorbed retinyl esters are hydrolysed into retinol at the luminal surface o f  the 
intestine, then the free retinol is re-esterfied before entering the lymphatic system in 
chylomicrons and transported to the liver. Retinol can either be stored in the liver or 
be secreted into plasma bound to retinol binding protein (RBP). Retinol is taken up by 
target tissues, probably by cell-surface receptors for RBP. Retinol can recycle back to 
the liver, and it can also recycle back to the plasma from extra hepatic tissues.
Absorption
In the intestine, retinyl esters are hydrolysed to retinol by a pancreatic non-specific 
lipase called cholesterol esterase (Lombardo et al., 1980). Rigtrup and Ong (1992) 
demonstrated the presence o f retinyl ester hydrolase (REH) activity associated with 
brush border membrane o f intestine that might be involved in hydrolysis o f  retinyl 
esters. Bile salts are required both for the activation o f  this enzyme and for the 
formation o f a micelle suitable for absorption. The resulting retinol is absorbed into the 
enterocytes (intestinal cells) by a protein carrier-mediated process when retinol is
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present in physiological amounts and by passive diffusion when it is present in 
pharmacological amounts (Hollander, 1981). Absorption o f retinol is 75% efficient 
and dependent on the availability o f fat (Blomhoff, et al., 1991). Bardos, (1996) 
reported that absorption o f retinol is an enzyme dependent and/or carrier mediated 
process even when given in pharmacological doses. The administration o f radiolabeled 
retinol resulted in highest levels in the liver, followed by the kidney, duodenum, colon 
and lung, while g-carotene administration showed highest accumulation in the lung 
(Schweigert et al., 1995).
Absorption o f  carotene is by passive diffusion and is dependent on the presence o f  fat. 
In humans, one-sixth o f the dietary P-carotene and one-twelfth o f other carotenoids 
are absorbed (Blomhoff, et. al., 1991). In the mucosal cell, P-carotene is cleaved to 
retinaldehyde at the central double bond. This reaction is catalysed by P-carotene 15; 
15-dioxygenase and requires molecular oxygen that reacts with the two central carbon 
atoms o f P-carotene to yield two molecules o f retinaldehyde (Goodman and Huang, 
1965; Lakshman et. al., 1989; Olson and Lakshman, 1990). Conversion o f  p-carotene 
to retinal, in large part, is by central cleavage rather than random cleavage (Nagao et 
al., 1996). Cleavage activity is higher in vitamin A-deficient rats than in rats with a high 
intake o f either vitamin A or P-carotene (Van-Vliet et al., 1995). Conversion o f  p- 
carotene to retinal occur in enterocyte 57% and liver 43% (Novotny et al., 1995). The 
retinaldehyde is reduced to retinol by retinal reductase and reesterfied with long chain 
fatty acids (Goodman et. al., 1967). Within intestinal cells, about 53-60% o f  the retinol 
is esterfied with palmitate and 19-27% with stearate and the remainder with oleate and 
linoleate. Over 80% o f the absorbed vitamin is recovered as retinyl esters and a small 
amount o f the vitamin is absorbed directly into the portal system. The retinyl esters are 
incorporated into chylomicron particles together with other lipids and transported via 
the lymphatics into the general circulation (Goodman et. al., 1966; Blomhoff et. al., 
1982). A small amount o f retinol is oxidised first to retinal and then to  retinoic acid 
(Fidge and Goodman, 1968), which may form a glucuronide and be excreted into the 
portal blood (Lippel and Olson, 1968). In the circulation, triglycerides are removed by 
lipoprotein lipase whereas the retinyl esters remain attached to  the resulting 
chylomicron particles (Goodman and Blaner, 1984).
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Storage
About 90% o f body stores o f vitamin A are found in the liver (Raica, et al., 1972). 
The remainder being present in bone marrow, spleen, adipose tissue, skeletal muscle, 
testes, lungs and kidneys (Goodman et a l , 1965; Blomhoff et a l , 1982; Hussain et a l , 
1989). The range o f vitamin A concentration in adult human liver is 100-300 pg/g wet 
tissue (Pearson, 1967).
Retinyl esters in chylomicron remnants are removed from the circulation by liver 
parenchymal cells, probably via a low-density lipoprotein receptor related protein 
(Goodman et. a l , 1965; Blomhoff et. a l , 1982). Some retinyl esters in the 
chylomicrons are taken up by blood cells and bone marrow (Hussain et. a l ,  1989), and 
the majority o f  retinyl esters are hydrolysed before they leave the parenchymal cells 
(Blaner et a l , 1987; Blomhoff et a l , 1988). Retinol is reesterfied and stored in stellate 
cells (Lawrence et. a l ,  1966). It has been demonstrated that parenchymal cells 
synthesise and secrete RBP (Goodman, 1984). Blomhoff et a l , have speculated that 
retinol may combine with RBP to be transferred from parenchymal cells to stellate cells 
for storage in association with lipid droplets (Blomhoff et a l , 1985; Blomhoff et a l , 
1991).
Lipid droplets in stellate cells have large capacity to  store retinol (Blaner et. a l ,  1985). 
About 80-90% o f the total retinol in liver o f  the rat was present in the stellate cells; 
and 98% o f the total retinol in stellate cells was in the form o f retinyl ester (Blomhoff 
et a l , 1985). Seventy-five percent o f  the administered retinyl esters were recovered in 
liver parenchymal cells 30 minutes after injection, after 2-4 hours redistribution occurs 
and stellate cells contain 60-80% o f the total retinyl ester (Blomhoff et a l ,  1982). The 
transfer o f newly absorbed retinol from parenchymal cells to stellate cells is influenced 
by the animal’s vitamin A status (Blomhoff et a l , 1982). Retinol enters the stellate 
cells when the intake o f  the vitamin is high. From these liver stores, vitamin A is 
mobilised as the free alcohol, retinol, bound to a specific plasma transport protein, 
retinol-binding protein (RBP).
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Mobilisation
Vitamin A is transported from its stores in the liver to target tissues by RBP. RBP is 
synthesised and secreted by the liver bound to a molecule o f  retinol. The isolation o f 
RBP was first reported by Kanai et al. (1968), and its primary sequence was reported 
by Rask et al. ( 1981). RBP is a single polypeptide chain with a molecular weight o f 
about 21,000 (Raz et al., 1970; Peterson, 1971a ), and has one binding site for one 
molecule o f retinol. In blood, most o f  the RBP circulates as a 1:1 complex with 
thyroxin binding prealbumin [transthyretin] (TTR). Interaction with TTR stabilises the 
RBP-retinol complex (Peterson, 1971a). TTR is a stable protein, produced by the liver, 
and composed o f four identical sub units with a molecular weight o f  about 55,000 
(Kanda et al., 1974). Human TTR may contain four binding sites for RBP (Van 
Jaarsveld et al., 1973). This complex formation (RBP-TTR) prevents the excretion o f  
the small RBP molecule through the kidney glomeruli (Peterson and Berggard, 1971). 
Together as a complex, they carry about 90% o f serum retinol, lipoproteins carry the 
remainder as retinyl esters (Goodman, 1974; Peterson et al., 1974).
After delivery o f vitamin A to the target cells, the RBP complex looses its affinity for 
TTR (Smith and Goodman, 1979). Due to its small size, the free RBP molecule is 
filtered through the kidney glomeruli, reabsorbed by the proximal tubuli cells and 
degraded (Goodman 1984). The plasma concentration o f free RBP is very low 
(Peterson, 1971b) except in patients with renal disease (Smith and Goodman, 1971; 
Vahlquist et al., 1978). Serum levels o f RBP range between 40-60 mg/1 (Smith and 
Goodman, 1971), and are lower in young children than in adults (Vahlquist et al., 
1975). A significant sex difference was reported (Smith and Goodman, 1971). The 
plasma levels o f RBP were slightly higher in men than in women. Normal ranges in 
serum for retinol, a -, and p-carotene have been reported as 34-74, 1.8-19.5, and 10- 
60 pg/dl respectively (Kaplan et al, 1987).
An excessive intake o f vitamin A causes the degradation o f myelin mainly in the sheath 
o f  nerve axons. This degradation appears to be due to the surface-active effects o f  
retinol (Roels et al., 1969) when it begins to  circulate in plasma, and to be presented to 
membranes, unbound to  RBP, as retinyl esters associated with lipoproteins. Since
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retinol bound to RBP is biologically inert, these retinyl esters may be responsible for 
some o f the toxic effects that have been observed (Mallia et al., 1975; Smith and 
Goodman, 1976).
RBP delivers retinol to specific cell surface sites (Fig. 1.3) that recognise RBP and 
release retinol at these locations (Heller and Bok, 1976). Retinol after passing through 
the plasma membrane binds to specific cellular retinol-binding protein (CRBP) (Bashor 
et. al., 1973). This protein binds only to retinol and not to retinal or retinoic acid; 
another protein which binds to retinoic acid with high specificity has been discovered 
in the rat (Ong and Chytil, 1975) and is called cellular retinoic acid-binding protein 
(CRABP). Retinoic acid appears to be able to substitute for retinol in some tissues, 
but not in visual or reproductive tissues (Sundaresan, 1972). These cellular proteins 
appear to function locally to  transport retinoids (Blomhoff et al., 1992).
It has been suggested that retinol may be recycled to the blood (Vahlquist and 
Peterson, 1972). This idea was confirmed by other investigators (Green, et al., 1987; 
Lewis et al., 1990). In the rat, retinol molecules are recycled to the plasma 7-13 times 
before irreversible utilisation (Lewis et al., 1990). Catabolism o f retinol may involve 
retinoic acid as an intermediate. Retinoic acid is a terminal product that cannot be 
converted back to retinal or retinol. Retinoic acid forms a glucuronide in the liver and 
these glucuronides are excreted into the bile. Retinol may be oxidised to  4-hydroxy 
retinol and 4-oxo-retinol (Leo and Lieber, 1985), or may conjugate to  form a p- 
glucuronide which is excreted in the urine.
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1.2.5 Metabolic interaction of vitamin A and Zinc
Studies on zinc deficient animals indicate that zinc might be an important factor in the 
regulation and maintenance o f plasma vitamin A levels (Solomons and Russel, 1980; 
Smith, 1982). Smith and associates (1973b), using rats, demonstrated that a zinc 
deficient diet with a normal vitamin A content caused a decline in plasma vitamin A 
with no change in vitamin A concentration in the liver. Vitamin A supplementation 
increased the hepatic concentration o f the vitamin without causing much increase in 
plasma concentration. However, supplementation o f  both zinc and vitamin A cause an 
increase in plasma vitamin A (Smith et al., 1973b). They postulated that zinc was 
needed to mobilise vitamin A from the liver and maintain its level in plasma, with their 
recognition that food intake and growth might be involved (Smith et al., 1973b). 
Subsequent experiments by the same group showed that RBP concentration were 
decreased both in plasma and liver o f zinc-deficient rats (Smith et al., 1974). This 
result indicated that zinc is involved in the synthesis o f RBP rather than its mobilisation 
from the liver. However, their data suggest that food restriction, although adequate in 
vitamin A and zinc, decrease plasma vitamin A and zinc levels (Smith et al., 1974). 
Moreover, hepatic cellular RBP was reduced by more than 50% in the liver o f  zinc- 
deficient rats as compared to that o f  control animals (Mobarhan et al., 1992), which 
indicated, in their opinion, that zinc may be an essential element for intra-cellular 
transport o f vitamin A. Shingwekar et al.(1979) reported that zinc supplementation 
resulted in an increase in plasma zinc levels in all children, while a significant increase 
in plasma vitamin A and RBP levels was noted in children with protein energy 
malnutrition (PEM )but not in those with vitamin A deficiency. The authors recognised 
that the degree o f  zinc deficiency was more severe in the PEM  children than in the 
vitamin A-deficient children. They attributed this rise in vitamin A and RBP to  zinc 
supplementation since there was no protein or vitamin A supplementation. However, 
plasma vitamin A and RBP had not reached normal levels following zinc 
supplementation. Furthermore, Duncan and Hurley reported that, in pregnant rats, 
deficiency o f both zinc and vitamin A was seen in maternal and foetal circulation as a 
result o f zinc deficiency, and that the proportion o f malformed foetus was dependent
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on intake o f both zinc and vitamin A. Their conclusion was that the hepatic vitamin A 
mobilisation was impaired due to  zinc deficiency (Duncan and Hurely, 1978). 
However, since weight gain and growth differences were not controlled, the effect o f 
zinc may be secondary to restricted growth (Smith, 1982). In contrast, Carney et al. 
(1976) have found, using rats, that zinc deficient diets caused decreased plasma zinc 
and vitamin A levels and growth retardation. However, they concluded that zinc 
deficiency did not interfere with hepatic mobilisation o f  vitamin A or urinary excretion 
o f its metabolites except as it affects growth and body demand for the vitamin. 
Sundaresan et al (1977) reported that plasma vitamin A levels o f the zinc-deficient rats 
were significantly lower than those o f rats fed zinc - sufficient diet ad libitunn. 
However, the plasma vitamin A concentrations o f the zinc-deficient group were not 
different from the zinc-sufficient pair-fed control group which indicated that growth 
restriction alone would result in a significant decrease in plasma vitamin A. Thus, 
adequate food intake as well as zinc appears necessary to reverse low plasma vitamin 
A levels in zinc-deficient rats (Brown et al., 1976). Hambidge et al., (1976) observed 
that a substantial percentage o f  children who have low growth percentiles also have 
low serum vitamin A and zinc levels. However, there was no significant correlation 
between height percentiles and plasma zinc or vitamin A levels. On the other hand, 
Peters and associates (1986) observed that high vitamin A intake could not overcome 
the effects o f  zinc deficiency on vitamin A metabolism, in rats during pregnancy.
Another area o f zinc-vitamin A interaction is at the oxidation/reduction o f  retinol in 
peripheral tissues. The enzymatic conversion o f retinol and retinal was first reported in 
1950 (Wald and Hubbard, 1950). Liver alcohol dehydrogenase oxidises a variety o f  
alcohols including vitamin A (Zachman and Olson, 1961). This oxidation is necessary 
for the conversion o f  retinol to retinal which functions as part o f the visual pigments o f 
the eye. Since alcohol dehydrogenase is a metalloenzyme (Vallee and Hoch, 1957), it 
would be expected that zinc deficiency may affect vitamin A metabolism in the retina. 
Huber and Gershoff reported that zinc-deficiency in rats did not alter the oxidation o f  
either retinol or ethanol by the liver. However, zinc-deficiency resulted in a significant 
reduction o f  alcohol dehydrogenase activity in the retina (Huber and Gershoff, 1975). 
They concluded that the retina was more sensitive to lack o f dietary zinc than the liver.
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However, young rats, bom to zinc-deficient females, showed the most severe changes 
in both liver and retina (Huber and Gershoff, 1975). Activities o f  alcohol 
dehydrogenase (ADH) and retinal oxidase (RO) enzymes that regulate the conversion 
o f retinol to retinal, were examined. The activity o f ADH was not altered in the liver in 
one study (Sundaresan et al., 1977), and significantly reduced in another (Boron et al., 
1988) in zinc deficiency. However, RO activity was significantly increased in the liver 
in both studies (Sundaresan et al., 1977; Boron et al., 1988). On the other hand, both 
ADH and retinal oxidase in the testes were decreased during zinc deficiency 
(Sundaresan et al., 1977). Boron et al (1988) examined the effect o f  zinc deficiency on 
the activities o f  acyl coenzyme A: retinol acyltransferase (ARAT) and retinyl ester 
hydrolase (REH); two enzymes that regulate the storage o f  retinol as retinyl esters and 
found that REH and ARAT enzymes were not affected by zinc deficiency.
1.3 Diabetes mellitus
Diabetes mellitus is a universal health problem affecting at least 40 million people 
throughout the world and the prevalence rate is increasing with the ageing population, 
urbanisation and changes in life style. Estimates o f the prevalence o f  diabetes mellitus 
in Western Europe and United States generally range between 1 and 6 % (Laakso et al., 
1991, Harris, 1991).
The disease is chronic and leads to abnormalities o f carbohydrate, protein, and lipid 
metabolism. It is a significant cause o f death and a major cause o f  disability, blindness, 
coronary artery disease and renal failure.
Diabetes mellitus has emerged as a major public health problem in Saudi Arabia as the 
country acquires more and more a life-style close to those characteristic o f
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urbanisation. It is possible that the “thrifty geno-type”  ^ phenomenon seen in other 
populations (Zimmet et al., 1990) is behind the emerging problem in the area. 
Interactions between genetics and environment, including sedentary life style, increased 
supply o f refined carbohydrates leading to obesity, hyperinsulinaemia and eventually to 
DM (Neel, 1962). However, Kingston, et al. (1982) reported their observation o f  222 
consecutive patients at diabetic clinic o f King Fiasal Specialist Hospital and noted that 
many patients (98% Type 2) were not overweight, had severe hyperglycaemia but 
rarely developed ketoacidosis. Although microvascular complications were common, 
coronary artery, retinopathy, proteinuria and peripheral vascular diseases were less 
common than in the West. Saudi diabetics were found to have higher renal thresholds 
for glucose than the American and European populations (Bell and Chang, 1982). 
Seventy-five per cent o f the women and 62% o f the men did not have glycosuria when 
their serum glucose levels were between 220 and 259 mg/100ml (Bell and Chang, 
1982).
1.3.1 Definition
It has been established that diabetes mellitus is not a single disease. It is a genetically 
and clinically heterogeneous group o f disorders that share glucose intolerance in 
common (National Diabetic Data Group (NDDG), 1984). The underlying pathogenetic 
mechanism o f Type 1 and Type 2 diabetes is different. Type 1 diabetes is due to  insulin 
deficiency resulting from loss o f p-cells. In contrast, insulin secretion is essentially 
normal (or even increased) in Type 2 diabetes, but there is peripheral resistance to  the 
action o f insulin particularly in terms o f insulin-mediated glucose uptake by skeletal 
muscle.
 ^ The hypothesis suggest that people who possessed the thrifty gene store energy with maximum 
efficiency at times of famine, but the thrifty geno-type becomes disadv antageous at times of abundance 
(Neel, 1962)
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1.3.2 Classification and diagnosis
A- Type 1 insulin dependent diabetes mellitus (IDDM) [formerly juvenile 
diabetes]
Type 1 is usually characterised clinically by abrupt onset o f  symptoms, lack o f  insulin, 
ketosis-prone and depends on injected insulin to  sustain life (NDDG, 1984). Usually it 
appears before the age o f  30 years. The major clinical features o f  Type 1 diabetes are 
polyuria, polydypsia, and weight loss. However, it can be recognised for the first time 
at any age. Approximately 10% o f all people diagnosed with diabetes have this type. 
(American Diabetes Association (ADA), 1992).
B. Type 2 - non-insulin dependent diabetes mellitus (NIDDM) [formerly 
maturity onset diabetes]
Found primarily in adults > 3 0  years. Patients are frequently asymptomatic but on direct 
questioning will usually give a history o f thirst and polyuria. The majority o f  Type 2 
patients are overweight. Other non-specific features include tiredness, lethargy and 
infection (particularly candidiasis in women). Patients with Type 2 are not dependent on 
insulin for prevention o f ketonuria and are not prone to ketosis. However, they may 
require insulin for correction o f symptoms or persistent, fasting hyperglycaemia. There 
may be normal levels o f  insulin, mild insulinopenia or above normal levels o f  insulin 
associated with insulin resistance (WHO, 1985). Type 2 has been subdivided according 
to the absence or presence o f  obesity.
C. Impaired glucose tolerance (IGT)
This is primarily a biochemical diagnosis. The tolerance to glucose is intermediate 
between normal and overt diabetes. The patient may develop diabetes ((NDDG, 1984) 
improve toward normal or remain unchanged.
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D. Gestational diabetes meiiitus (GDM)
GDM is a disorder with onset during pregnancy. It is estimated to  occur in ~ 3% o f 
the pregnancies and usually disappears after delivery (ADA, 1992). However, women 
diagnosed with GDM are at increased risk for developing diabetes later. GDM is 
usually mild. However, hyperglycemia is associated with increased foetal morbidity.
Table 1.1 Diagnosis o f different types o f diabetes mellitus (WHO, 1985)
Type 1 Type 2 IGT GDM
Random plasma glucose (mmol/1) > 1 1 . 1 > 1 1 . 1 ---
Fasting plasma glucose on two 
occasions (mmol/1)
> 7 .8 > 7 .8 6.4 - 7.8 > 5 .8
Two h after 75 g OGTT* with two 
hour value and one intervening 
value (mmol/1)
> 1 1 . 1 > 1 1 . 1 7.8-11.1 > 9 .2
*OGTT = Oral glucose tolerance test
1.3.3 Epidemiology
Epidemiological studies o f  diabetes are difficult to compare because different 
diagnostic methods are often employed. Even allowing for differences in methodology 
and diagnostic criteria, there are marked differences in the prevalence o f  diabetes 
between countries and populations.
In traditional societies, the incidence o f  diabetes mellitus is low (<3%) (Imperato et al., 
1978; Ben Khalifa et al., 1982). As these societies adopt Western life style, the picture 
changes. Diabetes mellitus prevalence rate was high in Mexican Americans (13%) with 
similar rate (13.4%) in Puerto Ricans, 9% in Cubans, 6 % in U.S whites (Harris, 1991) 
and 14% in Fiji Indians (Zimmet, 1982). The highest prevalence rate reported, 35%, is 
in the American Pima Indians (Bennet et al., 1976; Knowler, 1978). It reaches 50%
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among these over 35 years old. Prevalence rates are also quite high in a number o f 
other populations. These include Pacific islands inhabitants o f Nauru (30%) (Zimmet 
et al., 1982), Papua Guinea (22%) (Martin et. al., 1980) and Fiji Indians (14%) 
(Zimmet, 1982).
Low prevalence rates were reported in Tunisia (2.4 and 1.5% in urban and rural 
populations, respectively, Ben Khalifa et al., 1982), in Mali (1.4%, Imperato et al., 
1978), in Minnesota (1.6%, Palumbo et al., 1976), in India (2%, Gupta et al., 1978) 
and in Finland (2.6 - 3%, Laakso et al., 1991). Prevalence rates in Britain have been 
reported to be 1 .6 % (Reid et al., 1974; Fleming, 1994), 3.4 and 2.6% for men and 
women, respectively (Yudkin et. al., 1993).
Diabetes mellitus is a disease perceived to be rising in incidence in Saudi Arabia as a 
consequence o f  the sudden affluence, sedentary life-style and rapid socio-economic 
development which have taken place over the last three decades. I f  the current trend o f  
NIDDM continues to rise, NIDDM  could soon emerge as a serious health care 
problem in Saudi Arabia.
NIDDM occurs in all parts o f Saudi Arabia. However, the prevalence varies greatly in 
different parts o f  the country (1.86 in Najran to 7.24 in Medina) (El Hazmi et al., 
1995). In the mountainous Southern province, the prevalence tends to be low probably 
because o f the active peasant life. In the coastal part o f the Southern region, the low 
prevalence could be due to an African influence. A prevalence rate o f  1 .8 6 % was 
found in Najran (El Hazmi et al., 1995) and 4.6% in Semi-rural communities (Abu Zeid 
and Al-Kssab, 1992). In the Central province where the inhabitants are mostly one 
homogeneous ethnic group, the DM  prevalence rate is moderate. A prevalence o f 
2.55% was found in the A1 Kharj region. However, in males over 35 years o f  age, the 
prevalence was 6.5% (Bacchus et al., 1982). The prevalence in Riyadh area was 6.4% 
with higher prevalence in women (7.8%) than men (4.7%) (El Hazmi et al., 1995). In 
the Western region where the holy cities (Mecca and Medina) are situated, DM 
prevalence rate is high possibly due to  the different ethnic background o f  the 
inhabitants (Turkish, Russian, Moroccan, Indonesian, Pakistani, Indian and other parts 
o f the Islamic world). A prevalence rate o f 4.3% was found in rural population in the
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Western region o f Saudi Arabia (Fatani et al., 1987) and 7.24% in Medina (El Hazmi 
et al., 1995). A frequency o f  fasting, hyperglycemia ranged from 2.4 - 16.5% in 
different parts o f Saudi Arabia (El Hazmi and Warsy, 1989). In a more recent 
comprehensive study in different regions o f Saudi Arabia, the overall prevalence o f 
Type 1, Type 2 and IGT in the total population (2-70 years) was 0.127%, 4.99% and 
0.7%, respectively (El Hazmi et al., 1996). In the age group > 30 years, a higher 
prevalence was observed. The prevalence o f Type 1, Type 2 and IGT in men was
0.177%, 17.3%, and 1.3%, respectively, while in women it was 0.18%, 12.18%, and 
2.2%, respectively (El Hazmi et al., 1996).
The marked variation in the prevalence rate o f DM  in different regions o f Saudi Arabia 
could be due in part to genetic and ethnic differences. Genetics play an important role 
in the aetiology o f  both Type 1 and Type 2 DM and a strong familial tendency o f the 
disease has been reported (Zimmet, 1995). The high rate o f consanguinity may account 
for the increased prevalence o f DM  in some regions. In addition, environmental 
factors, dietary habits and the degree o f physical activity may contribute to the regional 
differences in the prevalence o f DM in Saudi Arabia. Urban Saudis are eating more 
foods rich in refined carbohydrates and fats, and leading sedentary lives. High-fat and 
high refined carbohydrate diets have been implicated in the aetiology o f  insulin 
resistance and glucose intolerance (Strolien et. al., 1996; Faure et. al., 1997). This 
effect may be due to obesity in response to habitual consumption o f a high-fat diet 
(Dreon et. al., 1988). NIDDM is strongly associated with obesity and a central 
distribution o f body fat and these factors are associated with decreased insulin 
sensitivity (Haffmer et. al., 1990). Considerable data suggested that both insulin 
resistance and hyperinsulinaemia are strong predictors o f  the development o f  NIDDM  
(Lillioja et. al., 1993; Sicree et. al., 1987). A number o f  studies have shown that 
hypertension, dyslipidaemia (reduced HDL-C and hypertriglyceridaemia), obesity, 
NIDDM and atherosclerotic cardiovascular disease are associated with 
hyperinsulinaemia and insulin resistance (De Fronzo and Ferrannini, 1991). This 
cluster has been referred to as the insulin resistance syndrome or ‘syndrome 
X ’(Reaven, 1988).
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1.3.4 Carbohydrate, protein and iipid metabolism in diabetes
People with diabetes have an increased risk for developing cardiovascular disease. 
Chronic hyperglycaemia may be a major risk factor for complications in diabetes 
(Diabetes Control and Complications Trial Research Group, 1993). These 
complications may be attributed to altered cellular metabolism that might lead to 
irreversible damage (Brownlee et. al., 1984). Elevated levels o f glucose in the medium 
or blood were reported to cause membrane damage and cell death o f  endothelial cells, 
retinal cells and red blood cells (Jones and Peterson, 1981; Mandel et. al., 1983; Li et. 
al., 1984; Cagliero et. al., 1988). It has been postulated that nonenzymatic glycoslation 
o f certain proteins resulted in cross-linking which may contribute to the loss o f 
elasticity characteristic o f cells exposed to hyperglycaemia (Cerami et. al., 1979).
Proteins react with glucose to form a Schiff bases and Amadori products. These 
products lead to the formation o f irreversible advanced glycation end products ( AGEs) 
(Bayness, 1991; Ruderman et. al., 1992). These AGEs accumulate in tissues, vessel 
wall and plasma and they are associated with pathogenesis o f diabetic complications 
(Ruderman et. al., 1992). AGEs altered cellular function through binding to  specific 
cell surface receptor for AGE (Schmidt et. al., 1996).
Premature onset o f atherosclerosis is a characteristic feature o f diabetes (Kannel and 
Larson, 1993). The earliest recognized lesion in atherogensis is the fatty streak, 
characterised by an accumulation o f  cells loaded with cholesteryl esters (foam cells) 
just beneath the endothelium (Smith et. al., 1977; Rosenfeld, 1987).
LDL was reported to be the source o f accumulating intracellular lipids, and LDL 
needs to be altered chemically in some way to  cause atherogenic effect (Haberland and 
Fogelman, 1987; Sobenin et. al., 1996). Several types o f  modified lipoproteins have 
been detected in diabetic patients including glycosylated LDL, oxidised LDL and 
glycoxidised LDL (Witztum et al, 1984; Virella et al, 1993). These products may be 
significant contributors to  the complications o f diabetes (Baynes, 1991).
Oxidation confers several properties on LDL, which render the particle atherogenic. 
An excess o f these molecules in the vascular system may induce endothelial cell
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dysfunction, such as vascular permeability, abnormal coagulation and cell lysis (Lewis 
et al, 1988; Zweier et al, 1988). Oxidised LDL induces the transformation o f 
macrophages into foam cells and may have prothrombotic and vasoconstrictor effect 
(Witztum, 1993). Several investigators demonstrated increased susceptibility o f LDL 
to oxidation in diabetic patients with poor glycaemic control (Asayama et al, 1993; 
Tsai et al, 1994). It was suggested that reciprocal protective effects between vitamin A 
and vitamin E may strongly contribute to the defence o f  membranes and lipoproteins 
against oxidative stress (Tesoriere et al., 1995; Subirade et al., 1996).
1.3.5 Vitamin A metabolism in diabetes
Several researchers have investigated the metabolism o f  the carotenoids and vitamin A 
in diabetes mellitus, but the results have been conflicting. It has been reported that 
individuals with diabetes mellitus Type I have higher blood concentrations o f carotene 
(Murrill et al, 1941 ; Mosenthal and Loughlin,1944) and lower concentrations o f vitamin 
A (Mosenthal and Loughlin, 1944) than normal subjects. It was postulated that in 
diabetes mellitus the conversion o f carotene to vitamin A was reduced both in human 
diabetics (Ralli et al., 1936) and in Alloxan diabetic rats ( Sobel et al., 1953). However, 
this suggestion was not supported by the finding o f a high vitamin A content in the 
livers o f deceased diabetic patients (Moore, 1937). It was noted that the presence o f  
hyper-carotenaemia in diabetic patients was associated with fatty infiltration o f  the liver 
(Mosenthal and Loughlin, 1944), high cholesterol levels in the blood (Mosenthal and 
Loughlin, 1944; Rabinowitch, 1930), severe diabetes and a poor prognosis 
(Rabinowitch, 1930), which indicated, in their opinion, that the disturbance in fat 
metabolism in diabetes mellitus has resulted in accumulation o f carotene in the blood. 
Ahmed (1931) shared the same line o f thought as the solubility o f  carotene in fat and 
the direct relationship o f  carotene absorption to that o f  fat support the concept that an 
excess o f carotene might be a result o f an excess o f  fat. However, several studies 
have reported that serum concentrations o f carotene (Kimble et al., 1946; 
Ramachandran, 1973) and vitamin A (Mosenthal and Loughlin, 1944; Kimble et al.,
1946; Ramachandran, 1973) in diabetes mellitus o f  both types were within the normal
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range^. M ore recently, an increase in plasma retinyl esters has been reported in Type 2 
diabetic patients (Wako et al. 1986) and a decrease in serum concentration o f retinol 
(Basu et al. 1989; Martinoli et al., 1993) and RBP in Type I diabetic patients (Basu et 
al., 1989). The mean retinol/RBP ratios in serum o f patients with diabetes Type 2 were 
higher than those o f the control subjects (Sasaki et al., 1995). Other investigators 
found that retinol concentrations were significantly decreased in Type 1 (Krempf et al.,
1991) and increased in Type 2 diabetes mellitus as compared to control subjects 
(Krempf et al , 1991; Havivi et al., 1991; Sasaki et al., 1995). In another study, no 
significant differences were found in vitamins A, E and carotene between neuropathic 
Type 2 patients and controls (Straub et al., 1993). Tuitoek and associates (1996) 
reported significantly lower plasma concentrations o f retinol in streptozotocin (STZ) - 
diabetic Wistar rats and indicated that the decrease in plasma retinol concentrations 
was a response to diabetes since a significantly lower plasma retinol concentrations 
was also found in pair-feeding and in vitamin A supplemented diabetic rats. Moreover, 
11-cis retinal (a component o f  rhodopsin) concentrations in the retina o f  the STZ- 
diabetic rats were also decreased (Tuitoek et al., 1996). However, hepatic vitamin A 
levels were significantly increased suggesting that retinol transport is disturbed 
(Tuitoek et al., 1996).
In addition, high serum levels o f  vitamin A were observed in diabetic patients with 
increase in P-lipoprotein levels after operation reflecting an observed correlation 
between serum vitamin A levels and serum P-lipoprotein levels(Kahan, 1969).
In rats with STZ-induced diabetes, high dose o f  vitamin A did not affect glucose levels 
in serum or urine (Seifter et al., 1981). However, using retinyl palmitate protected 
against streptozotocin and alloxan-induced diabetes in rats (Chertow et al., 1989). 
Bowls and Tucson reported that regular and globin-type insulin interfered with storage
 ^ Normal ranges in serum for retinol, a-, and (1-carotene have been reported as 34-74, 1.8-19.5, and 
10-60 jig/dl respectively (Kaplan et al, 1987).
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o f vitamin A in the liver o f rats. Injected insulin increased the rate o f  depletion o f 
stored vitamin A from the liver (Bowles and Tucson, 1967). Retinol and retinoic acid 
inhibit glucagon secretion in cultured rat islets and glucagon-secretion cell lines, and in 
cell lines the effect o f retinoic acid is dose dependent (Chertow et al., 1996). In 
contrast, others have shown that retinol deficiency reduces diabetes and insulitis in 
diabetes-prone (BB) rats (Driscoll et al., 1996).
1.3.6 Determination of vitamin A: old versus new methods
In earlier studies, total carotene content present in plasma was determined in some 
studies (Rabinowitch, 1930) by methods based on colour comparison with a standard 
(oleic acid). The results were expressed in terms o f units; that is the maximum amount 
o f  pigments found in the blood o f  normal subjects gave a colour corresponding to that 
o f a 10% solution o f oleic acid in petroleum ether . This is regarded as one unit o f 
pigment. Other blood pigments such as bilirubin might remain in the extracting solvent 
and contribute to the high values o f  carotene in serum o f diabetic patients. Other 
methods involved using the Carr-Price reaction in which measurements were made o f 
total vitamin A and carotene content, followed by subtraction o f the carotene value as 
determined by colorimetric analysis (Mosenthal and Loughlin, 1944). These methods 
differ substantially from the modern method o f  high pressure liquid chromatography 
where retinol and all its derivatives are separated and quantified individually and 
specifically. This difference between old and new methods may explain the 
discrepancies between older and more recent studies and clearly make comparison o f 
results extremely dubious.
1.3.7 Retinol binding-protein in diabetic nephropathy
Epidemiological studies have demonstrated that diabetic nephrophathy develops in 
35% o f patients with Type 1 diabetes mellitus with diabetes for ~ 20 years (Dekert et 
al, 1978). Renal disease is less common in Type 2 diabetes, occurring in 5-10% o f  
patients (De Fronzo, 1991). Diabetic nephrophathy is a serious complication o f  DM  
Type 1 with a grave prognosis after the onset o f proteinurea (Kussman et al, 1976).
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Diabetic nephropathy was defined clinically as proteinurea o f more than 0.5 g/24h or 
albuminuria o f  > 300 mg/day (Albustix- positive).
The vast majority o f IDM patients with proteinuria eventually will progress to end- 
stage renal failure or die prematurely from cardiovascular complication (Viberti et al,
1992).
Persistent proteinuria appears in approximately 31% o f insulin-dependent diabetics 
(Deckert and Poulsen, 1981) often preceded by a short period o f  intermittent 
proteinuria. However, well before clinical proteinuria becomes evident, an increased 
rate o f the urinary albumin excretion, as yet undetectable by Albustix 
(microproteinuria, Albustix negative), may occur in insulin-dependent diabetic patients 
(Viberti, 1979). Much effort has been devoted to the detection o f this complication at a 
stage when it is silent and potentially reversible. It is well established that urinary 
excretion o f protein can be 1 0  to 2 0  times higher than normal, without being detected 
by Albutsix (Parving et al., 1974).
Analysis o f the individual proteins in the urine provides a sensitive and specific index o f 
renal damage: Albumin has been established as a sensitive indicator o f  renal glomerular 
damage whereas increases in smaller molecular weight proteins, such as retinol-binding 
protein, P2 -"^icroglobulin and a j .  microglobulin, indicate tubular damage. (Peterson 
et al., 1969).
Retinol binding protein (RBP) is a low-molecular-mass protein present in plasma, 
where 90% o f the protein is bound to transthyretin (thyroxin binding prealbumin). RBP 
is synthesised and stored in the liver; and is catabolised mainly in the kidney. 
Consequently, its plasma levels among other factors are affected by the presence or 
absence o f  liver and kidney disease. High serum retinol and RBP concentrations were 
reported in a variety o f renal diseases (Smith and Goodman, 1971; Monji and Bosin, 
1986; Jaconi et. al., 1996). Jaconi and associates (1996) reported traces o f  two 
truncated forms o f RBP (RBPl and RBP2) circulating in normal serum. However, 
RBP2 levels were highly elevated in CRF serum (Jaconi et. al., 1996). It was observed 
that in chronic renal failure (CRF) serum, 50% o f  the holo-RBP (RBP complexed with
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retinol) was not bound to  transthyretin (TTR) (thyroxin binding prealbumin) (Jaconi et 
al., 1996). Low molecular weight protein concentrations in the serum o f patients on 
continuous ambulatory peritoneal dialysis (CAPD) were markedly increased and serum 
RBP declined with duration o f dialysis (Kabanda et. al., 1994).
The free fraction o f  RBP is filtered freely through the glomerulus and catabolised after 
reabsorption in the proximal tubules (Bernard et. al., 1982; Lucetini, 1984; Beetham 
et. al., 1985). Several investigators have observed an increased urinary excretion o f 
RBP in insulin-dependent diabetics in the absence as well as in the presence o f 
albuminuria (Holm et. al., 1987; Rowe et. al., 1987; Holm and Hemmingsen, 1993) 
which indicated a state o f proximal tubular dysfunction. The urinary excretion o f RBP, 
normally around 100 pg/24 h (Bernard, et. al., 1982; Beetham et. al., 1985), is thus a 
sensitive marker o f tubular proteinuria which is preferred to the assay o f  p 2- 
microglobulin because o f the greater stability o f RBP in acid urines (Beetham et. al., 
1985; Bernard et. al., 1982).
1.3.8 Zinc- Vitamin A interaction in diseases
Zinc and vitamin A have been shown to have a significant interrelationship in a wide 
variety o f  clinical conditions. Patek and Haig (1939) showed that cirrhosis is 
associated with night blindness and that cirrhotic patients with impaired dark 
adaptation were resistant to vitamin A therapy (Patek and Haig, 1939). Deficiencies o f 
zinc and vitamin A have been reported among alcoholics (Russel et al., 1978; McClain 
et al., 1979; Atukorala et al., 1986). Zinc deficiency in alcoholic cirrhotics is thought 
to be due to increased urinary excretion and/or marginal dietary intake (Russel et al., 
1978; Russel, 1980). Supplementation with vitamin A was not effective in correcting 
dark adaptation (Russel et al., 1978; McClain et al., 1979). When a zinc supplement 
was given, their dark adaptation, was normalised (Russel et al., 1978; M orrison et al., 
1978; McClain et al., 1979). In contrast, Weisman and associates (1979) reported that 
zinc supplementation increased serum zinc level but did not alter serum vitamin A level 
and decreased serum p-carotene in patients with liver cirrhosis. However, dark 
adaptation did not improve, probably, because serum zinc levels in these patients were
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within the normal range (Weisman et al., 1979). It was speculated that improvement in 
dark adaptation by zinc supplements may be due to enhanced activity o f previously 
depressed alcohol dehydrogenase (Morrison et al., 1978). Atukorala and associates 
(1979) reported that the lowest serum values o f  both vitamin A and zinc were 
observed more among lung cancer patients than among non-malignant lung disease or 
other non-malignant diseases patients
Hypogonadism has been recognised as a complication o f liver cirrhosis (Green, 1977). 
Indices o f retinol, zinc and RBP in serum o f 16 male cirrhotic patients with 
hypogonadism were compared to those o f  13 cirrhotic patients without hypogonadism, 
and they were found to be significantly lower for RBP and zinc but not for retinol 
(Abdu-Gusau et al., 1989). It was speculated that this deficiency may contribute to the 
genesis o f  hypogonadism in cirrhosis o f  the liver (Abdu-Gusau et al., 1989).
1.3.9 Zinc in diabetes meiiitus
Abnormal zinc metabolism has been suggested to play a role in the pathogenesis o f 
diabetic complications (Hagglof et al., 1983). A number o f investigations have been 
made with regard to  plasma zinc levels in diabetics, but with contradictory results 
(Rosner and Gorfien, 1968; Mateo et al., 1975; Arreola et al., 1986; Golik et al.,
1993). Studies by Rosner and Gorfien (1968), Khattab et al., (1976) and Kinlaw et al., 
(1983) revealed no significant difference between diabetic and control subjects. 
However, other studies pointed to a decrease in plasma zinc levels (Kumar and 
Rao,1974; Sjogren et al., 1986; Melinkeri et al., 1990; Walter et al., 1991). In contrast, 
others observed a significant increase in the serum zinc levels in patients with diabetes 
(Mateo et al., 1975; Failla and Kiser, 1981 ). There seems to  be more universal 
agreement about hyperzincuria, in U.S.A., Japan, England, India, and Sweden (Meltzer 
et al., 1962; Tarui, 1963; Pidduck et al., 1970; Kumar and Rao, 1974; Sjogren et al., 
1986 respectively).
Data concerning the concentration o f zinc in the tissues were conflicting, low in muscle 
or adipose tissue in Type 2 DM (Sircar et al., 1985; Sjogren et al., 1988), normal in
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Typel (Sjogren et al., 1986). Raz and Havivi (1989) reported a decrease in zinc 
concentrations in the haemoglobin o f Type 2 diabetes mellitus, although the 
concentrations o f  zinc in serum and leukocytes were similar to those with healthy 
controls which agreed with another study in which leukocytes zinc levels in diabetic 
were similar to  those in non-diabetics (Pidduck et al., 1971).
In rats, increased zinc concentrations in liver (Failla and Cardell, 1985) and kidney o f 
BB Wistar or Alloxan diabetic rats (Failla and Cardell, 1985; Tengrup et al., 1988 ).
The zinc content o f the pancreas was found to be lower in patients with diabetes 
mellitus than in normal controls. Zinc is 50% and insulin is 25% less in the diabetic 
pancreas than the normal pancreas (Scott and Fisher, 1938) and a correlation between 
zinc and insulin has been reported (Davies et al., 1968). Zinc is present in the islets o f 
Langerhans and it may have a role in the mechanism o f secretion o f insulin (Maske, 
1957). Zinc has been shown to enhance insulin action and promote glucose uptake by 
adipose tissue (Quarterman and Florece, 1972). M oreover glucose tolerance is lowered 
in zinc deficient rats (Boquist and Lernmark, 1969; Park et. al., 1986). However, 
Brandao-Neto and associates (1990) detected no change in plasma glucose or insulin 
levels in healthy subjects when administered 50 mg o f zinc.
1.3.10 Copper status in diabetes meiiitus
Several investigators have reported increased serum copper concentrations in diabetic 
patients (Failla and Kiser, 1981; Hagglof et al, 1983; Lau and Failla, 1984; Walter et. 
al., 1991). However, other studies found normal serum levels o f  copper in diabetic 
individuals (Pidduck et al., 1970). Raz and Havivi (1989) found an increase in serum 
copper in Type 1 and normal in Type 2 diabetes mellitus. Imbalances in the metabolism 
o f copper have been associated with impaired insulin release, insulin resistance and 
glucose intolerance in experimental animals (Fields et al., 1983; Reiser et al., 1983).
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1.4 Direction of thesis research
Studies 1 and 2 are concerned with the effect o f diabetes mellitus on vitamin A 
metabolism. However, our findings in study 1 o f a significant difference in serum P- 
carotene concentrations between diabetic and controls and the significant inverse 
relationship between p-carotene and FBG shifted the attention to another area o f  
research that might be more promising; that is the effect o f P-carotene supplementation 
on diabetes mellitus in STZ-diabetic Wistar male rats.
1.5 Objectives of the study
Conflicting results arise fi*om studies so far published on vitamin A status in diabetes. 
High serum P-carotene levels have been found in diabetes mellitus suggesting that the 
diabetic state may interfere with the conversion o f  P-carotene to retinol (Ralli et. 
al.,1936). More recent studies have shown that Type 2 diabetic patients have a lower 
plasma concentration o f  P-carotene (Ramachandran, 1973). Type 2 diabetic patients 
appeared to have normal (Straub et al., 1993), increased (Krempf et al., 1991) or 
decreased (Wako et al., 1986) serum retinol concentrations when compared to 
controls. Type 1 diabetic patients have lowered plasma concentrations o f retinol and 
RBP when compared to controls (Basu et al. 1989; Martinoli et al., 1993). 
Furthermore, zinc is known to be important in the mobilisation o f RBP (Smith, 1982) 
and its metabolism is affected in DM (Failla and Kiser., 1981; Golik et al., 1993).
In view o f these facts, it seemed to be o f interest:
1. To test the hypothesis that diabetes mellitus influences the concentration o f  serum 
and/ or urine concentration of retinol, a-carotene, P-carotene, zinc, copper and 
RBP.
2 . Attempt to  relate these levels to the type o f diabetes, its duration, and type o f 
treatment.
Chapter 1 30
3, Evaluate triglycerides and cholesterol for the adjustment o f  lipid-soluble vitamins 
for lipid levels and creatinine to  correct for urine zinc and RBP levels.
4. To use a-tocopherol as an internal control to exclude the possibility that the effects 
observed were not a generalised effect on all fat-soluble vitamins.
Based on study 1, in which diabetic patients were found to have significantly higher 
concentrations o f RBP, particularly those with renal impairment, and a significantly 
lower serum p-carotene concentrations in patients with Type 2 DM. In addition, there 
was a significant inverse relationship between serum concentration o f  P-carotene and 
serum fasting glucose; a subsequent two studies were under taken to:
a) Examine the association between diabetic control as measured by HbAic and 
plasma levels o f  retinol, a-tocopherol, a - , P -carotene and RBP in a group o f 
diabetic patients with a wide range o f  HbAic concentrations.
b) Include a larger proportion o f diabetic patients Typel and diabetic patients with 
nephropathy or renal failure.
c) To clarify whether any differences were due to diabetes or to renal failure, diabetic 
patients with chronic renal failure (CRF) were matched in age and sex with non­
diabetic patients with CRF.
d) To use an animal model to test the hypothesis that p-carotene supplement could 
reduce fasting blood glucose levels in STZ-diabetic Wistar male rats, and evaluate 
its effect on lipids in these rats.
CHAPTER TWO
MATERIALS AND 
METHODS
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MATERIALS AND METHODS
2.1 SUBJECTS:
The studies described in this Thesis involved two separate groups o f diabetic patients 
and some rats.
2.1.1 Study I 
Study design
110 patients predominantly (97%) with Type 2 DM  (aged 26-74 years) were recruited 
from those attending a diabetic clinic in King Khalid University Hospital in Riyadh City 
(Saudi Arabia). A group o f 143 control subjects, matched for age and sex, were 
selected after screening 182 apparently healthy subjects. The control subjects were 
recruited from King Saud University faculty, staff and employees. Their ages ranged 
from 27-75 years. The controls were selected according to the following criteria based 
on physical examination and laboratory investigation :
•  Healthy Saudi males and females;
•  Absence o f a family history o f diabetes mellitus;
•  Absence o f the following: kidney, liver, endocrine, or coronary heart disease; 
malignant disease; previous surgeiy on digestive tract, pancreas or biliary system; 
pregnancy; use o f oral contraceptives; physical or mental disability; drug abuse and 
alcoholism.
All cases were Saudi males or females aged more than 26 years with a diagnosis o f 
diabetes based on a morning fasting blood glucose (FBG) > 7 .8  mmol/1 on more than 
one occasion and/or 2 hour after a 75 g oral glucose tolerance test (OGTT) (> 200 
mg/dl; 11.1 mmol/L) (WHO, 1985).
Weight and height were measured and body mass index (BMI)^ was calculated for all 
subjects.
A single fasting venous blood sample ( 1 0  ml) and an overnight ten hour urine 
collection were obtained from all subjects. Serum and urine samples were stored at -70 
°C or -20 °C until analysis.
'BMI = wt/(ht)^; Kg/m^
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For diabetic patients, details o f duration o f diabetes, age at onset, family history, use o f 
insulin, type o f insulin, and use o f  hypoglycaemic drugs were recorded. Signed consent 
was obtained from patients and controls.
Dietary Assessment
During an initial visit, the subjects were asked about details o f dietary habits with 
particular stress on frequency o f consumption o f 35 food group items per day, week, 
month or year. At the same interview, a complete history (including details o f  
demographic characteristics, socioeconomic status, use o f medicine and vitamin 
supplements) was taken from all subjects.
The food frequency questionnaire was not used for a quantitative estimate o f  the 
dietary intake. It was used as a rough estimate o f  the qualitative aspects o f  the dietary 
intake. Another technique (24 h recall) was used for the quantitative dietary estimate. 
It would have been more useful if  the food frequency questionnaire had been evaluated 
by a 3“day weighed food records in a pilot study.
In the second visit, individuals were asked about their food intake during the previous 
24 h prior to blood sampling. The respondents were shown models o f  different food 
items o f different weights and sizes and different house-hold measures in order to 
facilitate the assessment o f  actually consumed food.
The 24-hour diet intake recall was analysed using a computerised nutrition analysis 
system, the Food Processor II (ESHA^ Research, 1996). Data were added to  the data 
base for some local and Mediterranean composite dishes (Pellet and Shadarevian, 
1970).
Sample Size
The sample size needed to demonstrate a significant difference between cases and 
controls with a 90% power at 5% level was determined. Size o f  the sample was found 
to be 46 subjects in each group. To account for dropouts and not being able to  carry 
out a suitable random sampling procedure, the size o f the sample was increased to at 
least 1 0 0  subjects in each group.
ESHA = Elizabeth Stewart Haunch and Associates
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The sample size equation used:
n (in each group) = (Si^+ 8 2 )^ (u + v )^ /(M rM 2)^ (Kirkwood, 1988)
Where M], M 2 = Means for cases and controls
8 1 , 8 2  = Standard deviation in each group
u = one-sided percentage point o f the normal distribution corresponding 
to  100- the power. Since power is 90%, u = 1.28.
V  = Percentage point o f the normal distribution corresponding to  the 
(two-sided) significance level. Since significance level = 5%, v = 1.96.
Data used for the sample size calculation was that o f  Basu et. al. (1989) for serum 
retinol concentrations in diabetic patients and controls (1.63 ± 0.33 and 1.86 ± 0.35 
respectively).
n (in each group) = (0.35  ^± 0.33^)(1,28 +  1.96)^/(1.86 -1.63)^
= 45.47 « 46
2.1.2 Study I!
Study design
One hundred and seventy five diabetic patients (aged 5-90 years) attending a diabetic 
clinic in King Khalid University Hospital in Riyadh City (Saudi Arabia) were classified 
into four subgroups: NIDDM  (n = 124; M/F, 43/81), IDDM  (n = 11; M/F, 4/7), 
diabetic Type 2 with renal impairment^ (n=27; M/F, 17/10), diabetic Type2 with 
chronic renal failure (CRF) (n = 13, M/F, 1/12). Non-diabetic patient with CRF (n = 8 ; 
M/F; 1/7) were matched in age and sex with the diabetic patients with CRF. Exclusion 
o f diabetes in these patients was based on WHO criteria. None o f the diabetic patients 
in study 1 was included in study 2 .
Blood samples were obtained and HbAic was determined immediately by the 
immunological routine two channel method with a BM/Hitachi Automatic Analyzer 
717 instrument (Boehringer Mannheim) by staff o f Clinical Chemistry Dept., KKUH, 
Riyadh, Saudi Arabia. Plasma for the determination o f  retinol, a-tocophero l, a -  
carotene, P-carotene and RBP was frozen in aliquots and stored at -70 °C until the
3
Renal impairment = Serum creatinine > 130 mmol/1
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time o f analysis. Blood samples (10 ml) from diabetics and non-diabetics with CRF 
were taken at different times during dialysis (pre-, middle and post dialysis).
2.1.3 Study n i  
Study design
One hundred and five Wistar male rats (180-250 gm), aged 6  weeks were obtained 
from the Research Center at King Faisal Specialist Hospital (KFSHRC), Riyadh. The 
animals were housed, four or five, in a cage, in an environment in which the 
temperature was maintained at 22-25 °C, with a normal day - night cycle, and humidity 
40-45%. The rats were maintained ad libitum on a commercial standard diet 
(containing approximately 20% protein, 4% fat, 70.6% carbohydrate, 3.5% crude 
fiber, 1% calcium, 0.5% salt, 0 .6 % phosphorus, 20 lU /g vitamin A, 2.2 lU /g vitamin 
D, and 70 lU/Kg vitamin E; Grain Silos and flour Mills Organisation, Riyadh, Saudi 
Arabia) and water. Concentrations o f  trace elements in water were measured by the 
mineral research laboratory in KFSHRC (El-Saleh, personal communications). W ater 
mineral content was: Be = 0.2, Cd = 0.3, Cu = 4, Fe = 0.7, Ni = 4.2, Ug =27, Zn =1.1 
pg/l. Rats were divided into six groups, three o f  which received supplementation with 
P-carotene (5 mg/kg three times per week) dissolved in com oil and administered with 
a catheter tube (Vygon; Ecouen, France) from 8  weeks o f age until the end o f  the 
experiment. Two o f the supplemented groups (25 in each group) were treated with 
streptozotocin (STZ), 60 mg/kg intra-peritoneally at either 8  or 13 weeks o f  age 
( ‘early diabetic’'* and ‘late diabetic’  ^ groups respectively), the third group (n =  15) 
received p-carotene supplementation but not STZ (non-diabetic group).
The three other (control) groups were treated similarly but received com  oil in the 
place o f P-carotene. Each group and its control were matched for weight at the 
beginning o f the study and weighed every two weeks until the end o f the experiment. 
There was no significant variation between each group and its corresponding control 
regarding weight. This non-significant difference in weight indicates that each 
experimental group and its control had consumed equal amounts o f diet which would
Supplemented with beta-carotene after inducing diabetes.
 ^Supplemented with beta-carotene for 5 weeks before inducing diabetes.
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offset any effect on P-carotene supplementation if  one group had consumed more o f 
the diet that contains vitamin A (20 lU/g).
Streptozotocin powder (Sigma- Aldrich Co. Ltd. Poole, England) was administered 
(60 mg/kg body weight) intraperitoneally. Streptozotocin solution was prepared 
immediately before use in citrate buffer (pH. 4.4). Control rats were injected with 
citrate buffer alone.
Rats were subjected to light ether anaesthesia and heart puncture blood samples for 
fasting serum glucose, cholesterol, and triglycerides were obtained at weekly intervals, 
after an overnight fast (food was removed from their cages) for over 1 0  weeks period. 
Rats with fasting serum glucose > 9 mmol/1 for two consecutive sampling days were 
recorded as diabetics.
2.2 ZiNC AND COPPER DETERMINATION
2.2.1 Introduction
Determination o f zinc and copper in biological material is usually performed by atomic 
absorption spectrophotometry (AAS). In the past, preparation o f  plasma or serum 
samples had to include precipitation and extraction to avoid frequent clogging o f  the 
standard burner head (Prasad et. al., 1965; Piper and Higgins, 1967; Olson and Hamlin, 
1968; Davies et.al., 1968). Prasad et. al. (1965) reported the use o f deproteinisation 
and two extractions with trichloroacetic acid. These pre-treatment techniques were 
time consuming and a source o f inaccuracies (James and MacMahon, 1971; Boyde and 
Wu, 1978; Taylor and Bryant, 1981). As AAS burner heads were modified to be 
capable o f aspirating high-solid matrixes, direct use o f serum (Kurz et al., 1972) or 
various sample dilutions with water were employed (Sprague and Slavin, 1965). Direct 
dilution produced differences in viscosity and aspiration rate between diluted serum 
samples and aqueous working standards (Hackley et. al., 1968). The viscosity o f  the 
standards was increased to match that o f the serum by adding dextran (Hackley et. al., 
1968), bovine albumin (Parker et al., 1967), butanol (Kelson and Shamberger, 1978; 
Meret and Henkin, 1971), and propanol (Peaston, 1973). Smith et. al. (1979) 
suggested that serum or plasma diluted fivefold was matched in viscosity by working 
standards that were prepared in glycerol:water (5:95 by vol.). The latter method was
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used as it is simple to use, requires a minimum handling o f the sample and o f 
glassware. The chances for contamination were therefore reduced.
Principle
The determination o f zinc/copper depends on the principle that a hollow cathode 
zinc/copper lamp produces radiations with a line spectrum specific for the element to 
be measured. A monochromator isolates the particular wavelength to be employed 
(213.9 nm for zinc and 324.7 nm for copper). A detection system converts the radiant 
energy received into an electrical signal. In the absence o f sample, the readout is 
displayed at 100% transmittance or 0% absorbance. A liquid sample is aspirated into a 
fiame-nebulizer system where the zinc atoms are converted into the atomic state by 
raising the temperature o f an aerosol to about 2000 °C in a flame. The zinc/copper 
atoms remain in the atomic state energy level and absorb their characteristic band. The 
intensity o f this light after it has passed through the flame before and after introduction 
o f  the sample is compared. This intensity is a measure o f the element concentration o f  
the element.
2.2.2 Instruments
A Perkin-Elmer Model 2380 flame atomic absorption spectrophotometer (Norwark, 
C.T., USA) equipped with a standard single slot burner head, a deuterium lamp for 
back ground correction and air/acetylene oxidising flame were used. Acetylene 
pressure was 10-15 psi and the flow rate was 25 and 50 1/min for acetylene and air 
respectively. The radiation source was a zinc/copper hollow cathode lamp using a 0.7 
nm slit and wave length o f  213.9 nm and 324.7 nm for zinc and copper respectively.
2.2.3 Reagents
Cupric chloride standard solution, 15.7 mmol/1 'Spectrosol' and zinc chloride standard 
solution, 5 mmol/1 'Spectrosol' were obtained from BDH (Poole, England). The 
diluent was 50 ml glycerol (Fisons) diluted to  1 liter with deionized water. High and 
low concentrations o f  quality control material for serum (test point and biotrol 33) and 
urine zinc and copper were kindly donated by Dr. A. Taylor (Robens Institute, 
University o f Surrey, U.K).
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2.2.4 Sample collection, preparation and control of contamination
Between 8  and 10 am, after an overnight fast, 10 ml venous blood was collected with 
disposable needles and polypropylene syringes (Terumo syringe. Toco, Japan). The 
blood was allowed to clot and the serum was separated by centrifugation at 1764 g 
(Beckman TJ- 6  centrifuge). Aliquots o f the serum for the various assays were 
dispensed in metal-free dark Eppendorf microcentrifuge tubes o f 1.5 ml capacity and 
stored at -70 °C or -20 °C until analysis.
A ten-hour urine sample was collected in plastic metal-free containers; the volume was 
measured and a sample was stored at - 2 0  °C until analysis.
To ensure complete freedom from contamination, all glassware used for metal 
determination was soaked overnight in 6  N  nitric acid and then rinsed 10 times with 
deionized water and dried before use.
2.2.5 Analysis of zinc and copper in serum
A working standard o f 0.1 mmol/1, for both metals, was prepared with deionized 
water in a 1 0 0  ml acid washed volumetric flask.
For the standard curve, solutions equivalent to copper and zinc concentration range o f 
5- 40 fj.mol/1 were prepared with 5% glycerol (v/v) deionized water. They were 
matched in viscosity with that o f diluted serum. Serum samples, standard and quality 
control specimens were diluted five times. The aspiration rates o f  the diluted serum 
and the working standards were compared after each group o f  10 samples. The 
instrument was set at zero with the diluent solution. Each standard was aspirated and 
its absorbance was read followed by diluent. At least 4 standard solutions were run to 
establish a working standard curve. After calibration, diluted samples, in triplicate, 
were aspirated followed by diluent. Working standards were aspirated after every 10 
samples.
Zinc and copper concentrations were plotted against absorbance to  obtain a standard 
curve. The concentrations o f the samples were calculated from the standard and 
multiplied by 5 (Fig. 2.1). The standard curve was linear in the relevant concentration 
level from 0-40 pmol/1.
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2.2.6 Analysis of zinc in urine
A working standard (1 mmol/1) was prepared and different volumes were added to 10 
ml pooled urine to correspond to test and 4-12 pmol/1 concentrations range. After 
adjustment and setting the digital display at zero using deionized water, test sample 
was aspirated, followed by other working standards and digital absorbance units were 
recorded. Reading o f the test tube was subtracted from the reading o f the standards 
and a standard curve was constructed by plotting absorbance units against 
concentration (pm ol/l). The concentrations o f the samples were measured from the 
standard and total excretion was calculated by multiplying the concentration by the 
urine volume (in litres) (Fig.2.2).
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2.2.7 Precision, reproducibility and quality assurance
Intraassay (short term) precision was evaluated by repeated measurement o f zinc and
copper in pooled samples o f  urine and serum at low and high concentration o f  zinc and 
copper for 8  consecutive times on one day. Interassay (long term) precision was 
estimated by weekly measurement o f  these samples for 8  weeks. Precision, expressed 
as coefficient o f  variation (CV) varied between 2.5 and 6 .2 % being highest in samples 
with low concentration (Table 2.1).
The accuracy o f the method was ascertained by analysing quality control serum with 
known contents o f zinc and copper. An average values o f  14.89 ± 1 and 7.65 ± 1 . 2  
pmol/1 were found for control sera (Test point and Biotrol) having zinc values o f 15 ± 
0 . 8  and a range o f  6 .1-9.2 pmol/1 respectively. Average values o f  18.12 ± 0.78 and
11.82 ±  0.92 pmol/1 copper were found in Test point and Biotrol as compared to the 
reported values o f  17-19 and 10.2-13.4 pmol/l respectively.
2.2.8 Analytical recovery and detection limit
Various amounts o f  zinc and copper stock solution were added to 2 ml o f  pooled 
serum and the mixture was diluted to 10 ml. Recoveries were calculated on the basis o f 
added zinc/copper and the amount o f these elements initially present in the serum. 
Satisfactory recovery o f  both elements was found ranging from 97.7-103% for zinc 
and 96.8-100% for copper (Table 2.2).
Detection limit
Concentrations o f 0.62 and 0.46 pmol/l o f copper and zinc, respectively, were found to  
be the lower working limits o f the present method.
Detection limit was determined by analysing a sample with zinc and copper 
concentrations two to  three times the noise level, ten consecutive times.
DL = 2 SD X cone/A; where A = absorbance
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Table 2.1 Variation in estimation o f copper and zinc in serum and in urine
INTRAASSAY (8 )
SERUM URINE
Concentration Zinc (pmol/I) Copper (pmol/I) Zinc (pmol/I)
Mean (±SD) C V % Mean (±SD) C V % Mean (±SD) CV %
Low 8.4 (0.23) 2.7 12.2 (0.43) 3.5 4.1 (0.14) 3.4
High 13.9(0.34) 2.5 19.2 (0.62) 3.2 12.2 (0.33) 2.7
I N T E R A S S  A Y ( N  == 2 0 )
Low 8.3 (0.32) 3.8 12.7 (0.79) 6 . 2 4.2 (0.23) 5.5
High 14.4 (0.5) 3.5 19.5(1.15) 5.9 11.89 (0.5) 4.2
Table 2.2 Recovery o f zinc and copper added in equal quantities to pooled serum
Zinc and 
Copper added
Found (iitmol/1) 
Mean (± SD)
Expected (pmol/1) Recovered % 
Mean (± SD)
(pmol/l) 
(n = 6 )
Zinc Copper Zinc Copper Zinc Copper
0 1 2 . 8
(0.62)
14.0
(0.54)
0.5 13.2
(0.58)
14.4
(0.72)
13.3 14.5 80.0 80.0 
(2.4) (3.1)
2 14.8
(0.53)
15.9
(0.87)
14.8 16.0 100 95.0 
(2.6) (2.9)
4 17.3
(0.78)
18.0
( 1 2 )
16.8 18.0 112.5 1 0 0  
(3.2) (2.2)
8 20.4
(0.9)
21.3
(1.4)
2 0 . 8 2 2 . 0 95 91 
(1 9 )  (Z 3)
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2.2.9 Discussion
Initially, serum was chosen for analysis o f  metals to avoid problems o f contamination 
associated with anticoagulants (Gervin et al., 1983; Smith, 1985). Haemolized serum 
was discarded, since haemolysis o f serum can result in zinc contamination from the red 
blood cells (Solomons, 1979). The time allowed between collection and centrifugation 
was 30 minutes as longer times results in a progressive increase in zinc concentration 
(English and Hambidge, 1988).
Disposable plastic syringes were used for blood collection since zinc was reported to 
be affected by the use o f  Vacutainer tubes (Helman et al., 1971; Williams, 1979). 
Disposable needles and syringes were tested for zinc and copper contamination. D e­
ionized water, 5 ml, was added to 5 disposable syringes each. They were inverted 
several times, and the water was analysed for zinc and copper and found to be free o f 
both metals.
Serum differs from the aqueous standards in that serum contains a variety o f  cations 
and anions. Some ions e.g. phosphate interfere with zinc analysis. Dilution o f  serum 
with water eliminates any effects o f  these cations and anions (Falchuk et. al., 1988). 
The sensitivity and precision are affected if  the samples are diluted 20 fold (Dawson 
and Walker, 1969). Dilution o f samples less than 5 folds is reported to  cause a variety 
o f  problems: deposition o f solids on the burner causing memory affects, differences in 
aspiration rate o f  samples and standards (Momcilovic et al., 1975). This problem can 
be eliminated by using glycerol/water (5/95 by vol.). Glycerol is an ideal additive for 
adjusting the viscosity and flow rate o f  the standards. The grade used was free o f  
contaminating zinc or copper. Bovine albumin has been used to  adjust viscosity 
(Parker et. al., 1967), but it has the disadvantage o f being a source o f  zinc 
contamination. The polysacchride dextran has been used (Hackley et. al., 1968), 
however, it is not suitable to be used in some instruments owing to clogging o f  the 
aspiration system (Smith et. al., 1979).
The method demonstrated intraassay run precision o f less than 3.5% and interassay CV 
o f  3.5-6.2% which demonstrated a satisfactory sensitivity for the method..
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2.3 Determination of retinol, a-tocopherol, a- and /3-carotene
2.3.1 Introduction
Assaying retinol, a-tocopherol, a -  and P-carotene by colorimetry is no longer 
considered reliable due to non-specific interference from other compounds (Mathews- 
Roth, and Stampler, 1984). High performance liquid chromatography (HPLC) methods 
are considered superior for the determination o f these nutrients. Many o f these 
methods required extraction o f the analytes from serum or plasma into an organic 
solvent, which was then evaporated to dryness; this is time consuming (De-Leenheer et 
al., 1979; Catignani and Bieri, 1983; Miller, and Yang, 1985; Kaplan et al., 1990; 
Bui, 1994; Lanvers et al., 1996). Thus, extraction methods that do not need this 
evaporation step would be preferable. Some investigators reported using this method 
(De Ruyter and De Leenheer, 1976; Nierenberg, 1984; Kalman et al, 1987; Lee et 
al., 1992). However, two o f  these reports attempted to determine retinol only (De 
Ruyter and De Leenheer., 1976; Nierenberg, 1984). Using the more recent method 
(Lee et al., 1992), the peaks o f a -  and P-carotene were not totally separated. 
Therefore, we attempted to develop a simple and rapid extraction procedure, 
incorporating extraction with butanol: ethyl acetate that allows direct injection into the 
HPLC system together with a different mobile phase that achieves a complete 
separation o f a -  and p-carotene.
Principle
Internal standards (retinyl acetate, a-tocopheryl acetate and retinyl palmitate) are 
added (in ethanol) to serum and allowed to  equilibrate with their respective 
compounds (retinol, a-tocopherol, a -  and p-carotene), then serum is deprotienized 
with ethanol and the lipid is extracted with ethyl acetate/butanol (1:1). Ethyl 
acetate/butanol was chosen for its excellent ability to extract lipids and lipid soluble 
vitamins. A portion o f this solution is injected onto a C jg  reversed phased 
chromatographic column and absorbances o f the vitamins and internal standards were 
measured at 292 nm for tocopherols, 325 nm for retinoids and 450 nm for carotenoids. 
Peak-height ratios were used to quantify each vitamin.
Chapter 2 45
2.3.2 Reagents and chemicals
All trans retinol, retinyl acetate, a-tocopherol, a-tocopheryl acetate, a-carotene, p- 
carotene and retinyl palmitate were obtained from Sigma Chemical Company (Poole- 
Dorset, England). Anhydrous sodium sulphate was obtained from BDH (Poole, 
England).
All solvents used were HPLC grade or better. Acetonitrile, ethylene chloride, methanol 
and ethyl acetate were obtained from Fisher Chemical Company (Fair Lawn, New 
Jersey, USA). Butanol and ethanol were obtained from Aldrich (Milwaukee, USA) and 
BDH (Poole, England) respectively.
2.3.3 Instrumentation
The HPLC system was from Waters Associates (Milford, Mass, USA) and consisted o f 
an automated sample injector (WISP 712B), a Model 510 pump, a Model 490 multi­
wavelength detector, a Model 745 data integrator modules, a Gradient controller 860 
and a Guard-Pak precolumn cartridge with disposable inserts o f 5 pm.
Supelco stainless steel column (25 cm x 4.6 mm, i.d.) and precolumn (5 cm x 4.6 mm, 
i d.) packed with ODS supelcosil LC 18, 5 pm particles, were obtained from Supelco 
(Supelco-Sigma-Aldrich; Poole, England)). The dual pen recorder was obtained from 
LKB (LKB, Bromma, Sweden).
2.3.4. Optimisation of the eluent
Initial experiments were performed to achieve capacity ratio (K') between 2 and 10, K' 
was defined (t^-t^)/tQ, where tj- and tg were the retention times o f the compound o f  
interest and the solvent front, respectively. The relationship o f  K' factors o f  the 
individual compounds under constant chromatographic conditions is known as 
selectivity ‘a ’ = K'^/K'^. In order to achieve good separation ‘a ’ should have a value >
1.1 (Gertz, 1990).
In study I, various strategies were tested to optimise the resolution between the 
analytes and their internal standards. Initially, the mobile phase was acetonitrile, 
methylene chloride, methanol (70: 20: 10) (Bieri et al., 1985). However, the proximity 
o f  the retinol peak to solvent front was improved by adding 1 % water to the mobile
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phase (69:20: 10:1). Peaks o f a -  and P-carotene were not separating well under 
chromatographic conditions achieving good resolution for retinol, retinyl acetate, a -  
tocopherol and a-tocopheryl acetate. To achieve reproducible results, increased 
sensitivity, and obtain good resolution for all analytes, two separate isocratic runs 
were performed with some modification in the mobile phase (77:13:10) for the 
carotenoids. It was pumped at a flow rate o f  Iml/min for retinoids and tocopherols and 
1.4 ml/min for carotenoids (method A). In study II, all the analytes were analysed in 
one run with little modification o f the same mobile phase (75:15:10). It was degassed 
under vacuum prior to use and pumped at a flow rate o f 1 . 0  ml/min for retinoids and 
tocopherols and 1.4 ml/min for carotenoids. With the help o f a gradient controller, the 
flow rate was increased from 1 ml/min for 14 min to 1.4 ml/min until the end o f the 
run. (method B) (Table 2.3).
The retinoids, tocopherols and carotenoids were monitored at 325, 292 and 450 nm 
respectively. The absorption unit full scales (Aufs) were 0.025 for the retinoids and 
tocopherols and 0.005 for the carotenoids.
(S
I
o
I
o
o
en
o
1
2o-
}
i
en
(S
<u
î
I O h
&0
Chapter 2 48
2.3.5 Quality control
Pooled normal human serum samples o f  endogenous concentration o f  23.4 pg/dl (0.82 
pmol/I) for retinol, 5.2 pg/ml (12 jiimol/l) for a-tocopherol, 3.75 pg/dl (0.07 pmol/l) 
for a  -carotene and 15.0 pg/dl (0.28 pmol/l) for P-carotene was divided into two 
portions. One portion was used at the low concentrations o f analytes. The other 
portion was spiked with 25 pg/dl (0.87 pmol/1) retinol, 6.0 pg/ml (13.9 p.mol/1) a -  
tocopherol, 4.0 pg/dl (0.074 pmol/1) a-carotene, 2 0  pg/dl (0.37 timol/l) P-carotene to 
produce known high concentrations o f  analytes. These portions were mixed thoroughly 
then aliquots o f 450 microliters were dispensed into 1.5 ml microcentrifuge tubes and 
stored at -70 °C. These quality control (QC) samples were used for each assay. They 
were prepared for analysis by the same procedure for the unknown and standard 
samples. Evaluation o f laboratory performance was assessed by comparing results o f  
the quality control (QC) samples with the mean and standard deviations that were 
calculated using results from several preliminaiy runs. I f  any value moved outside the 
range (± 2  standard deviations) from the mean, the run was rejected.
(Appendix A).
2.3.6 Standards and standard curve preparation
Standard solutions o f the following analytes were prepared by dissolving in ethanol, all 
trans retinol and retinyl acetate (each to 1 mg/ml), a-tocopherol and a-tocopheryl 
acetate (each to 25-40 mg/ml), and in chloroform, a -  and P-carotene (each to 0.5 
mg/ml) and retinyl palmitate (to 40 mg/ml). The concentrations, in ethanol, were 
determined sepectrophotometrically using Beer's Law. The absorbtivity values 
(E^ '^^ojqiy^) used were 1780 at 325 nm for retinol, 75.8 at 292 nm for a-tocopherol, 
1510 at 325 nm for retinyl acetate, 43.4 at 285 nm for a-tocopheryl acetate, 2800 and 
2620 for a -  and P-carotene respectively at 450 nm.
The standards were prepared under red light conditions and stored at -20 °C when not 
in use. To prepare a standard curve, a constant amount o f  internal standard and 4 
different concentrations o f the analytes, in ethanol, were added to serum. Five 
duplicates o f serum standards were prepared by adding 1 0  microliters o f combined 
working standards in the range o f  4-32, 80-640, 2-16, and 0.4-3.2 pg/ml for retinol,
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a-tocopherol, P-carotene and a-carotene, respectively, and 1 0  microliters o f 
combined internal standard o f 2.4 mg/ml for a-tocopheryl acetate, 30 jag/ml for retinyl 
acetate and 40 pg/ml o f retinyl palmitate to  200 microliters serum. No solutions were 
added to the fifth set o f tubes.
The samples were prepared by addition o f 10 pi mixed internal standard to each tube 
containing 200 pi o f serum. The mixture was vortex mixed for 10 seconds and allowed 
to stand in a cool dark place for 20-30 minutes for equilibration to occur. Absolute 
ethanol was added to  each tube to make a final volume o f 400 pi.
2.3.7 Extraction
Four hundred microliters o f ethyl acetate:butanol (1:1) were added. The solution was 
mixed using a vortex mixer for 1 minute. Approximately 20 mg o f  sodium sulphate 
were added. The mixture was vortex mixed for a further minute and allowed to stand 
at -20 ‘’C for 20 minutes before centrifugation at 1500 g for 5-10 minutes. The organic 
phase was transferred into injection vials and 40 microliters were injected into the 
HPLC. All samples were treated in duplicate and analyte concentrations were 
determined from a standard curve o f the peak height ratio o f the analyte/internal 
standard plotted against the concentration o f  analyte. Typical standard curves are 
shown in Figs. 2.3, 2.4, 2.5 and 2.6. The amounts o f vitamins were calculated using 
the regression equation obtained from the standard curves and multiplied by 4 (serum 
was diluted 4x during the assay).
Standard curves were constructed after correction for the contribution o f  endogenous 
analyte in the senim. Regression analysis was performed for each anal}4es and if  the 
regression coefficient was below 0.99 the standard curve was repeated.
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2.3.8 Analytical performance 
Precision
Table 2.4 summarises intra- and interassay variations, in both methods, for low and 
high concentrations o f  retinol, a-tocopherol, a -  and P-carotene. The coefficient o f 
variation (CV) o f the determinations ranged from 2.4 to  6.7% and 3.1 to  8 .2 % for 
intraassay and 4.3 to 8.5% and 6.1 to 9.7% for interassay replication for methods A 
and B respectively.
Detection Limits
Detection limit was determined by analysing a sample with vitamin concentrations 
three to  five times the noise level, ten consecutive times using the formula 
DL = 2 SD X conc/A; where A = absorbance
Detection limits for both methods were 12.5, 190, 3.5, and 9.4 ng/ml for retinol, a -  
tocopherol, a -  and p-carotene, respectively.
Recovery
Analytical recovery was measured by adding known amounts o f analytes into 36 
extraction tubes (A, B and C). These extraction tubes were taken through the method. 
The recovery o f the added analytes was expressed as a percentage. The analytical 
recovery for retinol, a-tocopherol a -  and P-carotene at various concentrations tested 
was 90-104% , 79-97%, 89-99% and 90-95% respectively, being lower in the low 
concentration range (Table 2.5).
Elution Profile
Elution profiles o f the fat soluble vitamins extracted from serum with internal standards 
are shown in Figs. 2.7b, 2.8b, 2.9b. They compare well with chromatograms o f  pure 
standards (Figs. 2.7c, 2.8c, 2.9c). Fig's 2.7a, 2.8a, 2.9a depict the same serum spiked 
with known concentrations as in the a. figures. Comparison o f the respective retention 
times and absorption spectra with those o f  pure standards established the peak 
identities. Table 2.6 summarises the elution time and selectivity a  = (k'2/k'i) o f  analytes 
and their internal standard for the two methods. The relative selectivity ‘a ’ for these 
compounds indicate good resolution.
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2.3.9 Discussion
It was thought desirable to develop an extraction process that avoids a solvent 
evaporation step. This extraction procedure was a modification o f the method 
established by De Ruyter and De Leenheer (1976). It allows direct injection into the 
HPLC system. De Ruyter and De Leenheer (1976) attempted to determine retinol only. 
Lee et al., (1992) achieved simultaneous separation o f retinol, a-tocopherol, a -  and P- 
carotene. However, base line resolution o f a -  and p-carotene was not achieved (Lee 
et. al., 1992). Extracted analytes were found to be stable in the extraction solvent 
(ethyl acetate:butanol) after dehydration with sodium sulphate (Lee et. al., 1992). The 
stability o f analytes allows a large number o f  samples to be extracted and stored for 
later HPLC analysis. However, our samples were extracted and analysed afterwards 
without delay. Plasma or serum samples with these nutrients can be stored up to two 
years at - 2 0  °C for retinol and a-tocopherol and for five months at - 2 0  °C for a -  and 
P-carotene without loss o f  stability (Craft et. al., 1988).
The optimal HPLC technique includes the presence o f  an internal standard. An internal 
standard is used to correct for the variations in the extractant volume, compensates for 
possible losses, caused by evaporation, spilling, or pipetting variability and improves 
the precision o f the method. The internal standards used are not present in human 
serum, have similar UV absorption characteristics to the analytes and retention times 
slightly longer than the analytes.
The two methods have sufficient sensitivity and precision; sensitivity is defined as the 
concentration o f analyte required to cause a given instrument response. Precision is 
concerned with variation among measurements o f the same sample. Detection limits 
were 1.25 (0.04), 19 (0.44), 0.35 (0.006) and 0.94 (0.017) jig/dl (pmol/1) for retinol, 
a-tocopherol a -  and p-carotene respectively. Detection limit was determined by 
analysing a sample with analyte concentration three to five times the noise level, ten 
consecutive times. Sensitivity could be increased by increasing the sensitivity o f  the o f 
the UV detector, or by increasing the volume injected. However, there was no need 
for either measure as the normal concentrations o f the analytes are well above the 
detection limits. These detection limits demonstrate good sensitivity for the method.
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The intra- and interassay variations, in both methods, for low and high concentrations 
o f  retinol, a-tocopherol, a -  and P-carotene were comparable with those reported by 
others (Catignani and Bieri, 1983; Bieri et. a l , 1985; Milne and Botnen, 1986; 
Nierenberg and Nann, 1992; Lee et. a l, 1992). The CV was, in all cases, less than 
10%.
The analytical recovery for retinol, a-tocopherol and a -  and P-carotene at various 
concentrations tested was 90-104%, 79-97%, 87-99% and 90-95%, respectively, being 
lower in the low concentration range (Table 2.5). Recovery was consistent and 
satisfactory and was comparable with reported values (De Leenheer et a l , 1979; 
Driskell et a l , 1982; Milne and Botnen, 1986; Lee et al 1992).
This method has clear advantages over several methods in which satisfactory recovery 
was achieved only after two extractions (Zaman et al 1993; MacCrehan and 
Schonberger, 1987).
Conclusion
In conclusion, the method described gives excellent recoveries and improved resolution 
o f  a -  and p-carotene. The sample preparation and analytical time is relatively short. 
The method is suitable for routine analysis and can be performed automatically using a 
multiwave length detector. It can be o f use in clinical or epidemiological studies where 
these vitamins are o f interest.
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2.4 Enzyme linked immunosorbent Assay of Serum Retinol Binding 
Protein (ELISA)
2.4.1 Introduction:
RBP is a low molecular mass protein. Its excretion may be a sensitive index for use in 
screening for tubular proteinuria. The known methods for determination o f RBP are 
radial immunodiffusion radio-immunoassay, latex immunoassay, immunonephrometric, 
and enzyme linked immunosorbent assay. The radial immunodiffusion, latex 
immunoassay, and immunonephlometric methods can be used only when blood is the 
body fluid to be analysed as they are less sensitive for detection o f low concentrations 
o f  RBP normally present in urine. Radio-immunoassay method can be employed only 
at facilities where y-radiation use is routinely allowed. The Double Antibody Sandwich 
Method is one o f the most useful o f the ELISA methods. The two-antibody assays 
described here is sensitive, precise and has low reagent consumption cost.
Principle
• Antibody (to antigen to be measured) is attached to  a solid phase which is then 
w ashed .
•  Samples thought to contain antigen were then incubated with sensitised solid phase 
which is then washed.
• Enzyme-labeled antibody to the antigen is then incubated with the solid phase 
followed by washing (washing removes unreacted components}.
•  Enzyme substrate is added. The colour change is proportional to the amount o f 
antigen present in the samples.
2.4.2 Preparation of conjugate
Conjugation o f alkaline phosphatase(Sigma, Poole, England) to the rabbit antihuman 
RBP Ig (DAKO, Glostrop, Denmark) was carried out according to the method 
described by Lucertini et al (1984). Alkaline phosphatase (350 |il) (alkaline 
phosphatase with specific activity o f  2300 kU/g protein was dissolved in 1 ml distilled 
water) was added to 1.1 ml o f phosphate buffered saline (PBS) and 110 pi o f  a 25 g/1 
glutaraldehyde solution in a tube with magnetic stirring and stirred for 50 min at room 
temperature. Then 300 pi o f  5 g/1 anti-RBP Ig, was added and stirred for 75 min. After 
dialysing the mixture against 1000 volumes o f PBS for overnight followed by a tw o 4-
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h period, the mixture was dialysed overnight against 1000 volumes o f 0.05 M Tris- 
HCL buffer (pH 8 .0 ) containing 0.1 mol o f NaCl, 1 mmol o f  MgCl2 , and 1 g o f  N aN ] 
g per liter and diluted to 2.5 ml with Tris-HCL buffer (pH 8.0) containing 2 o f  gelatine 
(Sigma, Poole, England) per liter. The conjugates were stored at 4 °C for one week. 
The materials were centrifuged at 6000 g (Minifuge 2, Heraeus Christ) and 4 C for 15 
min. and the supernatant divided into 2 0 0  pi aliquots and stored at -70 °C.
2.4.3 ELISA procedure
Disposable 96-well flat-bottomed (Combiplate 8 , Enhanced binding, Labsystems; 
Helsinki, Finland) microtitration plates were coated with 10 pg/ml o f  5 mmoL/L rabbit 
antiserum RBP in sodium carbonate (pH 9.6). After incubation at 4 °C, overnight, the 
plates were washed three times with 1 g/L gelatine solution in phosphate buffered 
saline (PBS). Each time, the plates were left 3 minutes before emptying them. Serum 
and urine samples were diluted 5000 and 20 fold respectively in 1 g/L gelatine in PBS. 
Diluent was filtered (0.45 mm-pore size filter) prior to use. Serial two fold dilution o f 
protein human standard (Behring, Marbarg, Germany) were made to obtain a working 
range o f 0.75- 48 pg/L. An aliquot o f 100 microliters o f either standard or unknown 
serum samples (in duplicate) was added to each well and incubated overnight at 4 °C. 
Diluent 1 g/L gelatine in PBS was used as a sample blank with no additions. After 
washing three times, 100 pi o f  alkaline phosphatase conjugated anti-human RBP 
diluted 2 0 0  fold were added and incubated 2  hours at room temperature. Excess 
conjugate was removed by washing the plates three times and enzyme activity was 
measured by adding 1 0 0  pi Nitrophenyl phosphate (PNP; Sigma Chemical Co. Poole, 
England) substrate in diethanolamine buffer (pH. 9.8, 1 0 0  g/L). After 30 minutes 
incubation at room temperature, the enzymatic reaction was stopped by adding 25 pL 
o f 3 N NaoH solution and the absorbance was measured at 405 nm with M r 700 
microplate reader (Dynatech Lab.) {study 1} and a Titertek Multiscan (Flow Lab., 
Irvine, UK) (study II}.
Standard curves were plotted as the log o f RBP concentration versus net absorbance 
(sample absorbance - background absorbance). Standard curve for RBP at 0.75-48 
pg/1 is shown in Fig. 2.10.
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2.4.4 Precision and analytical performance
The intraassay and interassay variability were examined by assaying two plasma 
samples with different concentrations o f RBP o f  at least 12 determinations in a single 
run and in 1 2  separate experiments o f at least 6  samples /experiments; the results are 
shown in Table 2.7 The coefficients o f variation for intra- and interassay variability 
ranged between 4.1 - 5% and 8.4 - 9.2% respectively.
The detection limit o f  this assay was 0.18 pg/1 and the analytical recovery o f  added 
RBP 12 pg/1. was 97% ± 2.9.
Table 2.7 Quality control data of intra- and interassay variability
RBP (pg/1) ± SD Absorbance Coefficient o f variation (%) Number
Intraassay
2.18 ± 0.096 0.26 ±0.013 5 1 2
18.99 ± 0 .72 0.56 ±0.023 4.1 1 2
Interassay
2.34 ±  0.2 0.28 ± 0 .026 9.2 72
19.2 ±  1.3 0..59 ±0 .05 8.4 72
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2.4.5 Discussion
ELISA has many advantages over other assays in terms o f simplicity, stability o f 
reagents and cost. The present assay eliminated the need for radioactive material and a 
second antibody. The radial immunodiffusion technique requires a minimum o f 3 days 
incubation period and requires sample concentration for expected low ranges. The 
working range o f this method (0.75-48 pg/1) was broad enough to measure a wide 
range o f  RBP concentrations in serum and urine. Serum samples were diluted 5000 
fold and urine samples were diluted 2 0  fold in such a way that they fell within the 
working range.
The CV variation for intra- and interassay variability ranged between 4.1- 9.2% which 
compared well with other ELISA methods (Monji and Bosin, 1986; Topping et al., 
1986) or with latex immunoassay (Bernard et al., 1982), and immunonephlometric 
(Parviainen and Ylitalo, 1983).
In conclusion, the assay reported here is simple, reproducible, sensitive and with good 
precision.
2.5 Determination of giucose, iipids, HBAic and creatinine
Fasting blood glucose was assayed immediately by a glucose oxidase method 
(Gochman and Schmitz, 1972), cholesterol and triglycerides were determined by 
enzymatic methods (Allain et al, 1974; M egraw et al., 1979). Creatinine in urine was 
measured by a routine Jaffe' method (Vasiliades,1976). These measurements were 
performed using Beckman Synchron Systems analyser (Beckman Instrument Inc., 
California, USA). The immunological assay o f HBAic was determined by the routine 
two channel method with a BM/Hitachi Automatic Analyzer 717 instrument 
(Boehringer Mannheim). High-density lipoprotein-cholesterol was determined by the 
phosphotungstate/magnesium chloride precipitation method using Hitachi 717 
(Boehringer Mannheim GMbH) by staff o f  Clinical Chemistry Dept., KKUH, Riyadh, 
Saudi Arabia. Low-density lipoprotein-cholesterol was calculated using the following 
formula:
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LDL-cholesterol = total cholesterol -HDL-cholesterol- (triglycerides/2.2) (Friedewald 
et. a l , 1972).
2.6 Statistical analysis
Differences between cases and controls, after correction o f fat-soluble vitamins for 
lipid levels, were evaluated by the t-test for unpaired data and the Wilcoxon Rank Sum 
test. Correlations were computed using Spearman's rank coefficient for non parametric 
data and because o f multiple correlations Bonferroni correction was carried out to 
adjust the significance levels. This Bonferroni method is very conservative; a true p- 
value is less than what is quoted as the upper bound or experiment-wise p-value. Chi 
square contingency table analyses were used to compare the frequency o f  consumption 
o f  individual foods in the two groups. Two-way analysis o f  variance (ANOVA), t-test 
(LSD) and Tukey's test were used to assess the effect o f sex, diabetes, nephropathy 
and hypertension. Differences were judged to be significant when P values were less 
than 0 . 0 1  to  take into accounts the increased probability o f a type 1 error because o f 
multiple comparisons. The classic analysis o f covariance technique was used to  adjust 
lipid soluble vitamins for lipid levels before comparing overall diabetics and controls. 
There was no differential relationship in the lipid: vitamin correlation between diabetics 
and controls. Graphing lipid by vitamins separately for diabetic and controls did not 
suggest that such a difference exists.
All statistical analyses for study I were performed using the Statistical Analysis System 
(SAS, version 6.09 in a Digital Alpha computer)(SAS, 1994). For study II and III, 
Mini Tab, version 10 (1996) (State College, PA, USA) was used for statistical 
analyses.
CHAPTER THREE
CASE CONTROL STUDY OF 
VITAMIN A STATUS IN 
DIABETES MELLITUS
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3.1 Introduction
It has been reported that patients with Type I diabetes mellitus have higher blood 
concentrations o f  carotene (Murrill et al, 1941; Mosenthal and Loughlin,1944) and 
lower concentrations o f vitamin A (Mosenthal and Loughlin,1944) than normal 
subjects. Ralli and associates (1936) observed human diabetics, and Sobel et. al. 
(1953) studied Alloxan diabetic rats; both suggested that conversion o f  carotene to  
vitamin A is less efficient in diabetic patients. In contrast, M oore (1937) found that 
vitamin A was present in high amounts in the livers o f deceased diabetic patients ruling 
out the suggestion o f reduced conversion o f carotene to vitamin A. Other studies have 
reported that serum concentrations o f carotene (Kimble et a l , 1946; Ramachandran, 
1973) and vitamin A (Mosenthal and Loughlin,1944; Kimble et a l ,  1946; 
Ramachandran, 1973 ) in diabetes mellitus o f both types were within the normal range. 
Recent studies have shown that Type 2 diabetic patients have increased concentrations 
o f  plasma retinyl esters (Wako et al. 1986) and decreased serum concentrations o f  
retinol (Basu et al. 1989; Martinloi et a l ,  1993) and RBP in Type I diabetic patients 
(Basu et a l , 1989). Furthermore, retinol concentrations were found to  be significantly 
decreased in type 1 (Krempf et a l, 1991) and increased in Type 2 diabetes mellitus as 
compared to control subjects ( Krempf et a l , 1991; Havivi et a l, 1991; Sasaki et a l , 
1995). Tuitoek and associates (1996) reported significantly lower plasma 
concentrations o f retinol in STZ-diabetic W istar rats which is thought to be a response 
to  diabetes since significantly lower plasma retinol concentrations were also found in 
pair-feeding and in vitamin A supplemented diabetic rats. Moreover, Tuitoek and 
associates (1996) reported a reduction in 11-cis retinal concentrations in the retina o f  
the STZ-diabetic rats.
Other blood constituents may influence vitamin A levels. Numerous reports have 
appeared concerning the interrelationships o f  zinc and vitamin A in a variety o f  clinical 
conditions (Jacob et a l ,  1978; Smith et a l , 1973b; Atukorala et a l , 1986).
Abnormal zinc metabolism has been suggested to  play a role in the pathogenesis o f 
diabetic complications (Hagglof et a l , 1983). A number o f investigations have been 
made with regard to plasma zinc levels in diabetics, but with contradictory results 
(Rosner and Gorfien , 1968; M ateo et a l , 1975; Arreola et a l , 1986; Golik et a l .
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1993). A number o f studies (Rosner and Gorfien, 1968; Davies et al., 1968; Khattab et 
al., 1976; Kinlaw et al., 1983; Melinkeri et al., 1990) revealed no significant differences 
between diabetic patients and control subjects. However, others pointed to  a decrease 
in plasma zinc level (Kumar and Rao, 1974; Sjogren et al., 1986; W alter et al., 1991). 
In contrast, numerous studies observed a significant increase in the serum zinc levels in 
the diabetics (Mateo et al., 1975; Failla and Kiser, 1981). These apparent discrepancies 
might be due to different methodologies employed and/or to the level o f  contamination 
control.
There seems to be more universal agreement about hyperzincuria, in USA, Japan, 
England, India, and Sweden (Meltzer et al., 1962; Tarui, 1963; Pidduck et al, 1970; 
Kumar and Rao, 1974; Sjogren et al., 1986 respectively).
D ata concerning concentrations o f  zinc in the tissues are conflicting. Sircar et al., 
(1985) and Sjogren et al., (1988) reported a decrease in muscle or adipose tissue in 
Type 2 DM  and normal in Type 1 (Sjogren et al., 1986). However, others reported an 
increase in zinc concentrations in liver (Failla and Cardell, 1985) and kidney o f  BB 
Wistar or Alloxan diabetic rat (Failla and Cardell, 1985; Tengrup et al., 1988). Raz and 
Havivi (1989) reported a decrease in zinc concentrations in the haemoglobin o f  Type 
2  diabetes mellitus, although the concentrations o f  zinc in serum and leucocytes were 
similar to those in healthy controls. Pidduck et al., (1971) found that leukocyte zinc 
levels in diabetic were similar to those in non-diabetics.
The pancreas was found to have a lower zinc content in patients with Type 1 diabetes 
mellitus than in normal controls. Zinc is 50% and insulin is 25% less in the diabetic 
pancreas than the normal pancreas (Scott and Fisher, 1938) and a significant 
correlation between zinc and insulin was found (Davies et. al., 1968). Zinc is present in 
the islets o f Langerhans and it may have a role in the mechanism o f secretion o f insulin 
(Maske, 1957). Zinc has been shown to enhance insulin action and promote glucose 
uptake by adipose tissue (Quarterman and Florece, 1972). M oreover glucose tolerance 
is lowered in zinc deficient rats (Boquist and Lemmark, 1969; Park et. al., 1986). 
However, Brandao-Neto and associates (1990) detected no change in plasma glucose 
or insulin levels in healthy subjects when given 50 mg o f zinc.
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Several investigators have reported increased serum copper concentrations in diabetic 
patients (Failla and Kiser, 1981; Hagglof et al, 1983; Lau and Failla, 1984; Walter et. 
al., 1991). However, other studies found normal serum levels o f copper in diabetic 
individuals (Pidduck et. al., 1970). Raz and Havivi (1989) found an increase in serum 
copper in Type ID M  and normal in Type 2 DM. Imbalances in the metabolism o f 
copper (Fields et. al., 1983; Reiser et. al., 1983) have been associated with impaired 
insulin release, insulin resistance and glucose intolerance in experimental animals.
3.2 Objective
In the light o f  such apparent discrepancies, the current study was undertaken to  test 
the hypothesis that diabetes mellitus influences the metabolism o f serum or urine 
retinol, a-carotene, P-carotene, a-tocopherol, zinc, copper, RBP and creatinine in 
subjects with diabetes mellitus; to compare the levels o f  these constituents in patients 
with diabetes mellitus with those in healthy controls; to explore the relationships o f  
these constituents in patients with diabetes mellitus; and to assess the effect o f  
duration, type and treatment o f  diabetes on these constituents.
3.3 Subjects and methods
The study involved 110 diabetic patients (aged 26-74 years) attending a diabetic clinic 
in King Khalid University Hospital in Riyadh City (Saudi Arabia). The majority were 
suffering fi'om Type 2 DM (97%) and the remainder were diabetic patients with Type
1. They were matched in age and sex with 143 non diabetic subjects selected after 
screening 182 apparently healthy subjects. The control subjects were recruited from 
King Saud University faculty, staff and employees. Their ages ranged from 27-75 
years. The controls’ selection was based on physical examination and laboratory 
investigation. Presence o f complications or infection among patients with D M  was 
evaluated by their physician.
Retinol, a-carotene, P-carotene and a-tocopherol were determined by high pressure 
liquid chromatography (HPLC) (Lee et al., 1992) with some modification. The 
concentrations o f RBP in serum and urine were determined by a double antibody 
sandwich enzyme linked immunosorbent assay (ELISA) (Lucertini et al., 1984). Urine, 
serum zinc and serum copper were determined by atomic absorption
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Spectrophotometry (AAS). Fasting blood glucose, cholesterol and triglycerides were 
assessed by routine methods using Beckman Synchron Systems (Beckman Instrument 
Inc., California, U.S.A.). Initial analysis revealed that the exclusion o f  Type I diabetes 
mellitus patients did not alter the results, hence all diabetics were included in the 
analysis except those individuals who were taking vitamin or mineral supplements or 
consuming large amounts o f  carrots (two cups juice or 1 / 2  kgm o f carrots).
A complete dietary history, frequency o f consumption o f  35 food items and 
information regarding demographic characteristics, socio-economic status, use o f  
medicine and vitamin supplements were obtained from all subjects.
The food frequency questionnaire was used as a rough estimate o f  the qualitative 
aspects o f food consumption. Another technique (24 h recall) was used for the 
quantitative dietary estimate. It would have been more useful if the food frequency 
questionnaire had been validated by a 3-day weighed food records in a pilot study. 
Prior to  blood sampling, subjects were asked about their food intake during the 
previous 24 hours. Assessments o f actually consumed food were facilitated by showing 
models o f  different food items o f  different weights and sizes and different house-bold 
measures.
The 24-hour diet intake recall was analysed using a computerised nutrition analysis 
system, the Food Processor II (ESHA Research, 1996). Data were added to  the data 
base for some local and Mediterranean composite dishes (Pellet and Shadarevian, 
1970).
Differences between cases and controls were evaluated by the t-test and the Wilcoxon 
Rank Sum test. The analysis o f  covariance technique was used to adjust lipid- soluble 
vitamins for lipid levels before comparing overall diabetics and controls. Correlations 
were computed using Spearman's rank coefficient. The significance levels were 
adjusted to accommodate Bonferroni method issue o f  multiple comparisons. This 
Bonferroni method is very conservative; a true p-value is less than what is quoted as 
the upper bound or experiment-wise p-value. Chi square contingency table analysis 
was used to compare the frequency o f consumption o f  individual foods in the tw o 
groups. Two-way analysis o f  variance (ANOVA), t-test (LSD) and Tukey's test were 
used to assess the effect o f sex, diabetes, renal impairment and hypertension. 
Differences were judged to  be significant when P values were less than 0 .0 1 . All
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statistical analyses were performed using the Statistical Analysis System (SAS, version 
6.09 in a Digital Alpha computer) (SAS, 1994).
3.4 RESULTS
3.4.1 Characteristics of the subjects
Table 3.1 shows that diabetic patients and control individuals were similar in terms o f 
age, weight, body mass index and income. Wilcoxon Rank Sum test was used for 
comparison between the two groups. M ost o f  the diabetic patients were o f  Type 2 
(97%) with a mean diabetes duration o f 6.9 ± 5 .1  yr., mean age at onset o f  43.4 ±  9.8 
y. Diabetics patients were treated either by diet alone (n = 24), a diet plus oral 
hypoglycaemic agents (n = 70) or treated with insulin (n = 16). The mean daily insulin 
dose was 45.15 ± 2 1 .9  units.
Table 3.1 Characteristics o f  cases and control
Diabetic patients (n = 110) Controls (n = 143)
Mean (± SD) Range Mean (± SD) Range
Age (years) 50.4 (9.3) 26-74 49.3 (9.4) 27-75
Weight (kg) 72.6 (12.9) 43-103 72.5 (13) 45-111
Height (m) 1.56 (0.08) 1.38-1.78 1.57 (0.08) 1.38-1.78
BMI (kg/m^) 29.75 (5) 16.8-39.6 29.5 (5.5) 19.5-45
FBG (mmol/L) 11.2(4.5) 3.5-25.5 5.5 (0.7) 4-7.5
Income * 1 196(1 480) 2 0 0 - 1 0  0 0 0 1 335 (2 098) 150-15 500
* Saudi Riyal/Month/Individual 
Wilcoxon Rank Sum test
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3.4.2 Dietary intake
Table 3.2 presents the mean 24-h nutrient intake. In general, both groups have similar 
values for all nutrient variables with the exception o f energy and carbohydrate intake, 
both o f which were significantly lower in diabetic patients (P < 0.0003 and P < 
0 .0 0 0 1 , respectively).
Chi square contingency table analysis was used to  compare the fi-equency o f  
consumption o f  individual foods in the two groups. Control subjects had a significantly 
higher consumption o f white bread, rice, spaghetti, butter, cream, vegetable oil, sugar, 
honey and soft drinks (p < 0 .0 0 0 1 ), while diabetic patients had significantly higher 
consumption o f  local dishes made fi'om whole wheat (p < 0.0001). It seems likely that 
the lower refined carbohydrate intake by patients with diabetes, was probably due to 
dietary instructions rather than being o f  any etiologic importance in the pathogenesis o f  
their diabetes.
Fig. 3.1 illustrates the mean intake expressed as a percentage o f  the U.S.A. 
Recommended Dietary Allowances (RDA) (Committee on RDA, 1989). Only zinc 
copper and polyunsaturated fats intakes were below 75% o f the RDA for both diabetic 
patients and control individuals. In addition, diabetic patients consumed less than 75% 
o f  the RDA with respect to  calories (67%) and total fat (72.7%). Although vitamin A 
intake was equal for patients with DM  and controls, patients with D M  consume more 
vitamin A fi*om vegetable sources while controls consume more vitamin A from animal 
sources which was probably due to dietary advice given to  patients with DM.
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Table 3.2 The 24-h dietary intake for diabetic patients and control subjects
D iabetic patien ts (n= 108) C ontrol subjects (n =142)*
Mean (±SD) Range Mean (±SD) Range p i  <
Energy (KCal) 1386 (448) 914-3 572 1606 (528) 900-3 344 0.0003
Protein (gm) 73.5 (23.2) 3 9 -1 5 6 77.3 (27.0) 30.7- 161 N.S.
Carbohydrate (gm) 161(60) 79.5 - 386 201 (67.9) 93.7- 497 0 . 0 0 0 1
Fibre (gm) 16.8 (6 .6 ) 2.2 - 36 14.6 (7.4) 3.7- 40 N.S.
Total fat (gm) 50.6 (22.4) 1 5 -1 6 5 57.0 (28.0) 12.2- 165 N.S.
Saturated fat (gm) 18.6 (8 ) 4 - 4 4 2 1 .0 ( 1 1 ) 2 .9 -5 3 .5 N.S.
M ono-unsaturated 17.8 (8.7) 4.6 - 52.6 18.3 (9.6) 3 .5 -5 7 N.S.
fat (gm)
Poly-unsaturated 8.4 (6.7) 1 .0 -5 1 9.2 (6 .8 ) 0.59 - 44 N.S.
fat (gm)
Cholesterol (mg) 256 (168) 62 - 784 255 (205) 1 0 -1 5 2 2 N.S.
Retinol (RE)^ 198(121) 21-622 234(161) 17-656 N.S
Carotenoids (RE) 456 (277) 47-1617 415(285) 30-1582 N.S.
Vitamin E  (mg) 9 3 .(8 5 ) 1 .9 -6 3 9.1 (7.5) 0.34 - 57.6 N.S.
Copper (mg) 0.94 (0.45) 0 .3 4 -3 .7 1.0 (0.4) 0 .0 9 -2 .6 N.S
Zinc (mg) 8.3 (2.8) 2 .8 -2 0 .5 8.9 (4) 1 .5 6 -2 2 N.S.
1- Wilcoxon Rank Sum with level o f  significance =1%
2- Retinol equivalent 
NS = N ot significant
* Subjects whose dietary data was doubtful were not included.
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3.4.3 Measured serum variables
Results o f vitamin and RBP measurements in serum are shown in Table 3.3. The 
preliminary analysis showed no significant difference in any o f the dependent variables 
among the treatment groups, duration groups and Type 1 and Type 2 D M  groups. 
Thus, diabetic patients as a single group were compared with controls. The fasting 
concentrations o f serum retinol, a-carotene, a-tocopherol, zinc, copper and 
cholesterol were similar in diabetic and control groups after correction o f  lipid soluble 
vitamins for serum lipids levels. Wilcoxon Rank Sum and Student t-test were used for 
comparing the two groups. However, the mean serum p-carotene concentration was 
significantly higher in controls (20.9 + 15.1 pg/dl) than in diabetic patients (14.9 ±
11.8 pg/dl) (p < 0.003). When compared with controls, diabetic patients had 
significantly higher concentrations o f  RBP in serum (45.1 ±  20.5 vs. 33.6 + 15.3 mg/L; 
p < 0.0001 ). Triglyceride concentrations in serum were also significantly higher in 
diabetic patients (2.0 ±1 .1  mmol/L) than in controls (1.54 ±  0.7 mmol/L; p < 0.0001).
3.4.4 Measured urine variable
Results o f  creatinine, zinc and RBP measurements in urine are shown in Table 3.4. 
Urine RBP and zinc concentrations (expressed either as total amount excreted/1 Oh or 
as ratio to creatinine) were significantly higher in diabetic patients than controls (p < 
0.0001, 0.0002, respectively). Urine creatinine concentration was significantly lower in 
diabetic patients than control individuals (P < 0.0001). Both male and female diabetic 
patients excreted significantly less creatinine/ 1 0  h than controls (p< 0 .0 0 0 1 ).
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3.4.5 Sex differences
When the results were examined according to  sex by two-way ANOVA, there was an 
overall significant sex effect for retinol and serum RBP (p<0.0001, p<0.0007 
respectively). However, it was also detected that there was a significant interaction 
(?<0.0007, ?<0.04, respectively). This indicates that the direction o f the significance is 
not the same for both groups. When a t-test was performed separately for diabetic and 
control, male control subjects had significantly higher serum concentrations o f  retinol 
and RBP than females (P< 0.02, p<0.0001, respectively), but there was no significant 
difference between males and females in the diabetic group. There was an overall 
significant sex effect in triglycerides (p<0.008), zinc (p < 0.0001), serum RBP 
(p<0.0007) and urine RBP (p< 0.005). In the case o f  these latter parameters there 
were no significant interactions indicating that the significance is consistent in both 
groups and in the same direction; men had significantly higher means than women. On 
the other hand, mean serum copper concentration was higher in females than in males 
(p < 0.0001) [Table 3.5]. There was an overall sex effect for urine creatinine/10 h (P < 
0 .0 0 0 1 ) but there was a significant Also interaction (p < 0.07). When a t-test was 
performed separately for diabetics and controls, male control subjects had significantly 
higher urine concentrations o f  creatinine/10 h (P < 0.0001), but there was no 
significant difference between males and females in the diabetic group [Table 3.6].
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3.4.6 Duration, treatment and complication differences
There was no relationship between duration since diagnosis o f diabetes (<5, 5-10, >10 
y) and any o f  the measured serum nutrients. Mean serum concentrations o f  a-carotene 
and retinol were lower in diabetic patients treated with insulin although the decrease 
was not significant when tested by the Student t-test or Wilcoxon Rank Sum. There 
was no association between mean serum concentrations o f measured variables and the 
use o f other medications (Brufin, Aspirin and antihistamine tablets) in both diabetic 
patients and controls.
There was no association between measured variables and the presence o f  either 
coronary heart disease (n = 2), neurophathy (n = 3), infection (n = 4) or other 
complications (n = 4) in diabetic patients. However, when a one way ANOVA was 
performed o f urinary RBP on the four groups: controls, diabetic patients, diabetic 
patients with hypertension and diabetic patients with renal impairment^ there was a 
significance (P < 0.0001). This indicates that some differences exist among the groups. 
In order to identify which groups differ from each other, Tukey's Studentized Range 
method was used with Alpha = 0 .0 1 . It was found that diabetic patients with renal 
impairment had a significantly higher excretion o f  RBP (expressed either as total 
amount excreted / 1 0  h or as ratio to  creatinine) when compared to other diabetics, to  
diabetic patients with hypertension, or to controls. Diabetic patients with renal 
impairment had significantly lower serum concentration o f  zinc when compared to 
other diabetics, or to controls (p < 0.002) (Table 3.7 ).
’ Renal impairment = Serum creatinine >130  mmol/1
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3.4 J  Correlation analysis
The associations o f measured variables with each other were assessed and the results 
o f  these analysis are presented in Tables 3.8-3.12. In the total group, a significant 
positive correlation was found between FBG and serum RBP (r = 0.22, p < 0.04), 
FBG and triglycerides (r =0.33, p < 0.007) and a significant negative correlation 
between FBG and g-carotene (r = -0.18, P< 0.05), FBG and urine creatinine (r =  - 
0.43, p < 0.007). In diabetic patients and controls combined, there was a significant 
positive correlation between FBG and urinary RBP/creatinine (r = 0.44, p < 0.007), 
FBG and urine zinc/creatinine (r = 0.55, p < 0.007) and a significant negative 
correlation between FBG and urine creatinine (r = -0.43, p < 0.007) (Table 3.8).
Retinol showed a significant positive correlation with serum RBP (r = 0.32, p<0.02) in 
normal but not in diabetic patients. Retinol significantly correlated with a-tocopherol 
(r = 0.3, p < 0.05), serum zinc (r = 0.24, p < 0.02) serum cholesterol (r =  0.3, p < 
0.05) and triglycerides (r = 0.28, p < 0.007). Beta-carotene correlated well with a -  
carotene (r = 0 .6 8 , p < 0.007), and a-tocopherol (r = 0.23, p < 0.05). Alpha- 
tocopherol correlated well in varying degrees o f  significance with a-carotene (r =  
0.24, p < 0.05), cholesterol (r = 0..55, p < 0.007) and triglycerides (r = 0.4, p < 0.02) 
(Table 3.9).
Serum zinc showed a significant positive correlation with cholesterol (r = 0.21, p < 
0.05) and serum RBP (r = 0.24, p < 0.02). In normal subjects but not in diabetic 
patients, there was a significant negative correlation between copper and each o f  the 
following: retinol (r = -0.31, P < 0.02), zinc (r = -0.32, P < 0.007) and serum RBP (r = 
-0.28, P < 0.007) (Table 3.10).
Triglycerides correlated significantly with serum cholesterol (r = 0.45, p < 0.007). 
There was a significant negative correlation between zinc/creatinine and urine 
creatinine (r = -0.55, p < 0.007), urine creatinine and urine RBP (r = - 0.43, p < 
0.007), urine creatinine and urine RBP/creatinine (r = -0.78, p < 0.007). There was a
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significant positive correlation between urine zinc and urine RBP (r = 0.41, p < 
0.007), zinc/creatinine and urine RBP (r = 0.65, p < 0.007) (Table 3.10).
The correlations between serum variables and nutrient intake were examined. Serum 
retinol significantly correlated with most o f  the nutrient intakes examined; energy (r = 
0.29, p < 0.007), protein (r = 0.24, p < 0.05), carbohydrate (r = 0.24, p < 0.05), fibre 
(r = 0.25, p < 0.007), copper (r = 0.29, p < 0.007), zinc (r = 0.28, p < 0.05) and fat (r 
= 0.27, p < 0.007). Serum RBP correlated with protein, zinc and copper intakes in 
normal subjects but not in diabetic patients. There was a significant positive 
correlation between serum RBP and fibre intake (r = 0.29, p < 0.007) in the two 
groups combined (Table 3.11).
Serum copper had a significant negative correlation with most o f the nutrients 
examined (energy, protein, fibre, zinc and fat). In normal but not diabetic, urinary 
creatinine showed a significant positive correlation with energy (p < 0 .0 2 ) intake in 
control subjects only (Table 3.12).
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3.5 Discussion
3.5.1 Vitamin A
This study indicated that there was no significant difference in serum retinol 
concentration between diabetic patients and control subjects after correction o f  
concentration o f lipid soluble-vitamin for lipids levels. These results agree with the 
findings o f some, but not all, previously published reports. In the U.S.A., Kimble and 
associates (1946) and Murrill et al., (1941) observed that vitamin A values in diabetics 
whether Type 2 (Kimble et al ,1946) or Type 1 (Murrill et al., 1941) were similar to 
those found in non-diabetic subjects. Similar results were found in Type 2 patients in 
India by Ramachandran (1973). In contrast, low serum levels o f retinol in up to  tw o- 
thirds o f diabetic patients have been found in other studies, both in children (Mosenthal 
and Loughlin, 1944) and adults (Basu et al., 1989). However, diabetic patients in both 
these studies were o f  Type 1 DM  indicating that may be Type 1 and Type 2 patients 
may behave differently with respect to vitamin A metabolism.
Increased concentrations o f  RBP both in serum and urine have been reported in both 
children (Gibb et al, 1989) and adults (Rowe et al, 1987) with diabetes in the absence 
o f either microalbuminuria (Holm et al, 1987) or impaired renal fiinction as assessed by 
serum creatinine (Holm et al, 1988). The present data agree with these findings but 
also show that the rise in both serum and urine RBP levels is greater in patients with 
renal impairment. This increase in urinary RBP in diabetic patients with no other 
evidence o f nephropathy may be useful in identifying diabetics at risk for nephropathy. 
The elevated concentrations o f  RBP in serum reflect the fact that the kidney is the 
main site for catabolism o f RBP. Owing to  its small size, RBP is filtered at the 
glomerulus and both reabsorbed and metabolised in the proximal tubule (Smith and 
Goodman, 1979). Both reabsorption and catabolism are impaired in the presence o f  
renal disease. The significant correlation between FBG and both serum and urine RBP 
in patients with normal renal function and without microalbuminuria indicate the 
possibility that poor glycaemic control may result in impaired renal handling o f  RBP 
even in the absence o f renal disease.
Our results are in contrast with those o f  Basu and associates, who found lower serum 
RBP levels in 25 Type 1 diabetic patients (Basu et al, 1989). This observed decrease in
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RBP levels in Basu and associates’ study may be related to the type o f  diabetes and 
the possibility that there are differences between Type 1 and Type 2 DM  with respect 
to RBP metabolism. However, although reduced, the RBP concentrations in that study 
were within the normal range (Basu et al, 1989).
Published studies reflect a clear lack o f agreement over the levels o f P-carotene in 
serum in diabetes mellitus. Our findings o f  significantly reduced levels agree with those 
o f  Kimble (1946) and Ramachandran (1973), but are in contrast to  those reported by 
other authors (Murrill et al., 1941; Mosenthal and Loughlin, 1944; Rabinowitch, 
1930). In a Canadian study in Montreal, Rabinowitch found that 85% o f the 1400 
diabetic patients studied had total carotenes levels above the normal limits, while in an 
American study, 28% o f 114 diabetic children had plasma carotene levels above the 
normal range with 16% below the normal range (Mosenthal and Loughlin, 1944). 
Moreover, Murrill et al. (1941) reported that the average carotene concentration was 
significantly higher in Type 1 diabetic patients than in normal subjects. Following 
administration o f  a large dose o f carotene, there was no difference in either the peak 
blood levels achieved or in the subsequent rate o f decline (Murrill et al. 1941). This 
observation was confirmed by Ramachandran (1973), and these two studies refiite the 
earlier suggestion that blood carotene levels are higher following an oral dose in 
diabetics (Ralli et al., 1935).
These earlier studies were measuring total carotene while this study and other recent 
studies measured p-carotene, a-carotene and or other caroteinoids separately which 
might be a plausible reason for the observed reduced levels o f P-carotene in our study 
and other recent studies.
In contrast to earlier studies which showed higher serum concentrations o f  carotene in 
diabetic patients, more recent studies suggest that levels o f p-carotene may actually be 
lower in this group. This may reflect a change in dietary advice given to people with 
diabetes. Older recommendations for a low carbohydrate diet inevitably led to  a higher 
intake o f  fat which may have entrained an increase in intake o f  fat-soluble vitamins. 
M ore recent advice, recommending a high (unrefined) carbohydrate diet may have 
reversed this trend.
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Discrepancies between older and more recent studies may also be attributable to 
differences in analytical methodology. In earlier studies, all carotene content present in 
plasma was determined either by methods based on colour comparison with a standard 
(oleic acid) (Rabinowitch, 1930), or by using the Carr-Price reaction in which 
measurements were made o f  total retinol and carotene content, followed by subtraction 
o f  the carotene value as determined by colorimetric analysis (Mosenthal and Loughlin, 
1944). Differences between these older methods and modem HPLC methods clearly 
make comparison o f results extremely dubious.
Factors that may be responsible for the observed decrease in circulating p-carotene in 
patients with DM include:
•  Malabsorption: this is unlikely since the concentrations o f other fat soluble
vitamins (retinol and a-tocopherol) were similar in the diabetic and the control 
groups.
•  Infections: it has been suggested (Kimble, 1946) that chronic infection may result 
in a decrease in circulating levels o f both vitamin A and carotene, possibly due to 
interference with intestinal absorption (Heymann, 1936). However, in the current 
study, there was no significant decline in serum levels o f  either retinol or P- 
carotene in diabetic patients with infections when compared to  other diabetic 
patients or control subjects (diagnosis o f infection was reported by their physician).
•  Low intake o f P-carotene: serum concentration o f the pro-vitamin is closely related 
to dietary intake, falling within a few weeks if the diet is deficient (Kimble, 1946). 
In the present study, there was no significant difference in the 24-hour carotene 
intake or frequency consumption o f either p-carotene or retinol. Subjects with 
carotenemia (one diabetic patient and 3 control subjects) had a history o f  excessive 
raw carrot intake and were excluded from the analysis.
•  Low fat diet: absorption o f both carotene and vitamin A is influenced by the 
amount o f fat in the diet (Ahmed, 1931; Blomhoff et. al., 1992). We found no 
relationship between serum concentrations o f p-carotene and either serum levels or 
dietary intake o f cholesterol and triglycerides. However, there was a significant 
correlation between serum retinol concentration and both serum cholesterol levels
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and triglyceride concentrations as well as dietary intake assessed by 24-hour recall. 
In addition, the higher dietary intake o f oil, butter and cream in control subjects (p 
< 0 .0 0 0 1 ) may have contributed to their higher levels o f serum p-carotene.
The importance o f  the A and E groups o f vitamins in diabetes may relate to  their 
antioxidant properties. Although the precise mechanism o f  many o f  the complications 
o f  diabetes is unknown, it is increasingly believed that oxidative tissue damage may 
play a role in their pathogenesis. Beta-carotene has been reported to be a potent free 
radical quencher, singlet oxygen scavenger and lipid antioxidant (Burton and Ingold, 
1984; Krinsky, 1993); it is possible that the reduced serum concentrations o f  P- 
carotene in diabetic patients may be due to its depletion as a sacrificed antioxidant 
(Bendich and Olson, 1989).
An alternative explanation is that in diabetes, there is an increased production o f  
singlet oxygen for which P-carotene is the scavenger. In other diseases with increased 
production o f oxygen free radicals, such as cystic fibrosis or renal failure, P-carotene 
was the most severely depressed antioxidant (Favier et al., 1994). However, the fact 
that the concentration o f a-tocopherol, the other antioxidant studied, was not reduced 
in diabetic subjects does not lend support to this possibility, although it has been shovm 
that there are situations (such as HIV infection) in which there is predominant 
suppression o f p-carotene compared with other antioxidants such as tocopherol, zinc 
and selenium (Favier et al., 1994).
3.5.2 Sex and age variations
Male subjects had significantly higher serum concentration o f retinol which is in 
agreement with the earlier published data (Murrill et al., 1941; Kimble et al., 1946; 
Kaplan et al, 1990; Arnaud et al, 1991; Ringer et al, 1991; Olmedilla et a l ,  1994), but 
contrary to  the findings o f  Kahan (1969).
The current study indicated that serum a-caro tene, P-carotene and a-tocopherol did 
not differ between men and women., and this is in agreement with several studies 
(Arnaud et al, 1991; Ringer et al, 1991). Others found that women had significantly 
higher values for a-carotene (Ito et al, 1987; Olmedilla et a l ,  1994) and P-carotene
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(Ito et al, 1987; Kaplan et al, 1990; Olmedilla et al., 1994; Brandt et al., 1994) than 
men.
In agreement with earlier observations (Kahan, 1969; Krasinski et al., 1990; Ringer et 
al.,1991), we found that the serum retinol increase with age. However, the increase 
was not significant. Serum concentration o f a-carotene and P-carotene in females 
increased with age, but did not increase for males (Ito et al, 1987). Others found that 
beta-carotene, alpha-carotene, concentrations tended to  increase with age (Ringer et 
al,1991). In this study there was no association between age and a-carotene or P- 
carotene.
3.5.3 Zinc and copper
In this study, there was a significant positive correlation between serum zinc and 
retinol levels (r = 0.24, p < 0.02). This supports reported data which suggest that there 
is a significant interaction between these two nutrients (Duncan and Hurley, 1978; 
Russel, 1980; Smith, 1980). In contrast, Hambidge et al., noted no significant 
correlation between plasma zinc and retinol in a group o f preschool children 
(Hambidge et al., 1976). Similarly, Henkin and Smith reported that serum zinc and 
retinol were not significantly correlated in viral hepatitis patients, although serum zinc, 
retinol and RBP were depressed in these patients (Henkin and Smith, 1972). There was 
a significant negative correlation between serum copper and retinol in controls but not 
in diabetics (-0.31, p < 0.02), which was in agreement with published reports (M oore 
et. al., 1972). In controls, there was a significant negative correlation between serum 
zinc and serum copper (r = -0.32, p <0.007). This support the theory o f  an antagonistic 
effect o f high zinc intake on serum copper levels in humans (Prasad et al, 1978; Festa 
et al 1985). In diabetic patients, there was a lack o f correlation between zinc and 
copper; this was supported by others (Pidduck et al, 1970; M ateo et al., 1978).
In controls and diabetic combined, significant positive correlations between serum zinc 
and cholesterol (r = 0.21, p < 0.05) was observed. This was in line with the Klevay 
hypothesis that an increase in zinc intake might lead to high serum cholesterol (Klevay, 
1973).
Serum zinc levels were similar in both diabetic and normal subjects. These results are 
in agreement with those reported by some workers (Rosner and Gorfien, 1968;
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Pidduck et. al., 1970; Khattab et al., 1976) who found that plasma zinc levels in 
diabetics are usually normal, but contrary to other authors who reported that the 
concentration o f zinc in plasma was significantly lower in the diabetics than in the 
normal subjects (Kumar and Rao, 1974; Chooi et al, 1976; Arreola et al., 1986). 
Others observed a significant increase in the serum zinc content in diabetics (Davies et 
al., 1968; M ateo et al., 1978).
There was no significant correlation between serum zinc and FBG, this was in 
agreement with other published results (Reusch and Bunch, 1969)
The current study data indicated that there was no significant difference in copper 
concentrations between diabetic patients and controls and this was in agreement with 
some reported data (Pidduck et. a l , 1970; Raz and Havivi, 1989), but in contrast with 
several investigators who have reported increased serum copper concentrations in 
diabetic patients (Failla and Kiser, 1981; H agglof et al, 1983; Lau and Failla, 1984; 
Walter et. a l , 1991).
3.5.4 Age and sex variation
M ost investigators have found no significant difference in the plasma zinc values o f 
different age groups (Davies et a l , 1968; Eisa et, a l , 1972; Chooi e t.a l, 1976; 
Niewoehner et. a l , 1986) or between males and females (Halsted and Smith, 1970). In 
the present study, there was no significant correlation between serum zinc or copper 
and age. With respect to  sex variation, there were a significant lower serum zinc levels 
in females than males (p < 0.0001), which is in agreement with some authors 
(Linderman et a l ,  1971; Nobels et al, 1986), and contrary to  some other published 
reports (Chooi e t.a l, 1976). Lahey et a l ,  (1953) reported that the concentration o f  
serum copper was higher in diabetic women than in diabetic men. We found similar 
result that serum copper levels are higher in women than men.
3.5.5 Zinc in urine
In the present study, concentration o f zinc in urine, whether expressed as an excretion 
per 10 hours or in terms o f  creatinine, was significantly higher in the diabetic patients 
compared to normal subjects. This finding is in line with those reported in the literature 
(Meltzer et a l , 1962; M ateo et a l , 1975; Heise et a l , 1988; Golik et al, 1993).
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The results o f  this study indicated significant positive correlations between urine zinc 
and FBG levels ( p < 0.007). This is in agreement with numerous studies (Tarui, 1963; 
McNair et al., 1981; Kinlaw et al., 1983; Canfield et al, 1984). Tarui (1963) indicated 
that the increase o f zinc excretion may be a reflection o f the severity o f diabetes. 
However, this has been disputed by some other investigators who found no correlation 
between FBG and urine zinc levels in diabetic patients (Mateo et al, 1975; Chooi et al, 
1976; Heise et al, 1988). Urinary zinc excretion was reduced with insulin treatment in 
humans (Tarui, 1963) and in animals (Lau and Failla, 1984). Lau and Failla (1984) 
found that insulin treatment reversed the increased urinary excretion o f  zinc and 
copper, suggesting that the increased urinary losses o f trace metals was due to an 
endocrine imbalance and not to  the renal toxicity o f the diabetogenic drug (STZ). It 
was speculated that hyperglycaemia interferes with the efficiency o f active transport o f 
zinc into renal tubular cells resulting in raised urinary zinc excretion (Golik et al, 
1993).
This hyperzincuria could not be related to the zinc contained in long-acting insulin 
preparations as less than 15% o f the diabetic patients in this study receive insulin. 
Furthermore, our data showed no correlation between insulin dose and urinary zinc in 
diabetic patients. This was in agreement with some published reports (Kinlaw et. al., 
1983). The assumption that it might be related to polyuria is refuted by the observation 
that the increase in urinary volume brought about by drinking excess water did not 
alter the total urinary zinc excretion in non-diabetic subjects (Kumar and Rao 1974). 
Serum zinc is largely protein-bound (Giroux, 1975). The current study indicated that 
there was a highly significant correlation between urinary zinc and RBP excretions (p < 
0.007). This might suggest that an alteration in renal function may contribute to  the 
increased urinary losses o f  zinc.
Diuretics have been shown to produce excessive urinary zinc excretion in hypertensive 
patients (Golik et al, 1987). However, this was not supported by another investigator 
(Kinlaw et al, 1983). The current data indicated no significant differences between 
diabetic patients with hypertension and other diabetic.
Raised urinary zinc excretion may be a result o f increased zinc absorption as was 
observed in STZ- diabetic rat (Craft and Failla, 1983). This was questioned by Kinlaw 
and associates (1983), who suggested that zinc was mal-absorbed by diabetic subjects.
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based on a decreased plasma zinc response to a large oral dose. However, in an animal 
study, there was no difference in zinc absorption between diabetic and normal rats 
(Johnson and Canfield, 1985), although the intestinal zinc excretion was reduced in 
diabetic rats (Johnson and Canfield, 1985). This reduced intestinal zinc excretion might 
be a response by the diabetic rat to compensate for the high zinc excretion (Heise et 
al., 1988).
This high urinary excretion o f  zinc in patients with diabetes mellitus could be related to 
a disturbed metabolism o f  zinc metal enzymes or to  an abnormality in the metabolism 
o f zinc protein complexes in the tissue in diabetes (Pidduck et al, 1970), or that the 
increased urinary zinc is due to muscle breakdown in the diabetic state (Fell et al, 
1973). Gol'dberg (1992) suggested that the damage to the islet P-cells is the cause o f  
zinc metabolism disturbance in the endocrine pancreas (Gol'dberg, 1992) .
An alternative explanation is that there is an abnormality in the utilisation o f zinc by the 
pancreas and perhaps reflects the break down o f  the insulin and its loss. It is known 
that zinc contributes to the polymerisation and storage o f  the insulin in the grains o f  
beta-cells (Scott and Fisher, 1938).
A completely different theory has been suggested following the discovery that the 
administration o f  chelating agents (Alloxan) to animals results in an increase in urinary 
zinc output. Tarui (1963) suggested that the body may produce its own chelating 
agents.
3.5.6 conclusion
In conclusion, this study indicated that levels o f P-carotene may be reduced in patients 
with diabetes and that there is a negative correlation between P-carotene and 
glycaemic control as assessed by fasting blood glucose. W hether P-carotene should be 
considered as a therapeutic agent in diabetes requires further studies.
Our data demonstrated that patients with predominantly Type 2 diabetes mellitus 
excreted excessive amounts o f  zinc. The correlation between FBG and urinary zinc, 
FBG and urinary RBP excretion might indicate that the hyperzincuria is caused by high 
FBG or that the cause is renal imbalance.
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The present data indicated a rise in both serum and urine RBP levels in patients with 
renal impairment and in diabetic patients with no other evidence o f nephropathy. This 
finding may be useful in identifying diabetics at risk o f nephropathy.
CHAPTER FOUR
VITAMIN A STATUS IN 
PATIENTS WITH TYPE I, 
TYPE 2 DIABETES 
MELLITUS, AND 
CHRONIC RENAL 
FAILURE
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4.1 Introduction
Our data in study 1 indicated a rise in both serum and urine RBP levels in patients with 
renal impairment and in patients with DM with no microalbuminuria and there was a 
significant negative correlation between p-carotene and glycaemic control as assessed 
by fasting blood glucose.
Two issues will be evaluated in this study:
♦ Reassessing the relationship between P-carotene and glycaemic control as assessed 
by HbAic. HbAic is the principle complex that formed with glucose; it normally 
forms 5% o f circulating haemoglobin (Hb). Since the half-life o f  Hb is about 60 
days, the HbAic value reflects the average level o f blood glucose over the previous 
1-2 months. Level o f  HbAic tend be higher in diabetics. The extent o f the elevation 
indicates the overall average degree o f  blood glucose control.
♦ Evaluating the effect o f both types o f  diabetes, renal impairment and CRF (both in 
diabetic and non-diabetic) on vitamin A metabolism.
4.1.1 Retinol and carotenoids in diabetes mellitus Type I
Several studies have reported a reduction in plasma retinol in Type I diabetic patients
(Mosenthal and Loughlin, 1944; Basu et al., 1989; Krempf et al., 1991). M oreover, 
other studies have indicated that individuals with diabetes mellitus Type I differ from 
those with diabetes mellitus Type 2 when their plasma or serum concentrations o f  
retinol were compared to  controls (Krempf et al., 1991; Martinoli et al., 1993). 
Krempf and associates (1991) have studied both Type I and Type II and found that 
serum concentrations o f  retinol were significantly decreased in Type I and increased in 
Type 2. In another study, it was found that the mean plasma level o f  retinol was 
significantly lower in the younger subset o f Type 1 diabetic patients (age < 45 y), but 
not in the older diabetic patients Type 2 (Martinoli et al., 1993).
An increase in plasma total carotene has been reported in insulin-dependent diabetic 
patients (Murrill et al., 1941; Mosenthal and Loughlin 1944). Kimble and associates 
(1946) found that patients with diabetes (unclassified; include children and adults) 
showed a wider range o f blood vitamin A and carotene. The most prominent trend
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among these diabetics was toward low levels, though values within the normal range in 
either direction were also observed (Kimble et. a l ,  1946).
4.1.2 Effects of Renal Disease
It has been shown that plasma concentrations o f  both retinol and RBP are markedly 
increased (Smith and Goodman, 1971; Monji and Bosin, 1986; Ayatse, 1991; Jaconi et 
a l ,  1996), and P-carotene slightly elevated (Gotloib et a l , 1978) in patients with 
chronic renal failure (CRF). Jaconi and associates (1996) reported that traces o f  two 
truncated forms o f RBP (RBPl and RBP2) circulate in normal serum. However, 
RBP2 levels were highly elevated in CRF serum. It was observed that in CRF serum, 
50% o f the holo-RBP (RBP complexed with retinol) was not bound to  transthyretin 
(TTR) (thyroxin binding prealbumin) (Jaconi et a l , 1996). Low molecular weight 
protein concentrations in the serum o f  patients on continuous ambulatory peritoneal 
dialysis (CAPD) were markedly increased and serum RBP declined with duration o f  
dialysis (Kabanda et. a l , 1994).
Several studies pointed out that the small molecular size o f  free RBP (MW = 21,000 
daltons), would allow it to  cross the glomerular barrier more easily than RBP bound to 
pre-albumin (MW = 75,000 daltons). (Kanai et a l ,  1968; Raz et a l , 1970). In the 
normal state, small proteins are filtered through the glomeruli and taken up and 
catabolised in the tubular cells. Glomerlar clearances decrease as M W  increases and 
the glomerular membrane was found to be nearly impermeable to molecules with MW  
> 60,000 daltons (Strober and Waldmann, 1974).
In tubular disease low MW proteins are not taken up and catabolised within tubular 
cells. Thus, they are excreted (tubular proteinuria). In nephron-loss disease, both 
excretion and endogenous (in tubular cells) catabolism o f low MW proteins declined, 
thus these proteins accumulated in the blood (Strober and Waldmann, 1974).
In patients with CRF, less free RBP may be catabolised by the renal tubules and a 
decrease in the glomerular filtration rate leads to  an increase in free RBP.
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In successful renal transplants, serum retinol levels decline and return to normal 
(Yatzidis et al., 1976).
In haemodialysis patients raised levels o f  both RBP and retinol have been found 
(Yatzidis et al., 1975; Werb et al., 1979; Delacoux et. al., 1984). The high plasma 
retinol levels in patients with CRF were entirely due to  retinol, not retinyl esters and all 
the increased retinol was carried by RBP (Stewart and Fleming, 1982). In 
hypervitaminosis A (Smith and Goodman, 1971; Frame et al., 1974), the excess 
vitamin A is present in plasma in the form o f  retinyl esters owing to  the binding 
capacity o f circulating RBP being exceeded (Smith and Goodman, 1976). These retinyl 
esters are attached to  lipoproteins and this form o f vitamin A is believed to  be toxic 
(Mallia et al., 1975; Smith and Goodman, 1976). RBP concentrations were normal in 
individuals with hypervitaminosis (Smith and Goodman, 1976).
In haemodialysis patients, the concomitant rise in RBP and in retinol prevents the 
binding o f retinol to lipoproteins and this may prevent clinical signs o f  hypervitaminosis 
(Delacoux et. al., 1984). However, some o f the biochemical effects o f  excess vitamin 
A have been reported in haemodialysis patients (Werb et al., 1979; Farrington et al.,
1981).
The clinical picture o f  chronic hypervitaminosis A in adults includes multiple features 
common in patients with chronic renal failure, such as skin pigmentation, hair loss, 
anorexia, vomiting, joint pains, weakness and several defects in bone metabolism 
(Jowsey and Riggers, 1968).
In chronic renal failure, high concentrations o f  creatinine were associated with high 
concentrations o f RBP (Smith and Goodman, 1971; Goodman, 1984). The RBP and 
creatinine increased significantly during the acute phase, then decreased to  baseline 
after remission (Bankson et al., 1987). However, most o f  the increase in RBP 
associated with increased creatinine was believed to be caused by an increased 
concentration o f  free RBP (Bernard et al., 1988).
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4.1.3 Objective
In our first study, diabetic patients were found to have significantly higher 
concentrations o f RBP and this observation was more pronounced in diabetic patients 
with renal impairment. Fasting blood glucose was inversely correlated with P-carotene. 
Hence, the present study was undertaken to investigate the relationship o f 
Haemoglobin Aic with retinol, a-tocopherol, a - , P-carotene and RBP in a group o f  
diabetic patients with a wide range o f HbAic concentrations. A larger number o f 
diabetic patients Typel and diabetic patients with nephropathy or renal failure were 
included. In order to clarify whether any differences were due to  diabetes or to renal 
failure, diabetic patients were matched in age and sex with non-diabetic patients with 
CRF. The change with time with the dialysis procedure for all parameters measured 
was evaluated.
4.2 Subjects and methods
One hundred and seventy five diabetic patients (aged 5-90 years) attending a diabetic 
clinic in King Khalid University Hospital in Riyadh City (Saudi Arabia) were classified 
into four subgroups: Diabetic Type 2 (n = 123; M/F, 43/80), Type 1 (n = 11; M/F, 
4/7), diabetic with renal impairment (n = 28; M/F, 17/11), diabetic with renal failure 
(DCRF) (n = 13, M/F, 1/12). Non-diabetic patients with renal failure (NDCRF) (n = 
8 ; M/F; 1/7) were matched in age and sex with the diabetic patients with chronic renal 
failure.
Blood samples were obtained and HbAic was determined immediately by the routine 
two channel method with a BM/Hitachi Automatic Analyser 717 instrument 
(Boehringer Mannheim) by staff o f  Clinical Chemistry Dept., KKUH, Riyadh, Saudi 
Arabia. Total protein concentrations in urine were obtained from patients files. Plasma 
for the determination o f  retinol, a-tocopherol, a-carotene, p-carotene and RBP was
frozen in aliquots and stored at -70 °C  until the time o f analysis. Blood samples for 
diabetic and non-diabetic patients with renal failure were taken at different times 
during dialysis (pre-, during and post-dialysis).
Retinol, a-carotene, P-carotene and a-tocopherol were determined by high pressure 
liquid chromatography (HPLC) (Lee et al., 1992) with some modification. The
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concentrations o f RBP in plasma were determined by a double antibody sandwich 
enzyme linked immunosorbent assay (ELISA) (Lucertini et al., 1984).
Correlations were computed using Spearman's rank coefficient for non-parametric data 
and Bonferroni correction was performed to take into account the increased 
probability o f  a type 1 error because o f  multiple correlations. Two-way analysis o f 
variance (ANOVA) and the t-test were used to assess the effect o f  sex and evaluate 
differences between groups. Differences were judged to  be significant when P values 
were less than 0 .0 1 .
The significance o f change in plasma parameter concentrations over time (pre-, during, 
and post-dialysis) were measured using Wilk’s Lambda for the two groups combined 
and Roy’ Max root for the two groups separate. Statistical analyses were done using 
Mini Tab, version 10, 1996; State College, PA, USA.
4.3 Results
4.3.1 Retinol and carotenoids levels
HbAic concentrations were significantly higher in diabetic patients with Type 1, Type 
2 , and in diabetic patients with renal impairment than those in diabetics with chronic 
renal failure (P < 0.001, 0.001, and 0.0001 respectively) (Table 4.1).
Type 1 diabetic patients had significantly lower plasma concentrations o f  retinol, a -  
tocopherol and RBP when compared with patients with Type 2 diabetes, diabetic 
patients with renal impairment, diabetic and non-diabetic patients with CRF. The fact 
that these fat-soluble vitamins were not corrected for lipid levels would have little 
effect on the results since the significance o f  the difference was high.
Type 1 diabetic patients had higher plasma concentrations o f  a -  and P-carotene than 
Type 2 diabetic patients but the difference was not statistically significant. However, 
diabetic patients Type 2  had significantly lower plasma concentrations o f  P-carotene 
when compared to  diabetic patients with CRF or CRF patients.
Diabetic patients with renal impairment or with CRF (diabetic and non-diabetic) had 
significantly higher plasma concentrations o f retinol when compared to  other groups 
(Type 1 and Type 2). Moreover, mean plasma concentrations o f  retinol and P-
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carotene were significantly higher in diabetic patients with CRF than those in diabetic 
patients with renal impairment. B eta-carotene was significantly higher in diabetic 
patients with CRF than those in non-diabetic with CRF. Diabetic patients with renal 
impairment had significantly higher plasma RBP levels than those in patients with Type 
1 or Type 2 diabetes and significantly lower plasma RBP levels than those in patients 
with CRF (diabetic and non-diabetic) (Table 4.1).
Diabetic patients with renal impairment had significantly higher serum creatinine and 
urine protein levels than those in patients with Type 1 or Type 2 diabetes (Table 4. 2). 
They showed modest decrease in creatinine clearance when compared to  diabetic 
patients Type 2. Patients with CRF (diabetic and non-diabetic) had significantly higher 
serum creatinine than those in other groups (diabetic patients Type 1, Type 2 and with 
renal impairment). There was no significant difference for serum creatinine and plasma 
RBP in the two CRF groups (Tables 4.1 and 4. 2).
4.3.2 Haemodialysis effect
Table 4.3 show the mean plasma concentration o f  parameters studied at pre-, during, 
and post dialysis for diabetics and non-diabetics with CRF.
The significance o f  change in plasma parameter concentrations with time (pre-, during, 
and post-dialysis) were measured using Wilk’s Lambda. A significant decrease was 
found for P-carotene (P< 0.003) and RBP (P < 0.003) and a modest decrease was 
found for a-tocopherol (P < 0.02) and a-carotene (P< 0.03). Retinol/RBP ratio 
significantly increased with time (p<0.0004). These lipid-soluble vitamins were not 
adjusted for lipid levels which might have an effect on the result. The lipid profile 
differs in Type 1 and Type 2 as well as in patients with CRF.
There was no difference between the two groups when Roy’ Max R oot was used for 
the two groups separately.
4.3.3 Sex effect
When the results are examined according to sex, male patients with Type 2 D M  had 
significant higher plasma concentrations o f  creatinine than female patients (p < 0 .0 1 ). 
Men had lower plasma concentrations o f  a-tocopherol, a-carotene and P-carotene
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levels than women in Type 1 and Type 2 diabetic patients with no statistical 
significance difference. However, male subjects had higher plasma concentrations o f 
retinol and RBP than female subjects in all groups with no statistically significant 
difference. (Table 4.4).
4.3.4 Correlation analysis
Correlation analysis are presented in Tables 4.5 and 4.6. There was a significant 
positive correlation between retinol and RBP (p <0.0001), serum creatinine (p< 
0.0001), a-tocopherol (p < 0.0002), and urine protein (p<0.0001). Serum creatinine 
was significantly associated with RBP (p<0.0001), and urine protein (p<0.0001). 
Beta-carotene had significant and positive correlation with a-carotene (p<0.0001). 
Alpha-carotene correlated positively with a-tocopherol (p<0.004). There was a 
significant positive correlation between age and retinol (p< 0.006), age and RBP 
(p<0.0001), age and creatinine (p<0.0001). There was a significant inverse relationship 
between creatinine clearance and retinol (p<0.003), creatinine clearance and urine 
protein (p<0 .0 1 ), creatinine clearance and serum creatinine (p<0 .0 0 0 1 ), creatinine 
clearance and age (p<0.0006).
In CRF, all significant correlations were lost with the exception o f  those o f  retinol and 
RBP (p<0.02), serum creatinine and RBP (p<0.02) and serum creatinine and retinol 
(p<0.04).
There was a lack o f significant relationship between HbAic and each o f the measured 
parameters (Table 4.5).
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4.4 Discussion
Retinol, RBP, a-tocopherol and carotenoids status in diabetic Type 1, Type 2 diabetic 
patients with renal impairment, diabetic patients with CRF and non-diabetic patients 
with CRF were evaluated.
4.4.1 Retinol and RBP in Type 1
A significant decrease was found in plasma retinol and RBP concentrations in Type 1 
when compared to those in Type 2. The difference was more significant when 
compared to diabetic patients with renal impairment or CRF (both diabetic and non­
diabetic). It was observed that the high plasma retinol levels in the renal failure groups 
were outside the normal range.
Several studies have reported a decrease in plasma RBP and/or retinol concentration in 
Type 1 (Mosenthal and Loughlin 1944; Basu et al., 1989; Krempf et al., 1991). This 
study confirms this decrease in retinol and RBP in Type 1. The fact that this reduction 
in plasma retinol was observed both in diabetic children (Mosenthal and Loughlin 
1944) and adult populations (Basu et al., 1989) may suggest that the decrease in 
plasma retinol is related to diabetes, with no reference to  age. However, the current 
study indicated a negative correlation between age and retinol (P < 0.006). In this 
study, the majority o f  the Type 1 diabetic patients were children or under the age o f 
twenty years (82%). This lends support to the possibility that this reduction in plasma 
retinol may be related to age, which was in agreement with previous reports (Martinoli 
et. al., 1993). Kimble and associates (1946) observed that diabetic patients with 
diabetic coma had a sharp decrease in the levels o f circulating vitamin A  and carotene 
and attributed that to the disturbed metabolism within the liver and kidneys. Type 1 
diabetes mellitus patients in particular children, are more prone to coma.
Low fat intake might cause a decline in plasma levels o f  both the vitamin and the pro­
vitamin, as their absorption is influenced by the amount o f fat in the diet (Blomholf et 
al., 1992). or may be related to  malabsorption as concentration o f  another fat soluble 
vitamin (a-tocopherol) were also decreased in patients with Typel diabetes mellitus 
and there was a significant correlation between retinol and a-tocopherol (p < 0 .0 0 0 2 ).
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Insulin deficiency, as reflected by the increased HbAic concentrations in Type 1, might 
account for the reduction. It has been reported that the storage o f  vitamin A in the liver 
could be influenced by insulin (Bowles and Tucson, 1967) or that retinol is required for 
normal insulin secretion (Chertow et al., 1987). Insulin deficiency may impair the 
release o f retinol from the liver and therefore be responsible for the low plasma 
concentration observed in diabetic patients Type 1. A reduction in the mobilisation o f 
retinol, as was reflected by the decreased RBP concentration, might account for the 
decrease in retinol concentration in diabetic patients Type 1.
4.4.2 Alpha-and p-carotene
This study showed no significant difference in plasma a -  and P-carotene between Type 
1 and Type 2 diabetes mellitus. Patients with Type 1 diabetes showed a very wide 
range o f plasma a -  and p-carotene levels which is in agreement with Kimble and 
associates (1946) observation o f  the presence o f  values outside the normal range in 
both directions {normal range for p-carotene = 10-60 pg (Kaplan et al, 1987)} 
was observed in a few o f our patients with diabetes Type 1 (18%), and in only one o f 
patient with Type 2 (1 out o f  123). Plasma p-carotene concentrations were 
significantly lower in diabetic patients Type 2 than in diabetic patients with CRF 
(P<0.0001), or non-diabetic with CRF (P<0.001). This rise in p-carotene in patients 
with CRF may be related to the disturbed metabolism o f RBP and retinol (see below). 
However, plasma p-carotene concentrations were significantly higher in diabetic 
patients with CRF than in non-diabetic with CRF (P<0.0001), which might be related 
to the disturbed metabolism o f  lipoproteins in the diabetic state (Cohen, 1958). It has 
been reported that p-carotene circulates in association with lipoproteins (Manago et 
al., 1992).
The possible factors that may increase plasma vitamin A and/or p-carotene other than 
very high intake o f the vitamin or its pro-vitamin, are hyperlipdaemia and renal disease, 
neither o f  which is limited to diabetics.
In our first study there was a significant inverse relationship between P-carotene and 
FBG. In this study there was an inverse relationship between P-carotene and HbAic,
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however, the relationship was not significant. It is known that the HbAic value reflects 
the average level o f blood glucose over a longer period o f  time ( 2  months) than does 
FBG. The level o f FBG reflects temporary changes in glucose metabolism which might 
at one point in time coincide with P-carotene in a significant inverse relationship higher 
than the overall average degree o f blood glucose reflected by HbAic.
4.4.3 Retinol and RBP In chronic renal failure
In this study, the two groups, with renal failure whether diabetic or non-diabetic had 
markedly increased concentrations o f  retinol, RBP and to a lesser degree P-carotene 
when compared to diabetics Type 1, and Type 2, and diabetic patients with renal 
impairment.
The highly increased levels o f retinol and RBP was in agreement with previous reports 
(Smith and Goodman, 1971; Vannucchi et al., 1992). In the CRF patients, plasma 
retinol and RBP concentrations were on the average 3 times normal, similar to  the 
levels reported by others (Smith and Goodman, 1971). Retinol levels were also high 
among patients with renal impairment but not yet on dialysis and this is in agreement 
with reported data (Yatzidis et al., 1975, Vannucchi et al., 1992).
It has been demonstrated that the nephron filters small free plasma RBP (M W  = 
21,000 daltons) and retains prealbumin and RBP- prealbumin complex (MW > 75,000 
daltons) (Glover et al., 1974). The filtered RBP is reabsorbed (Glover et al., 1974), 
and catabolised by the renal tubular cells (Strober and Waldmann, 1974). In diseases in 
which there is nephron-loss, both excretion and tubular catabolism o f low MW  
proteins are reduced (Strober and Waldmann, 1974). Thus, these proteins accumulate 
in the blood.
Hence, elevation o f  free RBP in plasma is expected in nephron diseases. The elevated 
plasma retinol in renal impairment and renal failure patients may be explained by 
increased RBP levels due to an increase in free RBP levels (Peterson, 1971b; Smith 
and Goodman, 1976; Stewart and Fleming, 1982), reduced vitamin excretion and 
decreased conversion o f  retinol to retinoic acid (Yatzidis et al., 1975).
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The simultaneous increase o f  plasma retinol and RBP noted in patients with CRF 
support this possibility. However, patients with CRF have been reported to  have a high 
liver retinol content (Yatzidis, 1975), which suggests that the whole body contains an 
excess o f retinol (Yatzidis, 1975). Gerlach and Zile (1990) pointed to the possibility 
that the increased serum retinol observed in nephrectomized rats was due to  the 
increase in retinol associated with RBP coupled with thyroxin binding protein 
(transthyretin - TTR) and suggested that the hepatic release mechanism is upregulated 
by lack o f  renal function. It was suggested that renal failure results in a change in the 
signal for release o f retinol-RBP into the circulation. The extent o f hepatic up- 
regulation and increased release o f  retinol together with RBP and TTR into the 
circulation depends on readily available liver stores (Gerlach and Zile, 1990).
4.4.4 Serum creatinine, urine total protein and creatinine clearance
There was a strong correlation between retinol and RBP levels (P < 0.0001). This was
consistent with reported data (Smith and Goodman, 1971; Vannucchi et al., 1992; 
Stewart and Fleming 1982) and the fact that RBP is the carrier protein for the vitamin. 
There was a positive correlation between serum creatinine and both plasma RBP and 
retinol (P< 0.0001; P< 0.001 respectively) which, again, was consistent with previous 
reports (Rask et al., 1980; Bernard et al., 1988; Ayatse, 1991). Also, there was a 
significant positive correlation between urine protein and plasma RBP and retinol (P< 
0.0001; P< 0.0001 respectively). Since serum creatinine and urine protein levels are 
usually a function o f  renal integrity, this positive correlation indicates that serum 
retinol and RBP may be dependent on renal function and changes in levels o f  RBP in 
serum and urine may be valuable in assessing alterations in renal function. Ayatse
(1991) reported that serum RBP levels were found to be dependent on creatinine 
clearance and increased with decrease in glomerular filtration. There was a significant 
negative correlation between RBP and creatinine clearance (Ayatse, 1991). The 
current study did not confirm these results although there was a significant negative 
correlation between retinol and creatinine clearance in male diabetic patients but not 
females (P< 0.003).
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4.4.5 Haemodialysis
In the CRF patients whether they were diabetic patients or not, in whom measurements 
were made before, during and after dialysis, plasma parameters declined across the 
procedure. The change with time was not significant for retinol. However, the decrease 
was significant for RBP (P< 0.003), a-carotene (P< 0.03), P-carotene (P< 0.003) and 
a-tocopherol (P<0.02). The retinol/RBP ratio significantly increased with time 
(p<0.0004) indicating that RBP was lost during dialysis, probably due to its small size. 
This change with time during dialysis was consistent with earlier reports (Gotloib et. 
al., 1978). Others found that plasma retinol levels in samples taken immediately post­
dialysis were on average higher than the pre-dialysis levels (Stewart and Fleming, 
1982).
4.4.6 Sex differences
There were no significant differences between the results for male and female for 
retinol and RBP and this was in agreement with some previous reports (Blumsohn et 
al., 1990). Some other researchers reported that men had significantly higher serum 
retinol and RBP levels than women (Morinobu et al, 1994; Kaplan et al, 1990). In 
study 1 , we found that there was no significant difference, for retinol, in diabetic 
patients between male subjects and females. However, in controls, men had 
significantly higher concentrations than women which was consistent with the results 
o f the current study. There was a trend among women to have higher plasma p- 
carotene levels, although the difference was not significant which is consistent with 
reported data (Arnaud et al, 1991), and in contrast to  some other data (Kaplan et al,
1990).
4.4.7 Conclusion
This study indicated that retinol and RBP were significantly lower in Type 1 diabetic 
patients. Patients with CRF (diabetic and non-diabetic) had extremely high 
concentrations o f  retinol and RBP. It was demonstrated that serum creatinine and total 
urine proteins concentrations were associated with plasma RBP indicating that RBP 
may be dependent on renal function and changes in levels o f  RBP in serum or urine 
may be used in the assessment o f renal function.
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4.5 Comparison between studies 1 and 2
Our studies provide no evidence for retinol and a-tocopherol deficiency in patients 
with Type 2 DM. However, diabetic patients with Type 1 showed significantly lower 
plasma retinol and a-tocopherol concentrations when compared to patients with Type 
2 DM (Table 4.7).
Serum or plasma concentrations o f retinol in Type 2 in both studies were within the 
normal range. Plasma retinol concentrations (49.2 ± 22 |ig/dl) in patients with Type 2 
DM (Study 2) were similar to those in diabetic patients (97% Type 2) (49.4 ± 1 3  
pg/dl) or in control subjects (48.9 ± 14.3 pg/dl) (Study 1). However, plasma retinol 
concentrations in 11 patients with Type 1 DM  (Study 2) were significantly lower (26.2 
± 9.0 pg/dl) than any o f  the above mentioned groups (p < 0.0001). The percentage o f  
patients with Type 1 DM  with retinol deficiency was significantly higher than that o f  
patients with Type 2 DM  (27% vs. 9%) [p < 0.0001] (Table 4.7).
Plasma a-carotene concentrations in patients Type 1 and Type 2 DM  (study 2) were 
similar in both diabetic patients and control subjects (Study 1). Plasma P-carotene 
concentrations were significantly higher (23.8 ± 2 1  pg/dl) in Type 2 diabetic patients 
(Study 2) than those in diabetic patients predominantly Type 2 (15 ± 11.8 pg/dl) (study 
1) [p < 0 .0 0 1 ] and similar to  those in control subjects (21 ± 15 pg/dl) (Study 1) when 
means were compared. However, there was no significant difference between the tw o 
diabetic groups (Type 2) in the two studies when median p-carotene values were 
compared (16 vs. 14.9 pg/dl). Non-diabetic subjects had higher median P-carotene 
values (18 pg/dl) than any o f  the diabetic groups with no significant difference. Type 1 
diabetic patients had higher plasma concentrations o f  P-carotene than patients with 
Type 2 DM  but the difference was not statistically significant (Table 4.7). Patients 
with Type 1 DM  exhibited a wider range o f plasma concentrations o f P-carotene than 
patients with Type 2 DM.
Factors that may be responsible for the observed lower concentrations o f  plasma 
retinol in Type 1 DM.
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• Malabsorption: the lower plasma retinol concentrations in patients with Type 1 
DM, could be related to malabsorption since the concentrations o f a-tocopherol, 
another fat-soluble vitamin, were also lower in those patients.
• Age: majority o f  patients with Type 1 DM  were children or under the age o f 
twenty years (82%). It is therefore possible that these lower concentrations o f  
plasma retinol may be related to  age, which would be in agreement with previous 
reports (Martinoli et. al., 1993). In study 1, there was a significant positive 
correlation between retinol and age in the control group (r = 0.18, p < 0.05), but 
not in the diabetic group. These discrepancies might be due to  the fact that diabetic 
patients in study 2  were a mixed group o f children and adults and the significant 
inverse relationship was a reflection o f  differences in age groups.
•  Insulin deficiency: as shown by the increase in glycosylated haemoglobin (HbAic) 
concentrations, might account for this reduction. It has been demonstrated in rats 
that daily injection o f 0.5 U  regular and globin- type insulin (3:1 mixture) increases 
the rate o f depletion o f vitamin A from the liver, causing a reduction in the liver 
content o f retinol (Bowles and Tucson, 1967). Excess or lack o f  vitamin A has 
been shown to inhibit P-cell secretion o f insulin in rats and to decrease the first and 
second phase o f  insulin secretion in studies with p-cell cultures (Chertow et al., 
1979; Chertow et. al., 1987).
•  Lipid: lipoprotein changes in blood in NIDDM, that might cause high serum retinol 
concentrations. The serum retinol level with hypercholesterolemia is usually high 
(Smith et al., 1992). Numerous studies have demonstrated that serum retinol 
concentrations are positively correlated with cholesterol and triglyceride levels 
((Tavridou et al., 1996).
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CHAPTER FIVE
EFFECT OF BETA-CAROTENE 
SUPPLEMENTATION ON 
FBG AND LIPIDS IN 
STZ-DIABETIC WISTAR 
MALE RATS
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5.1 Introduction
One o f  the important findings in study 1 was the significant negative correlation 
between P-carotene and glycaemic control as assessed by fasting blood glucose. This 
relationship between p-carotene and glycaemic control was reassessed by HbAic in 
study 2. There was an inverse relationship between P-carotene and HbAic, however it 
was not significant. In this study, the research is directed to look into a different angle 
or aspect o f diabetes-vitamin A interrelationship; that is the effect o f P-carotene 
supplementation on diabetes and in particular, FBG and lipid profile.
5.1.1 Free radicals
Free radicals are molecules with one or more unpaired electrons. The superoxide 
radical (O2* ) is the first unpaired reduction product o f oxygen (Dowling et al, 1990). 
The addition o f another electron to  superoxide results in the formation o f peroxide 
(H2O2). Hydrogen peroxide can react with the reduced form o f the transition metals, 
such as iron, (Dowling et al, 1990), or react with superoxide (Barber and Harris, 
1994) to form the highly reactive hydroxyl radical (OH") that attacks any molecule 
present at or close to its site (Dowling et al, 1990; Barber and Harris, 1994).
The removal o f an electron fi"om stable fatty acids leads to  the formation o f  unstable 
lipid peroxyl radicals, which participate in a chain reaction that can further damage the 
lipids in the cell membrane. End products o f lipid peroxidation include 
malondialdehyde, volatile substances such as ethane and pentane, crosslinked lipids in 
the membrane, conjugated dienes, and protein-lipid adducts (Halliwell and Gutteridge, 
1996).
Carbohydrates and proteins associated with membrane lipids may also be damaged by 
free radicals (Gutteridge, 1982). Chain reactions involving peroxyl radicals, become 
self terminating when two peroxyl radicals react to give stable products (Burton, 
1989). Chain reactions can be terminated by the presence o f a chain-breaking 
antioxidant such as vitamin E (Burton and Ingold, 1981).
It is well known that carotenoids are effective singlet oxygen (O2 ) quenchers (Foote 
and Denny, 1968). On the other hand. Burton and Ingold (1984) have suggested that
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P-carotene serves as a chain-breaking antioxidant by trapping chain-propagating 
peroxyl radicals at low oxygen partial pressure.
Under normal physiological conditions there is a balance between free radical 
production and antioxidant defense systems. Increased oxidative stress may arise 
either as a result o f  increased free radical production or reduced activity o f  antioxidant 
defences (Halliwell and Gutteridge, 1996), and in patients with diabetes there is 
evidence for both o f these phenomena (Oberley, 1988).
Glucose is prone to oxidation and consequently generates hydrogen peroxide and 
reactive intermediates (W olf and Dean, 1987), and peroxide formation is increased in 
elevated glucose solution (25 mM) (Hunt et. al., 1990). It has been suggested that 
hyperglycemia and oxidative stress may contribute to  the development o f 
complications in diabetes mellitus (Baynes, 1991; The Diabetes Control and 
Complications Trial Research Group, 1993; Tesfamariam, 1994).
Current evidence indicates that the damaging effects o f oxygen-derived free radicals 
are associated in different tissues with an elevation o f  antioxidant enzyme activity 
during exposure (Ichikawa et al, 1994).
5.1.2 Antioxidant effects on giucose
Insulin dependent diabetes mellitus (IDDM) results from the selective destruction o f  
pancreatic P-cells (Gepts and Mey, 1978). Loss o f P-cells causes an absolute insulin 
deficiency that leads to chronic hyperglycemia.
Clinical therapies for preventing IDDM have focused mainly on immunosuppressants 
and antioxidants. Nicotinamide, a weak antioxidant, has been used to lessen the 
severity o f recent-onset IDDM  (Vague et al, 1989; Mendola et al, 1989), and in one 
study, nicotinamide was not only successful in preventing IDDM  in prediabetic patients 
with impaired insulin secretion (Yamada et al, 1982), but also delayed the onset o f  
streptozotocin (STZ)-induced insulitis (Rossini, 1978; Yamada et al, 1982).
Several studies have evaluated the effectiveness o f  probucol, a potent lipid soluble 
antioxidant (Buckley et al, 1989), reporting a small reduction in the prevalence o f 
IDDM in some studies (Drash et al, 1988; Shimizu et al, 1991; Heineke et al, 1993) or 
no statistically significant effect in another study (Rabinovitch et al, 1992). Among the
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studies in which probucol was effective, Drash et al., evaluated probucol in BB rats 
and reported a reduction in diabetes from 8 6  to 62%. Shimizu et al (1991), 
demonstrated that probucol administration attenuated the degree o f hyperglycaemia 
(27 . 8  to  18.2 mmol/1) in ICR mice.
In the two studies in non obese diabetic (NOD) mice in which probucol was 
ineffective, a non significant reduction in IDDM  was reported from 6 8  to  58%, 
(Rabinovitch et al., 1992), and from 55 to 50% (Heineke et al, 1993). However, 
combination o f probucol with the anti-inflammatory corticosteroid, deflazacort, 
produced an early synergistic effect delaying diabetes onset by 3 weeks, and a later 
additive effect, decreasing diabetes incidence from 6 8 % to 23% (Rabinovitch et 
al,. 1992), and from 59% to 21% (Heineke et al, 1993) Protection against diabetes by 
the combination o f probucol and deflazacort was associated with a significant decrease 
in pancreatic islet insulitis and prevention o f islet p -cell loss (Rabinovitch et al. 1992).
Masukawa and Nakanishi (1994), observed that diethyldithiocarbamate (DEDC), a 
chelating agent, protected mice from alloxan-induced diabetes by the indirect 
mechanism o f producing hyperglycemia at the time o f alloxan administration.
Young and associates (1995), observed that oxidative stress was increased in the STZ- 
diabetic rats as shown by increased levels o f  conjugated dienes (CD) in plasma and 
malondialdehyde (MDA) in plasma, erythrocyte membranes, and urine. In addition, 
there was a depletion o f  the nutritional antioxidants ascorbate, alpha-tocopherol, and 
retinol. Insulin treatment returned all o f these parameters to  normal. Ascorbate 
supplementation or desferrioxamine (chelating agent) treatment alone failed to  reduce 
oxidative stress, but a combination o f  both interventions restored MDA, CD, and 
antioxidant vitamins to  control values. Both ascorbate and desferrioxamine also 
reduced HbAic and glycated albumin levels. M oreover, Roza and associates (1995) 
reported alterations in the cytosolic enzymes assayed: copper-zinc superoxide 
dismutase (CuZnSOD), catalase (CAT), and glutathione peroxidase (GPX) in male 
diabetic-prone BB rats.
Ceriello, et al, 1996 have demonstrated that high glucose stimulates CuZn- superoxide- 
dismutase (SOD), catalase, and gluathione peroxidase (GPX) over expression in 
human endothelial cells in culture. This finding suggests that high glucose might
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produce an oxidative stress in cells, which respond by increasing their antioxidant 
defences.
Hayward and co-workers (1992) observed that the incidence o f diabetes was reduced 
in non-obese diabetic (NOD) mice fed a diet containing 1000 lU /kg o f vitamin E.
Recent studies have examined the effect o f  intake o f vitamins A, E  and C, nutrients 
known to have antioxidant properties in vivo, on glycosylated hemoglobin (GHb) 
concentrations in human subjects (Ceriello et. al., 1991; Davie et. al., 1992; Shoff et 
al, 1993). Ceriello and associates (1991) found that 1200 mg/day vitamin E  orally 
administered to individuals with diabetes lowered GHb concentrations. Davie et al.
(1992) observed a similar pattern when 1 g/day o f  ascorbic acid was orally 
administered to non-diabetic subjects for three months. However, Shoff and associates
(1993) found no relationship between vitamin E or p-carotene intake and GHb in 
persons with diabetes. They observed a protective effect o f vitamin C intake on GHb 
in individuals without diabetes. Moreover, Bishop et al (1985) observed no effect on 
GHb o f daily supplementation with 500 mg vitamin C for 2 months in diabetics. It was 
suggested that reciprocal protective effects between vitamin A and vitamin E  may 
strongly contribute to the defence o f  membranes against oxidative stress (Tesoriere et 
al., 1995; Subirade et a l , 1996).
5.1.3 Antioxidant effects on iipid
Free radical induced lipid peroxidation has been associated with diabetes mellitus 
(Loven and Oberley, 1985). The concept that oxidation o f  lipoproteins might be 
important in diabetes was suggested by the studies o f Sato and associates (1979). 
Increased amounts o f malondialydehyde have been found in the serum and high density 
lipoprotein fractions o f patients with uncontrolled diabetes (Sato et. a l , 1979). Higuchi 
(1982) reported that lipid peroxides were elevated in the sera and liver o f rats with SZ- 
induced diabetes.
Evidence o f  lipid peroxidation has also been observed in a number o f  complications 
accompanying diabetes such as retinopathy, cataract formation and atherosclerosis 
(Murata et. a l , 1981; Zigler and Hess, 1985; Mowri et. a l ,  1986).
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Among the oxidative damages o f numerous biological constituents, oxidative 
modification o f  plasma low-density lipoprotein (LDL) seems to be o f importance 
because it is believed to  lead to fatty streak formation characterised by an accumulation 
o f cells loaded with cholesteryl esters (foam cells) (Steinberg et al, 1989). Human 
plasma possesses a well-organized defence system against oxidative damage (Wayner 
et al, 1987). Antioxidants such as vitamin E may slow the progress o f  atherosclerosis 
by modifying the synthesis and degradation o f  lipids in the arterial wall (Saito et al.,
1982) and/or by increasing the proportion o f blood cholesterol in the HDL-C fraction 
(Hermann et. al., 1979).
In vitro LDL does not become oxidised until its endogenous content o f antioxidants 
has been depleted.
Esterbauer et al., (1989) indicated that endogenous p-carotene and lycopene, as well
as gamma- and alpha-tocopherol, participate in the antioxidant defence against Cu 
induced lipid peroxidation o f  human LDL. However, Gaziano, et al. (1995) reported 
that supplementation with p-carotene in vivo or in vitro does not enhance the 
protection o f LDL against metal ion-dependent and -independent oxidation.
Conflicting reports exist on the effectiveness o f  P-carotene supplementation in 
protecting LDL from in vitro oxidation (Jialal et al, 1991; Princen et al, 1992; Ojima et 
al, 1993). Some reports indicated that incubation o f p-carotene with LDL in vitro 
inhibits oxidation o f LDL (Jialal et al, 1991; Ojima et al, 1993), whereas others have 
shown that oral supplementation with beta carotene has either no protective effect 
(Princen et al, 1992) or a protection not independent o f that o f alpha-tocopherol 
(Abbey et al, 1993). As a singlet oxygen scavenger (Burton and Ingold, 1984), it could 
theoretically provide antioxidant activity to lipoproteins.
Jialal and associates (1991) showed that p-carotene is more effective than a -  
tocopherol in prevention o f oxidative modification o f LDL when added exogenously. 
Beta-carotene has been found to  have an inhibitory effect on lipid peroxidation o f  rat 
liver tissue in cooperation with a-tocopherol (Leibovitz et al., 1990; Palozza and 
Krinsky, 1992). It was suggested that not only does P-carotene act as a potent
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antioxidant in mice but also its antioxidant effect is very specific in reducing the RBC 
phospholipid hydroperoxidase (Nakagawa et. al., 1996).
Increased blood triglyceride levels have been reported in rats being given 13-cis 
retinoic acid (Gerber and Erdman, 1979) and have been noted in patients taking 13-cis 
retinoic acid as part o f  a multicentre study for disorders o f keratinization (Dicken and 
Connolly, 1980).
The increase o f  serum triglyceride levels in rats or patients being given isotretinoin was 
dose related. In contrast, Poh-Fitzpatrick and Palmer (1984) indicated that mild 
hypertriglyceridemia occurs with increased frequency in patients with protoporphyria^ 
but not as a direct result o f  beta-carotene therapy.
Marenah and associates (1983) reported that serum beta-carotene concentrations 
increased with serum cholesterol, LDL and HDL concentrations. Another report 
indicated that beta-carotene increased HDL concentrations in young men (Bencich et 
al, 1989).
Moreover, a positive relation has been observed between plasma concentrations o f 
cholesterol and retinol (Shekelle et al, 1981), LDL and retinol (Marenah et al, 1983), 
and between a-tocophero l and LDL (Ringer et al, 1991).
Costantino et al., (1988) found that serum beta-carotene correlated directly with total 
cholesterol and HDL concentrations, but inversely with serum triglycerides. However, 
neither beta-carotene nor the other carotenoids correlated significantly at baseline with 
any cholesterol or lipoprotein subfractions (Ringer et al, 1991).
High intakes o f beta-carotene have been shown to have no effect on serum lipid 
concentrations in humans (Mathews-Roth and Gulbrandsen 1974; Nierenberg et al.,
1991). In contrast, Tsai and associates (1992).observed that an increase in the level o f 
dietaiy beta-carotene resulted in generally progressive decreases in fasting serum total 
cholesterol and total triglyceride concentrations. Compared with rats fed the basal diet, 
rats fed diets containing 250 or 500 mg beta-carotene/kg had significantly lower serum 
LDL cholesterol and LDL triglyceride concentrations. The HDL cholesterol
’ Patients with protopoq)hyria suffer from cutaneous photosensitivity. This symptom can be lessened 
by ingestion of b-carotene (Mathews-Roth et al, 1974.)
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concentrations were not significantly changed with beta-carotene supplementation at 
125 or 250 mg/kg diet but were significantly reduced with beta-carotene 
supplementation at 500 mg/kg. The HDL triglyceride concentrations were slightly but 
significantly increased with beta-carotene supplementation at the 125 mg/kg level but 
were not changed with higher levels o f supplementation. The ratio o f  HDL cholesterol 
to total cholesterol was either unchanged or slightly increased with beta-carotene 
supplementation (Tsai et al., 1992). On the other hand. Amen and Lachance (1974) 
observed that dietary beta-carotene reduced serum cholesterol concentrations in rats 
fed a vitamin A-deficient hypercholesterolemic diet.
Recent evidence suggests that oxidative damage, particularly oxidative modification o f  
LDL, is involved in the initiation and promotion o f coronary heart disease (Steinberg, 
1993). Several cohort studies have examined the role o f P-carotene in heart disease, 
and all have shown a risk reduction associated with the ingestion o f  foods rich in P- 
carotene. The Health Professional Follow-up Study observed a significantly lower risk 
o f coronary disease among men in the highest quintile o f  intake o f  P-carotene (Rimm 
et al., 1993). In addition, a European multicentre case-control trial showed that 
individuals with low adipose tissue P-carotene had a greater risk o f  myocardial 
infarction than those with high adipose tissue P-carotene concentrations (Kardinaal et. 
al., 1993). A subgroup analysis within the Physicians’ Health Study, a double-blind, 
randomised, placebo-controlled trial involving administration o f P-carotene 
supplements (50 mg on alternate days) to physicians with angina pectoris decreased the 
incidence o f  angina in patients and reduced major coronary events (myocardial 
infarction or cardiac death) by 44% and stroke by 49% (Gaziano et al., 1990).
5.1.4 Objective
An inverse relationship has been observed between serum concentration o f  p-carotene 
and serum fasting glucose (study I). Hence, the present study was designed to  test the 
hypothesis that a P-carotene supplement may reduce FBG in Wistar male rats, and to 
evaluate its effect on lipids in these rats.
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5.2 Material and methods
One hundred and five Wistar male rats (180-250 gm), aged 6  weeks were housed, 
four or five, in a cage, in an environment in which the temperature was maintained at
22-25 °C, with a normal day - night cycle, and humidity 40-45%. The rats were 
maintained ad libitum on a commercial standard diet and water. The rats were 
randomly assigned to  one o f six groups, three control groups (non-diabetic, N  = 15, 
early^ Streptozotocin (STZ)-diabetic, and late^ STZ-diabetic, each, N  = 12) received a 
standard diet and 500 pi com oil, whereas the other three groups (non-diabetic, N  = 
15; early STZ-diabetic, and late STZ-diabetic, each, N  = 25) were similarly fed with 
additional P-carotene supplement, at a dose o f  5 mg/kg o f  body weight, 3 times/week, 
dissolved in 500 pi com  oil and administered with a catheter tube (Vygon; Ecouen, 
France). The late STZ-diabetic group and its control were supplemented with P- 
carotene and com  oil respectively for 5 weeks before inducing diabetes (Table 5.1).
Streptozotocin powder (Sigma- Aldrich Co. Ltd. Poole, England) was administered 
(60 mg/kg body weight) intraperitoneally. Streptozotocin solution was prepared 
immediately before use in citrate buffer (pH. 4.4). Control rats were injected with 
citrate buffer alone.
 ^Beta-carotene treatment of STZ-diabetic rats, begun after hyperglycaemia was established. 
 ^Treated for five weeks with p-carotene before STZ administration
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Rats were subjected to light ether anaesthesia and heart puncture blood samples for 
fasting serum glucose, cholesterol, triglycerides, high density lipoprotein and low 
density lipoprotein were obtained at weekly intervals, after an overnight fast (food was 
removed from their cages) over a 10 weeks period. Rats were considered diabetic if 
the following criteria were met: weight loss, glucosuria and fasting serum glucose > 9 
mmol/1 for two consecutive sampling days. Urine was collected using individual rodent 
metabolism cages employing a funnel bottom with small mesh screen beneath the 
walking floor.
The number o f  rats declined during the course o f  the experiment due to  injury, 
anaesthesia, and diabetes (Table 5.2). The number o f  late-diabetic rats was 17 at the 
time o f  STZ administration, and was 11 at the end o f  the experiment. Among other 
groups, the decline in number was less. Death was related to anaesthesia or injury and 
bleeding if  it occurred while handling the rats; if  death occurred to a hyperglycaemic 
rat, then the cause was considered to be related to diabetes.
Table 5.2: Cause o f death in STZ-diabetic, non-diabetic and control during 13 weeks 
o f the experiment
No alive at 
beginning o f 
experiment
Death due 
to injury and 
anaesthesia
Death due 
to diabetes
N o live at end 
o f  experiment
Non-diabetic 15 3 — 1 2
Non-diabetic control 15 3 -------- 1 2
Early-diabetic 25 — 2 23
Early-diabetic control 13 3 2 8
Late-diabetic 25 1 0 4 1 1
Late-diabetic control 1 2 3 2 7
Fasting blood glucose was assayed immediately using a glucose oxidase method, 
cholesterol and triglycerides were determined by enzymatic methods. All were assayed 
in the Beckman Synchron Systems analyser (Beckman Instrument Inc., California,
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USA). High-density lipoprotein-cholesterol was determined by the 
phosphotungstate/magnesium chloride precipitation method using Hitachi 717 
(Boehringer Mannheim GMbH) by the staff o f Clinical Chemistry Dept., KKUH, 
Riyadh, Saudi Arabia. Low-density lipoprotein-cholesterol was calculated using the 
following formula:
LDL-cholesterol = total cholesterol -HDL-cholesterol- (triglycerides/2.2) (Friedewald 
et. al., 1972).
This equation was validated by measuring LDL in 12 samples directly using Kit (Cat. 
No. 1730738) or calculated using the Friedewald’ formula. There was a good 
correlation (r = 0.92) (Shaheen, Personal communication). Samman and Truswell 
(1993) noted that this equation has been used in numerous trials o f the effect o f dietary 
components on plasma lipids in humans and animals.
Differences between different groups were evaluated by the two-way analysis o f 
variance (ANOVA) and t-test. Differences were judged to be significant when P 
values were less than 0 . 0 1  to  take into account the increased probability o f  a type 1 
error because o f multiple comparisons. The prevalence o f  IDDM was defined as the 
cumulative percentage o f  rats that developed the disease after STZ administration. The 
difference in the frequency o f  diabetes was tested using Fisher’s Exact Test for 
comparison o f  two proportions.
Mini Tab, version 10 (1996) (State College, PA, USA) was used for statistical 
analyses.
5.3 Results
Base line means o f weight, FBG, cholesterol, triglycerides, HDL-cholesterol and LDL- 
cholesterol o f  rats supplemented with P-carotene were not significantly different from 
those o f  normal rats. The STZ-induced diabetic rats exhibited the characteristic signs 
o f  diabetes such as elevated blood glucose, increased urine output and weight loss. 
Early-STZ diabetic group showed a higher incidence o f  diabetes (76%, 19 o f  25) than 
late diabetic group that had been treated for five weeks with P-carotene before STZ 
administration (59%, 10 o f  17) However, the difference was not statistically significant 
(p = 0.135), and similar incidence when compared to early and late diabetic not 
supplemented with P-carotene (77%, 1 0  o f  13 and 75%, 9 o f  1 2  respectively).
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To evaluate the glucose lowering activity o f  P-carotene in non-diabetic, early-, and 
late diabetic rats independent o f preventing diabetes, rats were fed standard diet 
(control) or treated with p-carotene in addition to  the standard diet for eight weeks. 
Beta-carotene had no significant effect on FBG, triglycerides, cholesterol and LDL-C 
levels in non-diabetic rats when compared to non-diabetic control rats. In the early- 
diabetic rats supplemented with p-carotene, FBG was significantly lower (Table 5.3; 
Fig. 5.1), and there was a progressive decrease in serum triglyceride concentrations 
when compared to controls (Table 5.4; Figs. 5.2). In the late-diabetic rats 
supplemented with p-carotene, FBG was lower with no significant difference except in 
week 9 (Table 5.3). Also, there was no significant decline in serum triglyceride 
concentrations in late-STZ-diabetic rats (Table 5.4).
With respect to serum cholesterol, there was no significant difference between the 
early- or late-STZ- diabetic rats supplemented with p-carotene when compared to  their 
corresponding control rats except in the initial early weeks (Table 5.5).
HDL-C levels were significantly lower in non-diabetic rats supplemented with P- 
carotene when compared to controls (Table 5.6; Fig. 5.3). In early- STZ- diabetic rats 
supplemented with P-carotene, there was a transient significant decrease at week 7 
when compared to controls and there was no significance difference between late-STZ- 
diabetic rats supplemented with P-carotene and control rats (Table 5.6). However, the 
ratio o f HDL-C to total cholesterol was either unchanged in late-STZ-diabetic rats, 
slightly or significantly increased with a P-carotene supplementation in early-STZ- 
diabetic and non-diabetic rats (Table 5.7; Figs 4, 5).
Beta-carotene supplementation resulted in a significant decrease in serum LDL-C 
levels in the first 4 weeks for the early diabetic rats, and the levels started to  rise again 
in the last 3 weeks with no significant difference when compared to  the control rats. 
For the late-STZ- diabetic rats supplemented with P-carotene, there was no significant 
difference in the first 3 weeks when compared to the control rats, however, there was a 
significant difference in LDL concentrations between the two groups in weeks 9 and 
10 (Table 5.8; Figs. 5.6 and 5.7).
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Table 5.3 Effect of P-carotene supplementation on Mean ± (SE) serum FBG (mmol/1)
in Wistar male rats.
Control rats Beta-carotene supplemented rats
Weeks Non Early-STZ- Late-STZ- Non Early-STZ- Late-
__________ diabetic_____ diabetic_____ diabetic diabetic_____diabetic______STZ-
NO (15-12) (13-8) (12-7) (15-12) (25-19) (25-11)
“ Ô 5/7 5^ 9 6^ 0 5^ 6 6.02
(0.14) (1.17) (1.55) (0.15) (0.84) (1.15)
I  6^0 ÏL8 — 6^0 16^9 ----
(0.17) (1.33)’’ (0.15) (0.99)’’
~2 5^ 9 T l6  ^  5/7 iÔÔ -----
(0.17 (1.33) (0.15) (0.97)
1  Ï2Â —  I s  8Â5 ^
(0.17 (1.33)’’ (0.15) (0.99)’’
4 6.1 13.16   5.6 7.45 —
(0.17 (1.33)' (0.15) (1)'
1  ÏLÏÔ  6J  l 6  T5 l 6
(0.17 (1.33)' (1.55) (0.16) (1.05)' (1.55)
~ 6  l 9  Ï4J Ï6Â l 6  73  19.8
(0.17) (1.33)’’ (1.8) (0.17) (1.03)’’ (1.7)
~7 IÔ  ÎLÔ K e  I t  I o  16.s
(0.17) (1.33) (1.7) (0.17) (1.02) (1.7)
~8 l 9  i l2 6  l i s  I t l9 6  13.7
(0.17 (1.41) (1.8) (0.17) (1.02) (2.0)
9 —  -—- 20.3 — -— 14.3
(1.9)' (2.2)'
10 —— —— 21.6 —— — 16.65
(2.4) (2.0)
I I  —— —— 19.4 —— —- 14.0
(2.4) (2.2)
Means in a row sharing a common superscript are significantly different.
b = P <  0.001; c = P< 0.01
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FBG levels in early-STZ-diabetic rats
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Fig. 5.1 Effect o f beta-carotene supplement (5mg/Kg body weight, 3 times per 
week) on FBG in early-diabetic and control Wistar male rats. Early-diabetic rats 
were supplemented with beta carotene after 2 days o f STZ administration 
intraperitoneally (60 mg/body weight).
Significance levels = **P < 0 .01 ; * * * P <  0 . 0 0 1
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Table 5.4 Effect of p-carotene supplementation on mean ± (SE) serum triglycerides
(mmol/1) in Wistar male rats.
Control rats Beta-carotene supplemented rats
Weeks Non­ Early-STZ- Late-STZ- Non­ Early-STZ- Late-
diabetic diabetic diabetic diabetic diabetic STZ-
NO (15-12) (13-8) (12-7) (15-12) ( 25-19) (25-11)
0 1.04 1 . 0 2 0.94 1.08 1.08 0.93
(0.057 (0 .1 ) (0 .1 ) (0.057) (0.073) (0.067)
1 1.03 1 . 1 --- 1 . 0 1 . 0
(0.066) (0 .1 1 ) (0.06) (0.09)
2 1 . 0 1.32 ---- 1 . 1 1 0.7 ----
(0.063) (0 .1 1 ) ' (0.06) (0..09)'
3 1.05 1 . 2 ---- 1 . 1 0.71 ----
(0.06) (0 .1 1 ) ' (0.06) (0..09)'
4 1 . 1 1.37 ---- 1.18 0.73 ---
(0.064) (0 .1 1)'" (0.06) (0..098)"
5 1 . 1 1.39 1 . 1 1.18 1 . 2 1 1.07
(0.064) (0 .1 1 ) (0 .1 1 ) (0.06) (0.09) (0.084)
6 1.06 1.64 1 . 2 1 . 1 2 1 . 0 1.04
(0.06) (0 .1 1 )^ (0 .1 1 ) (0.06) (0.09)" (0 .1 1 )
7 1.09 1.57 1.3 0.98 1 . 2 0.9
(0.06) (0 .1 1 ) (0 .1 1 ) (0.07) (0.09) (0.17)
8 1 . 1 1 1.67 1 . 2 0.90 1.14 0. 95
(0.06) (0 .1 2 )" (0 .1 1 ) (0.07) (0 .1 )" (0.132)
9 1.58
(0.123)
1 . 0
(0.14)
1 0 1.57
(0.156)
1.05
(0.13)
1 1 1.5
(0.156)
1.16
(0.14)
Means in a row sharing a common
a = P < 0.0001; b = P < 0.001; c =
superscript are significantly different.
P< 0.01
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Serum triglyceride concentrations in early-STZ-diabetic rats
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Fig. 5.2 Effect o f beta-carotene supplement (5 mg/Kg body weight, 3 
times per week) on triglyceride concentrations in early-STZ-diabetic and 
control Wistar male rats. Early-diabetic rats were supplemented with 
beta-carotene 2 days affer STZ administration intraperitoneally (60 
mg/Kg body weight).
Significance levels = ** P <0.01; *** P < 0.001; **** P < 0.0001
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Table 5.5. Effect of p-carotene supplementation on mean ± (SE) serum cholesterol
(mmol/1) in Wistar male rats.
Control rats Beta-carotene supplemented rats
Weeks Non - Early -STZ- Late Non - Early-STZ Late-SZ-
diabetic diabetic diabetic diabetic diabetic diabetic
No (15-12) (13-8) (12-7) (15-12) (25-19) (25-11)
0 2 . 0 2 . 0 1.98 1.98 2.06 2 . 0
(0.06) (0 .1) (0 .1) (0.06) (0.08) (0.07)
1 1.98 1.98 --- 1. 84 1.61 —
(0.07) (0 .1 ) (0.06) (0.08)
2 1.97 2.08 1.84 1.59 —
(0.07) (0 .1 )" (0.06) (0.08)"
3 1.94 1.98 ---- 1.78 1.62 —
(0.07) (0 .1) (0.06) (0.08)
4 2 . 0 1.96 1.75 1.85 ——
(0.07) (0 .1 ) (0.06) (0.08)
5 2 . 0 2 . 0 2.13 1.7 2.06 1.83
(0.07) (0 .1) (0 .1) ' (0.06) (0.08) (0.08)'
6 1.95 2 . 0 1.78 1.61 2 . 0 1 1.75
(0.07) (0 .1 ) (0 .1 1 ) (0.07) (0.08) (0 .1 1 )
7 1.98 1.94 1.72 1.7 2 . 1 1 1 . 6 8
(0.07) (0 .1) (0 .1 1 ) (0.07) (0.08) (0 .1 1 )
8 2 . 0 2 1.96 1.81 1.69 2.05 1.91
(0.07) (0 .1) (0 .1 1 ) (0.07) (0.08) (0 .1 2 )
9 1.98
(0 .1 2 )
1.96
(0.14)
1 0 2.16(0.16) 2.17
(0.13)
1 1 2 . 2
(0.155)
2.39
(0.14)
Means in a row sharing a common superscript are significantly different,
b = P < 0.001; c = P<0.01
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Table 5.6 Effect of P-carotene supplementatin on mean ± (SE) serum HDL (mmol/1)
in Wistar male rats.
Control rats Beta-carotene supplemented rats
Weeks Non
diabetic
Early-STZ-
diabetic
Late-STZ-
diabetic
Non
diabetic
Early-STZ-
diabetic
Late-STZ-
diabetic
No (15-12) (13-8) (12-7) (15-12) (25-19) (25-11)
0 1.09 1.03 1.05 1.06 1.067 1.06
(0.031) (0.031) (0.033) (0.031) (0 .0 2 2 ) (0.023)
1 1 . 2
(0.036)"
1 . 1
(0.036)
0.97
(0.032)"
1.16(0.026)
2 1 . 2
(0.034)"
1.03 (0.036) 0.94
(0.032)"
1.10(0.026)
3 1.15
(0.035)'
1.06 (0.036) 0.96
(0.035)'
1.15
(0.027)
4 1.13
(0.035)'
1.1 (0.036) 0.96
(0.032)'
1.06(0.028)
5 1.09
(0.035)"
1 . 1 2
(0.036)
0.96
(0.033)
0.94
(0.033)"
1.06
(0.03)
0 . 8 6  (0.028)
6 1.04 1.06 0.84 0.94 1 . 0 0.9
(0.035) (0.036) (0.04) (0.034) (0.027) (0.037)
7 1.07 1.09 0.85 0.93 0.91 0.83
(0.035) (0.036)" (0.037) (0.036) (0.03) " (0.03)
8 1.06
(0.035)'
1.13 (0.038) 0.84
(0.039)
0.91
(0.035)'
1.08 (0.03) 0.85 (0.041)
9 0 . 8 8
(0.041)
0.83
(0.048)
1 0 1.07
(0.052)
0.92
(0.044)
1 1 1 . 1 2
(0.052)
0.94
(0.048)
Means in a row sharing a common superscript are significantly different,
b = P < 0.001; c = P<0.01
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HDL levels in non-diabetic rats
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Fig. 5. 3 Effect o f beta-carotene supplement (5 mg/Kg body weight 3 times per 
week) on HDL levels in non-diabetic and control Wistar male rats. Non-diabetic 
rats were supplemented with beta-carotene for eight weeks.
Significance levels =** P <0.01; * * * ? <  0,001
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Table 5.7 Effect of P-carotene supplementation on ratios of HDL-C/cholesterol in
Wistar male rats
Control rats Beta-carotene supplemented rats
Weeks Non­ Early-STZ- Late-STZ- Non­ Early-STZ Late-STZ-
diabetic diabetic diabetic diabetic diabetic diabetic
No (15-12) (13-8) (12-7) (15-12) (25-19) (25-11)
0 0.56 0.52 0.53 0.55 0.54 0.54
(0 .0 2 ) (0.03) (0 .0 2 ) (0 .0 2 ) (0 .0 2 ) (0 .0 2 )
1 0.61 0.57 ---- 0.60 0.74 ----
(0 .0 2 ) (0.06)' (0 .0 2 ) (0.04)'
2 0.61 0.50 ---- 0.59 0.71 ----
(0.017) (0.04)" (0.016) (0.03)"
3 0.59 0.58 ---- 0.64 0.74 ----
(0.05) (0.04)' (0.04) (0.03)'
4 0.56 0.63 ---- 0.63 0.59
(0.028) (0.03) (0.026) (0.026)
5 0.54 0.62 0.46 0.62 0.55 0.47
(0.025) (0.03) (0 .0 1 ) (0.024) (0.03) (0 .0 1 )
6 0.53 0.59 0.55 0.67 0.54 0.54
(0.025)' (0.03) (0.05) (0.024)' (0 .0 2 ) (0.04)
7 0.55 0.62 0.49 0.61 0.57 0.53
(0.03) (0 .0 2 ) (0.03) (0.03) (0 .0 2 ) (0.03)
8 0.52 0 . 6 6 0.48 0.62 0.59 0.59
(0 .0 2 )^ (0.03) (0.05) (0 .0 2 )" (0 .0 2 ) (0.04)
9 0.43
(0.03)'
0.55
(0.03)'
1 0 0.53
(0.05)
0.49
(0.04)
1 1 0.52
(0.06)
0.48
(0.06)
Means in a row sharing a common
a = P < 0.0001; b = P < 0.001: c =
superscript are significantly different.
P< 0.01
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HDL/total cholesterol in non diabetic rats
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Fig. 5.4 Effect o f beta-carotene supplement (5mg/Kg body weight, 3 times per 
week) on HDLC/cholesterol in non diabetic and control Wistar male rats.
Significance levels = **P<0.01;  * * * P <  0.001
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Ratio of HDL-C to total cholesterol in early-diabetic rats
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Fig. 5.5 Effect o f beta-carotene supplement (5mg/Kg body weight, 3 times per 
week) on HDL-C/cholesterol in early-diabetic and control Wistar male rats. 
Early-diabetic rats were supplemented with beta carotene after 2 days o f STZ 
administration intraperitoneally (60 mg/body weight).
Significance levels = **P<0.01;  0 . 0 0 0 1
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Table 5.8 Effect of p-carotene supplementatio on mean ± (SE) serum LDL-C (mmol/1)
in Wistar male rats
Control rats Beta-carotene supplemented rats
Weeks Non­ Early-STZ- Late-STZ- Non­ Early-STZ Late-STZ-
diabetic diabetic diabetic diabetic diabetic diabetic
No (15-12) (13-8) (12-7) (15-12) (25-19) (25-11)
0 0.52 0.51 0.51 0.51 0.51 0.53
(0 .0 2 2 ) (0.026) (0.034) (0 .0 2 2 ) (0.018) (0.024)
1 0.55 0.62 ---- 0.52 0.49 ----
(0.027) (0.029)' (0.023) (0.024)'
2 0.52 0.62 0.51 0.49 ----
(0.027) (0.03)’’ (0.023) (0 .0 2 ) ”
3 0.51 0 . 6 6 0.49 0.46 ----
(0.025) (0.03)’’ (0.023) (0 .0 2 ) ”
4 0.53 0 . 6 6 0.50 0.49
(0.025) (0.03) (0.023) (0 .0 2 )
5 0.54 0.65 0.55 0.48 0.58 0.53
(0.025) (0.03)” (0.034) (0.024) (0.023)” (0.029)
6 0.56 0.64 0.56 0.49 0.62 0.58
(0.025) (0.03) (0.034) (0.025) (0.023) (0.037)
7 0.57 0.63 0.60 0.49 0.63 0.54
(0.025) (0.03) (0.038) (0.027) (0.023) (0.038)
8 0.58 0.63 0.82 0.48 0 . 6 6 0.56
(0 .0 2 ) (0.03) (0.04) (0.025) (0.023) (0.04)
9 0.94 
(0.05) =
0.60 
(0.04) =
1 0 0.80
(0.045)'
0.59
(0.05)'
1 1 0.85
(0.048)
0.60
(0.05)
Means in a row sharing a common
a = P < 0.0001; b = P < 0.001; c =
superscript are significantly different.
P< 0.01
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Seum LDL concentrations in early-STZ-diabetic rats
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Fig. 5.6 Effect o f beta-carotene supplement (5 mg/Kg body weight, 3 times per week) on 
serum LDL concentrations in early-diabetic and control Wistar male rats. Early- diabetic 
rats were supplemented with beta-carotene 2 days after STZ administration 
intraperitoneally (60 mg/Kg body weight).
Significance level = **P<0.01;  * * * P <  0.001
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Serum LDL concentrations in late-STZ-diabetic rats
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Fig. 5.7 Eflfect beta-carotene supplement (5 mg/body weight, 3 times per day) on 
serum LDL concentrations in late-STZ-diabetic and control Wistar male rats. Late- 
diabetic rats were supplemented with beta-carotene for 5 weeks before STZ 
administration intraperitoneally (60 mg/Kg body weight).
Significance levels = **P<0.01;  0 . 0 0 0 1
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5.5 Discussion
Results o f  this study showed that in Wistar male STZ-diabetic rats, supplementation 
with P-carotene at 5 mg/kg body weight may result in a significant reduction in FBG 
and serum triglycerides in early- but not late-STZ-diabetic rats; in LDL-C 
concentrations in both early- and late-STZ-diabetic rats. The effect on total cholesterol 
was not significant except in the early 1-2 weeks in both early- and late-STZ-diabetic 
rats. In the non-diabetic rats, the data showed a significant decrease in HDL- 
cholesterol concentrations. However, because o f parallel changes in total cholesterol, 
HDL-C and LDL-C concentrations, the ratios o f HDL cholesterol to total cholesterol 
were significantly higher in the supplemented non-diabetic rats than in the controls in 
the last 4 weeks. In the early- and late STZ-diabetic rats, the HDL-C to  total 
cholesterol ratio was slightly or significantly increased by p-carotene supplement when 
compared to  their controls.
The sharp increase in FBG in the early-STZ-diabetic rats afl;er P-carotene 
supplementation could be related to the pro-oxidant effect P-carotene exhibits under 
certain non-physiological conditions (Burton and Ingold, 1984). It is possible that P- 
carotene might stimulate free radical production under the influence o f  STZ as it was 
supplemented simultaneously with STZ unlike the late- STZ-diabetic rats that were 
supplemented for 5 weeks before inducing diabetes.
It was observed that although P-carotene supplementation for 5 weeks before inducing 
diabetes was protective against diabetes in the late STZ-diabetic rats, the effect on 
reducing FBG, triglycerides and LDL was less significant than in the case o f  the early- 
STZ-diabetic rats. It is not clear why; it is possible that the P-carotene effect wears o ff 
as the body adjusts to it. A more plausible reason is that younger and leaner rats exhibit 
larger responses to P-carotene supplementation than rats with higher adipose tissues 
that require a higher dose o f  P-carotene to produce the same effect.
These results were consistent with several studies that pointed to the possibility that 
antioxidant supplementation may reduce FBG (Yamada et al, 1982; Shimizu et al., 
1991; Ceriello et al 1991; Davie et al, 1992; Paolisso et. al., 1993). Shimizu and 
coworkers reported a reduction in the degree o f  hyperglycaemia in STZ-induced
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diabetic mice when fed a 1% probucol-containing diet. In humans, 600 and 1200 mg/d 
o f vitamin E (Ceriello et al 1991), and vitamin C at 1 g/d (Davie et al, 1992) 
significantly lowered GHb whether in IDDM  patients (Ceriello et al 1991) or non­
diabetic subjects (Davie et al, 1992). Paolisso et. al., (1993) showed that 
supplementation with 900 mg dose a-tocopherol in NIDDM  subjects improved both 
glycémie control and insulin action. However, the results o f  the present study were in 
contrast to some other studies (Morel and Chisolm, 1989; ShofF et al, 1993; Reaven et 
al., 1995; Fuller et al., 1996). Morel, and Chisolm (1989) reported that neither vitamin 
E  nor probucol treatment for 6 - 8  weeks had any effect on hyperglycaemia. Shoff and 
associates found no relationship between p-carotene, vitamin E  or vitamin C and GHb. 
Fuller et al. (1996) and Reaven et al. (1995) showed that high-dose a-tocopherol 
supplementation (1200-1600 lU ) did not have any effect on protein glycation.
Retinol and retinoic acid were reported to cause hypertriglyceridaemia with high levels 
o f  intake (Dicken, 1981; Gerber and Erdman 1982; Lyons et. al., 1982; Ellis et al., 
1986). However, relatively few studies in the literature have reported the effects o f  
dietary p-carotene on serum lipid concentrations in animals or humans. Amen and 
Lachance (1974), suggested that a P-carotene supplement had a hypocholesterolaemic 
effect in rats fed either a cholesterol-fi’ee or a cholesterol-enriched diet. For an effect 
to  occur, the animal had to receive at least 300 jug o f  P-carotene per day. Conversely, 
rats fed high amounts o f P-carotene (2 mg/d) could have serum cholesterol as low as 
108 mg/ 1 0 0  ml. This amount was much higher than the amount o f P-carotene given to 
the rats in this study (5 mg/Kg body weight). The authors suggested that the effect was 
due to  the vitamin A activity o f p-carotene. Erdman, and Lachance (1974) compared 
the hypocholesterolaemic effect o f  similar levels o f lycopene, P-carotene, and retinol in 
hyperchloesterolaemic rats. All dietary lycopene levels, except 1650 pg/day resulted in 
an increased (P < 0.05) serum cholesterol when compared to  the control diet. Retinol 
at 1985 pg/day or 1916 pg/day o f  P-carotene under the same conditions significantly 
reduced (P < 0.05) serum cholesterol. In contrast with the findings o f  Fuller and 
associates (1996) who reported that supplementation o f  1632 mg/d o f  a-tocopherol 
did not show an effect on plasma lipid concentrations in both diabetes Type 1 and Type
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2, Paolisso et al (1993) and Khoja and Marzouki (1994) showed a decrease in serum 
lipid concentrations as a result o f a-tocopherol administration to Type 2 diabetic 
patients or hyperlipidémie rats respectively.
The significant or slight decrease in serum concentrations HDL-C in non-diabetic and 
STZ-diabetic rats respectively is consistent with the findings o f  Tsai and associates 
(1992) who reported that P-carotene supplementation at 500 mg/kg retinol-fortified 
and cholesterol-enriched diet for a period o f  44 days resulted in significant decreases in 
serum total, LDL-C and HDL-C concentrations and serum total VLDL and LDL 
triacylglycerol concentrations in hypertensive rats. These effects were generally 
correlated with the levels o f  P-carotene supplementation (Tsai et a l ,  1992). In our 
study and that o f Tsai and associates (1992) the ratio o f HDL-C to total cholesterol 
was not changed, slightly or significantly increased. Reduction in serum HDL-C levels 
may be mediated by a variety o f  factors such as modification o f  the activity o f  
lipoprotein lipase, or increased conversion o f P-carotene to retinol. Conversion o f p- 
carotene to  retinol may be not as effective in the diabetic state which may explain the 
significant decrease in HDL-cholesterol in non-diabetic rats. Vitamin A-related drugs 
had been reported to cause hypertriglyceridaemia, hypercholesterolaemia, and 
reduction in HDL-cholesterol levels (Dicken 1981, Bershad et. a l , 1985). Another 
factor that may contribute to  lower HDL-C is that P-carotene could influence serum 
lipids via alteration o f sex steroid hormones (Caffiaey e t al., 1990; R inger e t al.,
1991). It is known that sex steroids influence the activity o f  the hepatic and 
lipoprotein lipases (Ehnholm et a l , 1975). It generally is accepted that androgens 
increase the activity o f hepatic lipase and lead to  the reduction o f  HDL-cholesterol 
levels (Applebaum et a l ,  1977).
It is well known that p-carotene is highly lipid soluble, and the P-carotene is carried 
largely in the atherogenic low density lipoproteins (LDL) cholesterol fraction (75%) 
and with the putative cardioprotective HDL cholesterol (25%) (Krinsky et a l ,  1958; 
Marenah et. a l , 1983), and that a positive correlation between serum p-caro tene and 
total cholesterol has been found (Costantino et al, 1988). I f  there was a linear 
relationship between cholesterol or triglyceride transport and p-carotene levels, then 
one would expect increased serum cholesterol levels with increased p-caro tene
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absorption and transport. This is not what this study showed, although the decrease in 
cholesterol levels in both early- and late-STZ-diabetic was transient and non­
significant. It has been reported that liver cholesterol concentration showed an inverse 
relationship with dietary P-carotene and with liver P-carotene concentrations (Tsai et 
a l , 1992). Although the mechanism o f the hypolipidemic effect o f  dietary p-carotene, 
is unknown, these inverse relationships seem to suggest that P-carotene may play a 
role in altering the rate o f  cholesterol metabolism in the liver or the efficiency o f  
cholesterol absorption in the intestine.
Results o f this study raise the question o f whether dietary P-carotene might exhibit 
similar effects in humans. A limited number o f studies with humans suggest that oral 
P-carotene does not have a great impact on serum lipid concentrations. M athews-Roth 
and Gulbrandsen (1974) found no significant changes in serum cholesterol 
concentrations in VLDL, LDL and HDL o f five carotenemic subjects receiving 180 mg 
p-carotene/d for 1 0  weeks compared with five similar controls receiving placebos, 
although total plasma P-carotene concentration was markedly increased. In patients 
with protoporphyria, chronic oral administration o f  P-carotene has been shown to 
cause no consistent changes in serum trigylceride concentrations, and the mild 
hypertriglyceridemia that occurs in these patients was not a direct result o f  P-carotene 
therapy (Poh-Fitzpatrick and Palmer 1984). In a skin cancer prevention study, 
Nierenberg et a l ,  (1991) showed that oral administration o f  p-carotene (50 mg/d) for 
1 y had no effect on serum cholesterol concentrations compared with similar subjects 
receiving placebos. These studies suggests that the effects o f  oral p-carotene 
administration on lipid metabolism and serum lipid concentrations in humans are 
different from those observed in rats.
On the other hand, some recent studies have demonstrated that p-carotene 
supplementation increased serum HDL-cholesterol concentrations in normolipidemia 
subjects by 10 % but had no effect on total cholesterol, VLDL, LDL and triglycerides 
concentrations in humans (Bencich et a l , 1989, Ringer et a l ,  1991). However, the 
order o f  magnitude o f  increase o f  HDL-C levels in these studies (about 10%) is 
consistent with biologic (within-subject) and/or analytic variation (Bookstein et a l ,  
1990; M o g ad am e ta l, 1990).
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Calzada, et. al. (1995) investigated the effects o f the individual dosages o f vitamin E 
(300 mg), vitamin C (250 mg), P-carotene (15 mg) or combined supplement o f  vitamin 
E, vitamin C and P-carotene on their uptake in vivo in plasma and LDL in 50 human 
subjects Avith mean age o f 30 ±8 . 1  years and sex ratio o f  6/4 (M/F). The lipid profiles 
pre- and post-supplementation showed that the mean levels o f  cholesterol, LDL, HDL 
and triglyceride for each individual group were not significantly different from the 
mean levels o f the control. These differences between animal and human studies might 
be related to the large doses administered to these animal (Amen and Lachance, 1974) 
compared to the small doses given to humans if weight and height are taken into 
consideration (Nierenberg et al., 1991; Calzada, et. al., 1995). For example, the dose 
o f  p-carotene (5 mg/ Kg body weight) given to the rats in this study would represent ~ 
32 times the RDA/day o f vitamin A for the rat (National Research Council, 1972) and 
amounts to 350 mg for a 70 Kg man (RDA for vitamin A = 1000 fag/d); this dose 
might be toxic.
Hughes, et al. (1994) investigated the short-term effects o f high-dose p-carotene (300 
mg daily for 30 days) upon serum lipids, and lipoproteins in 59 adult patients with 
hyperlipidaemia and 36 healthy subjects. Total HDL-C levels increased by 10% (p < 
0.01) over baseline in all groups by day 14 but returned to baseline by day 30. Total 
cholesterol, LDL-C, and triglyceride levels transiently increased by up to  9%, 8 %, and 
2 0 %, respectively, only in the patients with hyperlipidaemia, but returned to  baseline 
on day 30.
In humans, a daily dose o f  2 0  mg P-carotene for 2 years has been shown to  increase 
serum KDL-C levels by up to  12.5% (C affiiey e t al., 1990). However, the 
supplemented group showed no significant changes in serum cholesterol or 
triglycerides (C affiiey e t al., 1990). Administration o f  P-carotene supplements (50 
mg on alternate days) to physicians with angina pectoris decreased the incidence o f 
angina in patients and reduced major coronary events (myocardial infarction or cardiac 
death) by 44% and stroke by 49% (Gaziano et al., 1990). In contrast, a recent study o f 
long-time male smokers given daily supplements o f 2 0  mg o f p-carotene for 6  years 
did not find a protective effect against ischematic heart disease or reduction in the 
incidence o f  lung cancer or in mortality(Alpha-tocopherol- Beta-carotene Cancer
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Prevention Study Group, 1994). Other studies raise the possibility that these 
supplements may actually have harmful effects. The Beta-carotene and Retinol Efficacy 
Trial (CARET) showed that in smokers, former smokers and asbestos workers treated 
for 4  four years with 30 mg P-carotene/day and 25000 lU  retinol/day, the treated 
group had a relative risk o f  lung cancer o f  1.28 as compared with placebo group, the 
relative risk o f  death from lung cancer o f 1.46 (Omenn et. al., 1996). On the basis o f  
these findings, the randomised trial was stopped 2 1  months earlier than planned.
It was reported that lipid peroxidation o f the polyunsaturated fatty acids in LDL only 
starts after the endogenous antioxidants such as a -  and y-tocopherol, P-carotene and 
lycopin have been consumed (Esterbauer et al., 1989). This observation pointed to the 
need to increase dietary intake o f  antioxidants to avoid this critical decrease in the 
antioxidants defences.
Tesfamariam (1994) postulated that increased plasma and tissue glucose is the 
proximal source o f  the increased oxidative stress apparent in diabetes. It is may be 
possible to assume that alleviating the increased oxidative stress by an antioxidant may 
help to normalise and attenuate serum GHb and lipid concentrations. The data o f  this 
study suggest that p-carotene supplementation to  W istar rats for 5 weeks before STZ 
administration might have a protective effect against diabetes. This result was similar 
to the observations reported by other studies in humans using nicotinamide (Yamada et 
al, 1982), and in BB rats using probucol (Drash et al., 1988), and in NOD mice using 
vitamin E  (Hayward et. al., 1992). However, other studies reported a non significant 
reduction in diabetes incidence in NOD mice (Heineke et al., 1993; Rabinovitch et al.,
1992).
In conclusion, the data o f  this study as well as current research suggest that 
supplementation with an antioxidant appears to be both hypoglycaemic, hypolipdemic, 
and confer some resistance to diabetes mellitus. Therefore, dietary supplementation o f  
human diets deserve careful consideration, and well controlled clinical trials are 
warranted.
CHAPTER SIX
GENERAL DISCUSSION
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6.1 Introduction
Our studies demonstrated many important aspects o f  diabetes-vitamin A 
interrelationships:
•  A significantly lower P-carotene in patients with Type 2 DM  compared to controls.
•  An elevation o f both serum and urine RBP levels in patients with Type 2 DM 
compared to controls. The increases in serum and urine RBP concentrations were 
more in patients with renal impairment and in patients with CRF.
•  There was a significant inverse relationship between p-carotene and glycaemic 
control as assessed by fasting blood glucose.
•  This relationship between P-carotene and FBG was re-evaluated in study 2 using 
HbAic as the glycaemic control. This relationship was inversely correlated, 
however the correlation was not significant.
•  Study 3 dealt with diabetes-vitamin A interrelationships in a different way; looking 
into the effect o f  P-carotene supplementation on diabetes instead o f looking into 
the effect o f DM  on vitamin A.
6.1.1 Retinol, RBP and caroteinoids in Type 1 and Type 2
Our studies showed that patients with Type 2 DM  had similar serum retinol and a -  
tocopherol concentrations when compared to controls. In contrast, patients with Type 
1 DM  had significantly lower plasma retinol and a-tocopherol concentrations when 
compared to  patients with Type 2 DM.
Plasma p-carotene concentrations were significantly lower in Type 2  diabetic patients 
when compared to controls. Type 1 diabetic patients had higher plasma concentrations 
o f  p-carotene than patients with Type 2 DM  but the difference was not statistically 
significant. Patients with Type 1 DM  exhibited a wider range o f  plasma concentrations 
o f  P-carotene than patients with Type 2 DM.
Urine data showed significant increased excretion o f  RBP and zinc concentrations in 
diabetic patients than controls and in diabetic patients with renal impairment when 
compared to  other diabetics, to diabetic patients with hypertension, or to controls.
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Urinary excretion o f  small proteins, such as RBP, is an expression o f  the functional 
integrity o f  the proximal tubules that normally reabsorb and metabolise the small MW  
proteins (Strober and Waldmann, 1974). This marked increase in the excretion o f  RBP 
indicates reduced capacity o f  the tubules to  reabsorb RBP due to  tubular dysfunction 
in these patients. RBP measurement in urine may therefore be useful in evaluating renal 
tubular function alteration.
Our findings o f lower plasma retinol and RBP concentrations in Type 1 diabetic was in 
agreement with some previous reports (Basu et al., 1989; Krempf et al., 1991; Pontuch 
et al., 1992).
The reason for the lower concentrations o f  plasma retinol in Type 1 DM  is unclear. 
The depressed plasma retinol levels in patients with Type 1 suggests that there may be 
an impaired mobilisation o f  the vitamin from the liver into the circulation, possibly due 
to  inadequate synthesis o f  RBP in the liver. Our study and other human studies showed 
there is a parallel decrease in plasma RBP with a decrease in plasma retinol (Basu et 
al., 1989; K rem pf et al., 1991; Martinoli et. al., 1993).
Lowered levels o f vitamin A have been linked with deficiency o f  zinc which is required 
for the synthesis o f  RBP (Smith, 1982). It is also possible that synthesis o f  RBP may 
be affected by depressed protein synthesis (Smith et. al., 1973a).
Figure 6 .1 outlines a number o f  different mechanisms that may cause a reduction in 
serum retinol in patients with Type 1 DM.
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Fig. 6.1 Possible mechanisms for reduction in serum retinol in DM
Anorexia, PEM  
Weight loss
Impaired mobilisation from liverDietary deficiency
Low Serum Retinol
Insulin deficiencyMalabsorption
Low fat diet Infection
Zinc deficiency
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6.1.2 Retinol and RBP in nephropathy
The highly elevated levels o f  serum and urine retinol and RBP in diabetic patients with 
nephropathy or CRF was in agreement with previous reports (Smith and Goodman, 
1971; Yatzidis et al., 1975; Vannucchi et al., 1992).
Factors that may be responsible for the observed increase in serum and urine retinol 
and RBP in patients with nephropathy or CRF (diabetic and non-diabetic):
♦ In the normal state, nephrons filter small free plasma RBP molecules and retains 
prealbumin and RBP- prealbumin complex. The filtered RBP is reabsorbed and 
catabolised by the renal tubular cells. In nephron-loss, both excretion and tubular 
catabolism o f low MW proteins are reduced. Thus, these proteins accumulate in 
the blood.
♦ The elevated plasma retinol in renal impairment and renal failure patients may be 
due to  reduced vitamin A excretion and decreased conversion o f retinol to retinoic 
acid, which is a fimction o f  the kidney.
♦ The simultaneous increase o f plasma retinol and RBP in patients with CRF is 
probably due to  an increase in hepatic up-regulation and increased release o f  retinol 
together with RBP and TTR into the circulation. It was suggested that renal failure 
results in a change in the signal for release o f  retinol-RBP into the circulation; that 
is the hepatic release mechanism set point is up-regulated by lack o f  renal function 
(Gerlach and Zile, 1990). In haemodialysis patients, the concomitant rise in both 
retinol and RBP prevents the binding o f  retinol to lipoprotein and this may prevent 
signs o f  hypervitaminosis (Mallia et al., 1975).
The significant positive correlation between FBG and excretion o f  RBP raises the 
possibility that poor glycaemic control may be important. The significant inverse 
correlation between urine RBP and urine creatinine concentrations suggest a 
relationship between RBP and renal function.
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Ayatse (1991) observed that serum RBP rose earlier than serum creatinine. Serum 
creatinine has been used to  answer whether the renal function is abnormal. However, it 
is known that serum creatinine appears abnormal only when up to 50% o f the nephrons 
have already been compromised. Serum RBP may therefore be suggested as a useful 
and more sensitive alternative to serum creatinine for monitoring changes in renal 
function when renal insufficiency has not progressed enough to be detected by serum 
creatinine. RBP may have another advantage o f  being independent o f sex and muscular 
mass.
Chronic liver diseases are associated with low serum RBP concentrations (Smith and 
Goodman, 1971), and in such cases the interpretation o f  RBP values in the assessment 
o f  renal function needs to be done with caution.
6.1.3 Effect of p-carotene supplementation on diabetes
The results o f the rat study (chapter 5) indicate that in male Wistar STZ-diabetic rats, 
P-carotene supplementation at 5 mg/kg body weight may have at least two, possibly 
separate, beneficial effects in diabetes - an effect on lipoprotein level and an effect on 
the development o f  diabetes following STZ. The effect on lipoprotein level - lower 
LDL-C, triglycerides, and higher HDL-C to total cholesterol ratio is similar to that 
observed in human studies. This indicates that the rats may be an appropriate model for 
studying the effect o f antioxidant vitamins on lipoprotein metabolism in diabetes.
Late-STZ-diabetic rats that had been treated for five weeks with P-carotene before 
STZ administration showed a lower incidence o f diabetes (59%, 10 o f 17) than early- 
STZ diabetic group (76%, 19 o f 25).
This protective effect against the induction o f  diabetes fi-om STZ suggests a possible 
therapeutic role for P-carotene. This may be due to  a number o f  different mechanisms. 
Young and associates (1995), observed that oxidative stress was increased in STZ- 
diabetic rats and then there was a depletion o f the nutritional antioxidants ascorbate, 
alpha-tocopherol, and retinol. Ceriello, et al, 1996 have suggested that high glucose
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levels might produce an oxidative stress in cells, which respond by increasing their 
antioxidant defences.
These observations have given rise to the numerous clinical therapies used in both the 
prevention o f  IDDM  and the complications o f diabetes. Nicotinamide and probucol 
have been used in preventing EDDM in prediabetic patients with impaired insulin 
secretion (Yamada et al, 1982) and to  reduce the prevalence o f  diabetes in BB rats 
(Drash et al, 1988).
The long-term complications o f  diabetes include both microvascular diseases 
(especially retinopathy and nephropathy) and macrovascular disease (accelerated 
atherosclerosis). The precise cause(s) o f the complications is unclear. Chronic 
hyperglycaemia may be a major risk factor for macrovascular complications in diabetes 
(Diabetes Control and Complications Trial Research Group, 1993). However, there is 
little evidence that glycaemic control is an important factor in the development o f  
macrovascular complication especially cardiovascular disease. A number o f  other 
factors are believed to  be involved.
Persons with DM  (Parving et. al., 1982) or high blood pressure (Parving et. al., 1974) 
may show increased rate o f urinary albumin excretion before they have developed 
kidney damage (albumin >30 mg/dl). This intermediate range (20-200 pg/min) o f  
albumin excretion rate (AER), designated “microalbuminuria” is a predictor not only 
o f nephropathy but also o f  increased mortality from cardiovascular disease (Mogensen, 
1984). The presence o f  microalbuminuria is believed to  indicate generalised endothelial 
dysfunction and hence the risk o f  arterial disease.
Our data shows a significantly increased urinary excretion o f  the low MW  RBP in 
diabetics, a sensitive index o f  proximal tubule function, even in the absence o f  renal 
impairment. Whether this abnormality in the renal function will be useful in predicting 
early nephropathy or selecting those diabetics at risk for nephropathy require further 
studies. Our data o f  increased urinary excretion o f  RBP are in accordance with other 
findings indicative o f  tubular dysfunction in diabetes (Holm et. al., 1987)
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The concept that oxidation o f lipoproteins might be an important factor in the 
development o f  diabetic complications was suggested by the studies o f  Sato and 
associates (1979), and that LDL needs to be altered chemically in some way to  cause 
atherogenic effect (Haberland and Fogelman, 1987; Sobenin et. al., 1996). Increased 
susceptibility o f  LDL to oxidation in diabetic patients with poor glycaemic control has 
been demonstrated in several studies (Asayama et al, 1993; Tsai et al, 1994). Evidence 
o f  lipid peroxidation has also been observed in a number o f  complications 
accompanying diabetes such as retinopathy, cataract formation and atherosclerosis 
(M urata et. al., 1981; Zigler and Hess, 1985; Mowri et. a l , 1986). In vitro, LDL does 
not become oxidised until its endogenous content o f  antioxidants has been depleted.
In rats, Tsai and associates (1992) observed that an increase in the level o f  dietary 
beta-carotene (250 or 500 mg/kg) resulted in generally progressive decreases in fasting 
serum total cholesterol, total triglyceride, serum LDL-C and HDL-C concentrations. 
HDL triglyceride concentrations were slightly but significantly increased with beta- 
carotene supplementation at the 125 mg/kg level but were not changed with higher 
levels o f supplementation.
In humans, a number o f studies have shown that high intakes o f beta-carotene have 
been shown to have no effect on serum lipid concentrations (M athews-Roth and 
Gulbrandsen 1974; Nierenberg et a l ,  1991). In contrast, some recent studies have 
demonstrated that vitamin E, vitamin C and P-carotene supplementation may, indeed, 
have an effect on lipoprotein levels in man. The most consistent effect appears to  be an 
increase in serum HDL-C concentrations (Bencich et a l , 1989, Caffney et a l ,  1990; 
Ringer et a l , 1991; Hughes, et al. 1994) with relatively little effect on total cholesterol, 
VLDL, LDL or triglycerides. However, a recent study o f  29,133 long-time male 
smokers 50-69 years o f  age given daily supplements o f 20 mg o f  P-carotene for 6 years 
did not find a protective effect against ischematic heart disease reduction, in the 
incidence o f lung cancer or in mortality (Alpha-tocopherol- Beta-carotene Cancer 
Prevention Study Group, 1994). Other studies raise the possibility that these 
supplements may actually have an adverse effects on the incidence o f  lung cancer. The 
Beta-carotene and Retinol Efficacy Trial (CARET), a placebo-controlled trial showed 
that in 29,000 Finnish male smokers and asbestos workers supplemented for 4 four
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years with 30 mg P-carotene/day and 25000 lU  retinol/day. This trial evaluated the 
combined treatment with P-carotene and retinol and found no benefits o f  such 
supplementation in terms o f  the incidence o f cancer or cardiovascular disease; indeed, 
they found somewhat higher rates o f  lung cancer and cardiovascular disease among 
subjects given P-carotene (Omenn et. al., 1996). On the basis o f  these findings, the 
randomised trial was stopped earlier than planned.
Nevertheless, oxidative damage, particularly oxidative modification o f LDL, is believed 
to be involved in both the initiation and promotion o f  coronary heart disease 
(Steinberg, 1993). Several cohort studies have examined the role o f  P-carotene in 
heart disease, and all have shown a risk reduction associated with the ingestion o f 
foods rich in P-carotene. A subgroup analysis within the Physicians’ Health Study, a 
double-blind, randomised, placebo-controlled trial involving administration o f  P- 
carotene supplements (50 mg on alternate days) to 333 male physicians (age 40-84 
years) with angina pectoris decreased the incidence o f  angina in patients and reduced 
major coronary events (myocardial infarction or cardiac death) by 44% and stroke by 
49% (Gaziano et al., 1990).
It was reported that lipid peroxidation o f  the polyunsaturated fatty acids in LDL only 
starts after the endogenous antioxidants such as a -  and y-tocopherol, p-carotene and 
lycopin have been consumed (Esterbauer et al., 1989). This observation pointed to the 
need to increase dietary intake o f  antioxidants to avoid this critical decrease in the 
antioxidant defences. It is may be possible to assume that alleviating the increased 
oxidative stress by an antioxidant may help to normalise and attenuate serum GHb and 
lipid concentrations and protect lipid from being oxidised..
These results suggested that the demand for the antioxidant P-carotene is increased in 
diabetes, and that dietary p-carotene should be sufficient to meet this demand. The 
results o f  the two diabetic studies (chapters 3 and 4) indicate that patients with 
diabetes are at a higher risk o f  antioxidant depletion.
A variety o f  free radical scavengers have been shown to protect animals against STZ- 
induced diabetes. Superoxide dismutase (SOD) for example, a scavenger o f  superoxide
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radicals, injected 10 seconds or 50 minutes before STZ significantly attenuated STZ- 
induced diabetes in rats (Gandy et al., 1982). Superoxide dismutase was reported to  
have a protective effect against both STZ-induced diabetes in rats (Robbins et al., 
1980) and alloxan-induced diabetes in mice (Grankvist et. al., 1981). However, Gold et 
al., (1981) questioned these observations and concluded that SOD treatment did not 
protect mice against STZ-induced diabetes.
Pre-treatment with dimethyl urea, an OH scavenger, given before streptozotocin, has 
been found to protect mice against the development o f hyperglycaemia, but does not 
prevent the development o f insulitis (Sandler and Andersson, 1982).
The finding that P-carotene protects against STZ-induced diabetes suggests that it may 
act at a membrane or biochemical site common to the diabetogenic action o f STZ. 
Although the primary mechanism o f the cytotoxic action o f streptozotocin is thought 
to be damage to DNA (Uchigata et al., 1982; Wilson et al., 1984), it may also cause 
other cellular effects (Uchigata et al., 1982). STZ may: also (1) alter the permeability 
o f cell membranes, (2) react with specific membrane glucose transport sites, and (3) 
increase the production o f free radicals (Gandy et al., 1982). These effects could be 
considered common steps in the pathway leading to beta cell damage.
The mechanism by which p-carotene may protect the rats from diabetes include
(1) a direct protective effect on the P-cell (2) interference with the production o f  the 
toxic oxygen radicals (3) stop harmfiil reactions.
Further studies o f  the susceptibility o f  islets to damage by oxygen radicals will be 
required to  distinguish between these possibilities.
Another possible explanation for the protective effect o f P-carotene is that P-carotene 
decreases STZ-induced toxicity from free radicals by stimulating fi-ee radical scavenger 
activity. I f  so, stimulation o f  superoxide dismutase, which is a scavenger o f superoxide 
radicals, could protect the islet fi"om free radical damage.
Chapter 6 162
6.2 Conclusions
In the present studies we attempted to establish whether changes in serum retinol and 
P-carotene were a generalised effect o f  DM  or specific to  a certain type o f  DM. We 
also wished to test the hypothesis that a p-carotene supplement may reduce FBG in 
Wistar male rats, and evaluate its effect on lipids in these rats. We also attempted to 
investigate whether the high excretion o f  RBP that had been observed in patients with 
DM  could be demonstrated in small groups o f  patients with different categories o f 
kidney problems. Although we have shed some light on these issues, further work is 
necessary before the questions can be clearly answered.
These studies indicate that levels o f  P-carotene may be reduced in patients with 
diabetes and that there is a significant negative correlation between P-carotene and 
glycaemic control as assessed by fasting blood glucose. W hether P-carotene should be 
considered as a therapeutic agent in diabetes requires further studies.
Although, the results o f  the Alpha-tocopherol- Beta-carotene Cancer Prevention Study 
Group (1994) and the Beta-carotene and Retinol Efficacy Trial raise the possibility that 
p-carotene supplements may be harmful, a human double blind placebo-controlled trial 
evaluating the effect o f  p-carotene supplementation in patients with DM  should be 
initiated. The effect in the diabetic state may actually be different.
Future studies should focus on the minimum p-carotene supplementation that 
decreases the susceptibility o f  LDL to oxidation in subjects with diabetes and should 
test the effects o f P-carotene on the progression o f vascular complications; given the 
increased oxidative burden that patients with diabetes endure.
Retinol and RBP were significantly lower in the comparatively small number Type 1 
diabetic patients. Patients with CRF (diabetic and non-diabetic) had extremely high 
concentrations o f retinol and RBP. Our data demonstrating increased excretion o f  RBP 
in association with a significant positive correlation with creatinine in diabetics indicate 
that renal tubular function is impaired early in the course o f  the disease. Furthermore, 
serum creatinine and total urine protein concentrations were positively associated with
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plasma RBP indicating that RBP may be dependent on renal function and changes in 
levels o f  RBP in serum or urine may be used in the assessment o f renal function.
The assay o f  RBP in urine proves to  be more advantageous than that o f P2- 
micoglobulin for two reasons. (1) RBP is more stable in acid urine and requires no 
precaution for the collection o f urine sample (Beetham et. a l , 1985) and (2) renal 
insufficiency is practically the only clinical situation susceptible to increase in the serum 
level o f RBP, whereas the increase in the serum level o f  p2-micoglobulin might be 
encountered in several non-renal diseases such as malignancy and the acquired 
immuno-deficiency syndrome
Our data demonstrated that patients with Type 2 diabetes mellitus excreted excessive 
amounts o f zinc. The correlation between FBG and urinary zinc, FBG and urinary RBP 
excretion might indicate that the hyperzincuria is caused by high FBG or that the cause 
is renal imbalance.
The data o f  this study as well as current research suggest that supplementation with an 
antioxidant appears to be both hypoglycaemic, hypolipidemic, and confer some 
resistance to diabetes mellitus. Therefore, dietary supplementation o f  human diets 
deserves careful consideration, and well controlled clinical trials are warranted.
The rising incidence o f NIDDM in Saudi Arabia warrants some measures that might 
alleviate the oxidation stress and help to  contain the disease and lessen its 
complications. Therefore, dietary supplementation o f P-carotene, proper diet, weight 
reduction and exercise should be encouraged. Patients should avoid smoking.
Studies determining how P-carotene interacts with STZ at the islet membrane or in 
subsequent biochemical reactions may prove helpful in further defining the 
pathogenesis o f streptozotocin-induced diabetes. Further studies are needed to  
determine whether retinoids can modify the development o f  diabetes in other animal 
models and, if so, in the prediabetic state in man.
In addition to  their potential effect on the development o f  diabetes, the effect o f  
antioxidants on the complications o f diabetes need to  be examined in greater detail
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This will provide insight to the mechanisms o f the complications and, in particular, the 
role o f  oxidative injury in their pathogenesis. In addition, it suggests the possibility that 
relatively simple, inexpensive measure may be effective in reducing the social and 
economic burden o f  diabetes and its complications.
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APPENDIX A
CHARTS OF THE HPLC 
QUALITY CONTROL DATA
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